data_6r96_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6r96 _Structure_validation_residue.Date_analyzed 2019-09-20 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.2 pt . . . . . 0 C--O 1.221 -0.431 0 N-CA-C 117.701 2.482 . . . . 0.0 117.701 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.0 mt -34.99 -45.34 0.26 Allowed 'General case' 0 C--N 1.344 0.365 0 N-CA-C 117.738 2.496 . . . . 0.0 117.738 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.93 -45.44 92.47 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 120.695 -1.253 . . . . 0.0 113.223 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.2 m -67.78 -31.92 72.13 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 120.113 -1.617 . . . . 0.0 114.077 171.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.63 -40.24 92.35 Favored 'General case' 0 CA--C 1.511 -0.529 0 O-C-N 119.235 -2.166 . . . . 0.0 113.375 170.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.4 -42.56 87.41 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 123.415 0.686 . . . . 0.0 111.156 169.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.84 -43.92 97.64 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 172.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -84.28 -41.96 16.33 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 120.25 -1.531 . . . . 0.0 113.968 -173.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -86.58 -18.92 30.23 Favored 'General case' 0 CA--C 1.503 -0.841 0 O-C-N 120.323 -1.486 . . . . 0.0 111.274 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -107.7 86.86 0.47 Allowed Glycine 0 N--CA 1.435 -1.401 0 CA-C-O 117.771 -1.572 . . . . 0.0 110.897 162.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -62.2 -27.64 78.65 Favored 'Trans proline' 0 CA--C 1.514 -0.487 0 CA-C-N 123.095 3.447 . . . . 0.0 109.242 157.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.9 mttt . . . . . 0 N--CA 1.445 -0.718 0 C-N-CA 123.859 0.864 . . . . 0.0 112.484 163.972 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.6 pt . . . . . 0 CA--C 1.512 -0.517 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.8 mt -59.43 -38.91 81.89 Favored 'General case' 0 C--N 1.345 0.404 0 O-C-N 120.053 -1.654 . . . . 0.0 113.725 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.26 99.15 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-O 122.55 1.166 . . . . 0.0 113.036 169.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.6 m -64.56 -39.15 93.23 Favored 'General case' 0 C--N 1.345 0.381 0 O-C-N 120.285 -1.509 . . . . 0.0 114.182 174.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.62 -38.42 90.95 Favored 'General case' 0 CA--C 1.51 -0.585 0 O-C-N 120.537 -1.352 . . . . 0.0 113.375 173.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.48 -39.57 80.37 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.862 0.865 . . . . 0.0 112.236 170.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.65 -48.13 67.56 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 168.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -72.55 -42.73 64.35 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -172.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -93.6 -9.26 38.65 Favored 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 120.57 -1.331 . . . . 0.0 110.042 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -120.62 75.19 0.33 Allowed Glycine 0 N--CA 1.434 -1.464 0 CA-C-O 117.694 -1.614 . . . . 0.0 112.584 169.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.81 -29.42 76.71 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 CA-C-N 123.022 3.411 . . . . 0.0 109.025 157.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.2 mtpp . . . . . 0 N--CA 1.445 -0.719 0 C-N-CA 125.736 1.614 . . . . 0.0 112.839 165.291 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.8 pt . . . . . 0 C--O 1.221 -0.403 0 N-CA-C 117.028 2.233 . . . . 0.0 117.028 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.8 mt -41.88 -43.07 2.92 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.57 -44.04 97.76 Favored 'General case' 0 C--N 1.351 0.661 0 O-C-N 120.686 -1.259 . . . . 0.0 113.004 172.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.1 m -67.38 -33.5 75.33 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 120.394 -1.442 . . . . 0.0 114.153 172.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.9 -42.49 90.16 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 119.739 -1.85 . . . . 0.0 113.315 171.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.1 -40.68 86.09 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 123.827 0.851 . . . . 0.0 111.331 170.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.02 -48.53 78.37 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 172.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -81.3 -45.92 15.49 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 119.463 -2.023 . . . . 0.0 112.729 -175.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -91.2 -8.5 48.37 Favored 'General case' 0 CA--C 1.5 -0.958 0 O-C-N 120.583 -1.323 . . . . 0.0 111.034 -173.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.8 81.58 0.38 Allowed Glycine 0 N--CA 1.439 -1.145 0 CA-C-O 117.625 -1.653 . . . . 0.0 110.626 156.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.07 -19.55 29.82 Favored 'Trans proline' 0 CA--C 1.512 -0.578 0 CA-C-N 123.895 3.847 . . . . 0.0 108.908 167.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? . . . . . 0 N--CA 1.44 -0.935 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 161.695 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.6 pt . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.1 mt -54.27 -40.15 67.54 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -173.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.35 -42.42 99.38 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-O 122.727 1.251 . . . . 0.0 112.801 171.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.2 m -68.68 -32.73 72.75 Favored 'General case' 0 C--N 1.343 0.323 0 O-C-N 120.192 -1.568 . . . . 0.0 114.387 173.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.8 mt -66.12 -40.1 90.42 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 119.429 -2.044 . . . . 0.0 112.981 171.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.44 -43.01 88.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.062 0.545 . . . . 0.0 111.324 168.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.19 -46.35 90.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 173.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -81.07 -44.02 18.62 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 120.8 -1.188 . . . . 0.0 114.127 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -85.86 -17.77 34.68 Favored 'General case' 0 CA--C 1.501 -0.933 0 O-C-N 120.336 -1.477 . . . . 0.0 111.111 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.46 85.35 0.41 Allowed Glycine 0 N--CA 1.435 -1.412 0 CA-C-O 117.804 -1.554 . . . . 0.0 110.633 163.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -62.45 -28.18 77.78 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 CA-C-N 123.071 3.435 . . . . 0.0 109.378 160.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.352 0.711 0 C-N-CA 123.153 0.581 . . . . 0.0 112.516 163.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.4 pt . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.7 mt -60.48 -35.23 75.42 Favored 'General case' 0 C--N 1.345 0.403 0 O-C-N 120.495 -1.378 . . . . 0.0 113.17 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.85 98.79 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-O 122.193 0.997 . . . . 0.0 112.646 169.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.1 m -64.02 -41.03 97.58 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 120.269 -1.52 . . . . 0.0 113.896 173.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.05 -42.11 99.65 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 120.85 -1.156 . . . . 0.0 113.095 173.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.77 -42.06 92.49 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.676 1.19 . . . . 0.0 112.55 173.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.72 -48.38 66.66 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 172.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -76.95 -45.67 26.82 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -173.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -105.03 -9.28 17.96 Favored 'General case' 0 CA--C 1.5 -0.944 0 O-C-N 121.198 -0.939 . . . . 0.0 110.329 -173.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -107.13 61.45 0.32 Allowed Glycine 0 CA--C 1.5 -0.867 0 CA-C-O 115.603 -2.776 . . . . 0.0 112.134 162.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -65.53 -23.24 57.7 Favored 'Trans proline' 0 N--CA 1.46 -0.493 1 CA-C-N 127.081 5.441 . . . . 0.0 110.714 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.352 0.699 0 C-N-CA 122.998 0.519 . . . . 0.0 112.171 165.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.3 pt . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.6 mt -50.94 -38.94 53.55 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.21 -42.94 99.76 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 120.657 -1.277 . . . . 0.0 113.011 171.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.6 m -68.41 -34.04 75.31 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 120.085 -1.635 . . . . 0.0 114.137 172.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.79 -38.12 89.91 Favored 'General case' 0 CA--C 1.508 -0.665 0 O-C-N 119.575 -1.953 . . . . 0.0 113.236 172.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.61 -39.57 77.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.646 0.778 . . . . 0.0 111.551 168.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.27 -47.87 77.91 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 170.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -77.61 -43.12 32.61 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -171.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -91.39 -14.63 30.32 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 120.628 -1.295 . . . . 0.0 110.49 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -112.76 81.2 0.29 Allowed Glycine 0 N--CA 1.437 -1.262 0 CA-C-O 118.474 -1.181 . . . . 0.0 111.317 164.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -62.9 -27.41 74.76 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 CA-C-N 122.151 2.975 . . . . 0.0 109.36 160.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.35 0.603 0 CA-C-O 121.303 0.573 . . . . 0.0 112.403 163.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.7 pt . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 117.137 2.273 . . . . 0.0 117.137 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 64.9 mt -52.13 -41.42 62.49 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -173.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.42 -44.85 95.45 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-O 122.794 1.283 . . . . 0.0 112.685 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.0 m -65.49 -38.6 90.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.982 1.313 . . . . 0.0 113.793 173.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.5 mt -64.32 -38.86 92.53 Favored 'General case' 0 CA--C 1.504 -0.793 0 O-C-N 120.536 -1.352 . . . . 0.0 113.954 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.69 -47.06 83.39 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.25 0.548 . . . . 0.0 111.232 173.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.74 -46.63 87.17 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 169.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.79 -38.4 70.29 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 118.061 -2.899 . . . . 0.0 115.833 -176.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -92.21 -22.24 19.92 Favored 'General case' 0 CA--C 1.496 -1.098 0 O-C-N 119.703 -1.873 . . . . 0.0 112.573 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.27 90.13 0.89 Allowed Glycine 0 CA--C 1.492 -1.38 0 CA-C-O 116.494 -2.281 . . . . 0.0 109.421 161.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -63.59 -27.82 69.57 Favored 'Trans proline' 0 CA--C 1.517 -0.373 1 CA-C-N 125.654 4.727 . . . . 0.0 109.882 170.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 89.7 mttt . . . . . 0 N--CA 1.445 -0.722 0 C-N-CA 125.953 1.701 . . . . 0.0 112.453 164.364 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.6 pt . . . . . 0 C--O 1.224 -0.24 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 62.4 mt -38.16 -46.1 1.01 Allowed 'General case' 0 C--N 1.347 0.462 0 C-N-CA 128.242 2.617 . . . . 0.0 117.571 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.53 -45.99 90.47 Favored 'General case' 0 C--N 1.35 0.602 0 O-C-N 120.702 -1.249 . . . . 0.0 113.123 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.3 m -65.76 -39.48 91.09 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 124.994 1.317 . . . . 0.0 113.456 171.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.3 mt -62.59 -36.66 83.42 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 120.718 -1.238 . . . . 0.0 113.634 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.58 -49.09 78.73 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 118.508 0.595 . . . . 0.0 111.795 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.88 -46.15 90.64 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 168.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.13 -38.41 82.16 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 118.642 -2.536 . . . . 0.0 116.589 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -94.48 -19.62 20.4 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 119.589 -1.944 . . . . 0.0 112.37 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.49 93.49 1.43 Allowed Glycine 0 CA--C 1.489 -1.549 0 CA-C-O 116.646 -2.196 . . . . 0.0 110.32 163.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.87 -25.87 67.41 Favored 'Trans proline' 0 C--N 1.328 -0.533 1 CA-C-N 125.779 4.79 . . . . 0.0 110.653 171.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.692 0 C-N-CA 124.068 0.947 . . . . 0.0 112.647 162.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.0 pt . . . . . 0 C--O 1.224 -0.284 0 N-CA-C 117.178 2.288 . . . . 0.0 117.178 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.6 mt -39.05 -43.69 1.03 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 127.744 2.417 . . . . 0.0 117.192 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.25 -43.12 99.56 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 120.512 -1.367 . . . . 0.0 113.309 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 m -69.47 -33.89 73.57 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 120.042 -1.661 . . . . 0.0 113.845 172.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.08 -36.84 85.6 Favored 'General case' 0 CA--C 1.509 -0.63 0 O-C-N 119.919 -1.738 . . . . 0.0 113.296 172.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.42 -42.35 82.19 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.776 0.831 . . . . 0.0 111.235 168.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.17 -49.39 77.38 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 168.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -76.64 -41.66 44.96 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -101.81 -5.51 24.76 Favored 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 120.32 -1.488 . . . . 0.0 111.107 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -112.57 82.33 0.3 Allowed Glycine 0 N--CA 1.437 -1.295 0 CA-C-O 118.644 -1.087 . . . . 0.0 110.73 164.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -62.59 -31.15 79.79 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 122.029 2.915 . . . . 0.0 109.659 162.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.8 mptt . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 162.6 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.6 pt . . . . . 0 N--CA 1.446 -0.631 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.7 mt -57.65 -37.05 72.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 120.344 -1.473 . . . . 0.0 114.415 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.48 -43.56 98.52 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-O 122.697 1.237 . . . . 0.0 112.606 169.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.2 m -66.06 -35.88 81.73 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 120.366 -1.458 . . . . 0.0 114.746 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.4 mt -65.91 -39.96 91.04 Favored 'General case' 0 CA--C 1.504 -0.801 0 O-C-N 119.63 -1.919 . . . . 0.0 113.189 172.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.17 89.23 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 122.965 0.506 . . . . 0.0 111.113 168.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.33 -46.05 91.86 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 173.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -83.89 -43.7 15.03 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 120.753 -1.217 . . . . 0.0 114.174 -173.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -85.01 -19.7 31.6 Favored 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 120.418 -1.426 . . . . 0.0 111.171 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.18 85.12 0.4 Allowed Glycine 0 N--CA 1.435 -1.367 0 CA-C-O 118.067 -1.407 . . . . 0.0 110.411 161.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -62.43 -31.04 80.95 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 CA-C-N 122.873 3.337 . . . . 0.0 109.056 160.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.443 -0.779 0 C-N-CA 124.746 1.218 . . . . 0.0 112.822 163.823 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.6 pt . . . . . 0 CA--C 1.513 -0.447 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.2 mt -33.1 -44.48 0.12 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 128.06 2.544 . . . . 0.0 117.821 174.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.72 96.11 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 120.582 -1.324 . . . . 0.0 113.155 174.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.2 m -70.7 -30.66 67.28 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.226 -1.546 . . . . 0.0 113.558 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.9 mt -66.96 -40.27 87.44 Favored 'General case' 0 CA--C 1.509 -0.597 0 O-C-N 119.525 -1.984 . . . . 0.0 113.559 170.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.7 -43.53 90.05 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.866 0.866 . . . . 0.0 111.317 169.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.2 -46.84 88.36 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 172.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -79.45 -44.05 22.11 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 120.282 -1.511 . . . . 0.0 114.679 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -85.88 -18.41 32.84 Favored 'General case' 0 CA--C 1.501 -0.928 0 O-C-N 120.156 -1.59 . . . . 0.0 111.177 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -107.2 85.11 0.41 Allowed Glycine 0 N--CA 1.436 -1.354 0 CA-C-O 117.365 -1.797 . . . . 0.0 110.321 162.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -62.27 -27.59 78.23 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 CA-C-N 123.579 3.69 . . . . 0.0 109.469 160.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.352 0.7 0 C-N-CA 123.829 0.851 . . . . 0.0 112.419 164.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.3 pt . . . . . 0 N--CA 1.447 -0.59 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.6 mt -55.95 -40.22 72.89 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.77 -42.93 97.7 Favored 'General case' 0 C--N 1.349 0.565 0 O-C-N 120.823 -1.173 . . . . 0.0 112.376 171.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.7 m -66.08 -35.98 81.98 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 174.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.0 mt -65.18 -42.01 94.06 Favored 'General case' 0 CA--C 1.506 -0.739 0 O-C-N 119.671 -1.893 . . . . 0.0 112.788 172.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.29 -42.4 91.2 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 123.327 0.651 . . . . 0.0 111.345 169.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.3 -47.83 82.54 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 174.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -84.9 -48.1 9.65 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 119.959 -1.713 . . . . 0.0 112.841 -173.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -84.56 -16.45 42.18 Favored 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 120.518 -1.364 . . . . 0.0 111.123 -175.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.47 84.89 0.47 Allowed Glycine 0 N--CA 1.436 -1.362 0 CA-C-O 117.8 -1.556 . . . . 0.0 111.089 159.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.29 -28.53 63.76 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 CA-C-N 123.461 3.63 . . . . 0.0 109.638 165.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? . . . . . 0 N--CA 1.445 -0.695 0 C-N-CA 122.921 0.488 . . . . 0.0 112.149 163.928 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.513 -0.479 0 N-CA-C 117.081 2.252 . . . . 0.0 117.081 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.1 mt -39.45 -42.32 1.09 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 127.667 2.387 . . . . 0.0 116.987 177.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.95 -43.72 98.25 Favored 'General case' 0 C--N 1.35 0.616 0 O-C-N 120.624 -1.298 . . . . 0.0 112.967 173.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.5 m -71.84 -29.27 64.23 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 120.199 -1.563 . . . . 0.0 113.741 172.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.57 -38.95 88.15 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 119.362 -2.086 . . . . 0.0 113.315 170.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.21 -41.78 84.79 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.536 0.734 . . . . 0.0 111.015 168.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.01 -47.27 87.21 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 172.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -80.52 -42.66 22.07 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -173.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -86.39 -18.76 30.97 Favored 'General case' 0 CA--C 1.502 -0.871 0 O-C-N 120.287 -1.508 . . . . 0.0 110.983 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -111.94 85.43 0.39 Allowed Glycine 0 N--CA 1.435 -1.377 0 CA-C-O 118.075 -1.403 . . . . 0.0 111.212 164.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -61.88 -29.54 82.64 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 CA-C-N 122.508 3.154 . . . . 0.0 109.264 157.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.3 mttt . . . . . 0 N--CA 1.445 -0.705 0 C-N-CA 124.136 0.974 . . . . 0.0 112.461 163.654 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.254 45.2 pt . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 20.6 mt -35.41 -33.72 0.03 OUTLIER 'General case' 0 C--N 1.356 0.851 0 C-N-CA 129.311 3.044 . . . . 0.0 118.35 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.64 85.96 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-O 123.026 1.393 . . . . 0.0 112.619 171.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.9 p -77.4 -19.23 56.45 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 120.301 -1.499 . . . . 0.0 113.402 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.6 mt -65.84 -39.19 90.55 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 120.188 -1.57 . . . . 0.0 112.478 169.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.55 -44.07 89.54 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 121.867 -0.521 . . . . 0.0 111.531 168.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.29 -40.26 93.48 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 174.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -89.75 -46.88 8.28 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -93.47 -9.13 39.54 Favored 'General case' 0 CA--C 1.492 -1.271 0 O-C-N 120.503 -1.373 . . . . 0.0 112.039 -172.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.77 82.6 0.3 Allowed Glycine 0 N--CA 1.43 -1.727 0 O-C-N 121.144 -0.973 . . . . 0.0 111.41 170.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -65.11 -32.13 53.35 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 CA-C-N 123.289 3.544 . . . . 0.0 110.256 157.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.7 tptm . . . . . 0 C--N 1.348 0.522 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 166.228 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 CA--C 1.511 -0.543 0 N-CA-C 117.034 2.235 . . . . 0.0 117.034 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 62.8 mt -53.72 -38.77 64.64 Favored 'General case' 0 C--N 1.344 0.368 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.98 97.81 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-O 122.46 1.124 . . . . 0.0 112.772 170.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.8 m -67.85 -35.44 78.57 Favored 'General case' 0 C--N 1.343 0.32 0 O-C-N 120.178 -1.577 . . . . 0.0 114.5 174.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.2 mt -65.45 -39.17 91.71 Favored 'General case' 0 CA--C 1.509 -0.63 0 O-C-N 119.733 -1.854 . . . . 0.0 113.391 172.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.1 -39.2 78.02 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.622 0.769 . . . . 0.0 111.356 168.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.49 -48.77 71.44 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 170.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -77.59 -42.67 34.29 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 120.775 -1.203 . . . . 0.0 114.111 -171.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -94.93 -7.75 39.06 Favored 'General case' 0 CA--C 1.502 -0.9 0 O-C-N 120.769 -1.207 . . . . 0.0 110.105 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -117.38 78.8 0.29 Allowed Glycine 0 N--CA 1.432 -1.59 0 CA-C-O 117.215 -1.881 . . . . 0.0 111.184 161.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -62.62 -35.94 67.1 Favored 'Trans proline' 0 CA--C 1.512 -0.588 0 CA-C-N 123.607 3.703 . . . . 0.0 109.351 167.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.703 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 166.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.4 pt . . . . . 0 C--O 1.223 -0.325 0 N-CA-C 117.19 2.293 . . . . 0.0 117.19 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.8 mt -39.93 -42.68 1.39 Allowed 'General case' 0 C--N 1.343 0.311 0 C-N-CA 127.754 2.422 . . . . 0.0 117.356 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.92 -43.45 98.82 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 120.592 -1.318 . . . . 0.0 113.191 173.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.2 m -70.73 -31.33 68.13 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 119.902 -1.749 . . . . 0.0 113.873 171.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.66 -36.44 82.55 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 119.261 -2.15 . . . . 0.0 113.41 171.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.03 -38.93 77.16 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.817 0.847 . . . . 0.0 111.465 168.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.57 76.9 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 169.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -77.31 -41.92 38.77 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -170.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -95.05 -5.55 44.15 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 120.627 -1.296 . . . . 0.0 110.177 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -122.58 81.34 0.35 Allowed Glycine 0 N--CA 1.43 -1.705 0 CA-C-O 117.713 -1.604 . . . . 0.0 110.673 164.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.47 -34.33 86.15 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 CA-C-N 122.719 3.259 . . . . 0.0 109.688 164.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.665 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 165.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.8 pt . . . . . 0 CA--C 1.511 -0.536 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.56 -39.0 82.62 Favored 'General case' 0 C--N 1.346 0.425 0 O-C-N 119.953 -1.717 . . . . 0.0 113.599 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.15 -42.87 99.67 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-O 122.507 1.146 . . . . 0.0 112.79 169.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.1 m -63.96 -39.27 93.75 Favored 'General case' 0 C--N 1.345 0.395 0 O-C-N 120.426 -1.421 . . . . 0.0 114.275 174.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.8 mt -64.6 -40.97 96.47 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 120.421 -1.424 . . . . 0.0 113.132 173.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.32 -44.66 88.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.318 0.58 . . . . 0.0 111.519 171.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.88 -45.82 87.68 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 171.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.84 -25.76 19.73 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 118.416 -2.677 . . . . 0.0 114.356 -169.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -99.17 -12.35 20.54 Favored 'General case' 0 CA--C 1.498 -1.024 0 O-C-N 119.548 -1.97 . . . . 0.0 111.209 173.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.68 83.36 0.36 Allowed Glycine 0 N--CA 1.438 -1.176 0 CA-C-O 117.159 -1.912 . . . . 0.0 109.832 157.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -63.06 -29.92 75.45 Favored 'Trans proline' 0 CA--C 1.517 -0.35 1 CA-C-N 124.468 4.134 . . . . 0.0 110.093 168.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--N 1.353 0.747 0 C-N-CA 123.815 0.846 . . . . 0.0 111.887 164.364 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.5 pt . . . . . 0 N--CA 1.446 -0.675 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 64.5 mt -59.56 -38.47 81.18 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 120.122 -1.611 . . . . 0.0 114.671 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.5 -44.67 95.8 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-O 122.805 1.288 . . . . 0.0 112.137 170.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.5 m -63.92 -38.92 92.87 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.952 1.301 . . . . 0.0 114.174 175.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.71 -41.2 92.59 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 125.215 1.406 . . . . 0.0 113.817 175.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.72 -45.91 88.54 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-O 121.888 0.852 . . . . 0.0 111.115 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.44 -48.21 80.67 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 170.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -72.24 -43.52 64.26 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 118.012 -2.93 . . . . 0.0 115.161 -177.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -85.33 -24.12 27.78 Favored 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 120.132 -1.605 . . . . 0.0 112.165 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.2 92.72 0.95 Allowed Glycine 0 CA--C 1.492 -1.389 0 CA-C-O 116.616 -2.213 . . . . 0.0 110.026 167.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -63.7 -28.46 68.82 Favored 'Trans proline' 0 C--N 1.329 -0.484 1 CA-C-N 125.269 4.535 . . . . 0.0 110.028 164.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm . . . . . 0 C--N 1.35 0.626 0 C-N-CA 125.203 1.401 . . . . 0.0 112.828 164.426 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.5 pt . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.0 mt -52.64 -40.04 62.39 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -174.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.81 -44.42 96.89 Favored 'General case' 0 C--N 1.35 0.596 0 CA-C-O 122.621 1.201 . . . . 0.0 112.772 172.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.7 m -67.42 -33.9 76.12 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 120.49 -1.381 . . . . 0.0 113.948 173.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.4 mt -65.01 -40.77 95.38 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 119.968 -1.708 . . . . 0.0 113.462 172.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.03 -45.71 90.04 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.461 0.648 . . . . 0.0 111.103 171.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.51 -45.71 93.04 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 172.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.29 -47.72 26.58 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 118.312 -2.742 . . . . 0.0 114.86 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -97.03 -8.98 29.05 Favored 'General case' 0 CA--C 1.498 -1.052 0 O-C-N 120.28 -1.513 . . . . 0.0 111.491 -169.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.31 92.69 0.94 Allowed Glycine 0 N--CA 1.435 -1.415 0 CA-C-O 117.5 -1.722 . . . . 0.0 109.449 158.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.69 -28.78 69.01 Favored 'Trans proline' 0 C--N 1.329 -0.497 0 CA-C-N 123.876 3.838 . . . . 0.0 109.493 160.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt . . . . . 0 C--N 1.351 0.639 0 C-N-CA 123.471 0.708 . . . . 0.0 112.641 164.032 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.313 20.7 pt . . . . . 0 C--O 1.225 -0.196 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 53.6 mt -51.42 -33.62 31.25 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 120.24 -1.538 . . . . 0.0 114.731 174.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.13 -39.67 79.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.759 0.79 . . . . 0.0 111.856 173.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.5 m -64.91 -35.97 82.86 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 120.522 -1.361 . . . . 0.0 114.343 171.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.0 mt -62.9 -45.48 92.31 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 120.269 -1.519 . . . . 0.0 112.875 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.63 -21.67 59.33 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 120.968 -1.083 . . . . 0.0 113.804 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.89 -31.08 23.9 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 119.51 -1.994 . . . . 0.0 113.739 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -97.83 -31.52 12.18 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 120.272 -1.517 . . . . 0.0 111.352 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -110.11 9.17 24.09 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 120.457 -1.402 . . . . 0.0 110.879 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -141.7 46.47 0.89 Allowed Glycine 0 C--N 1.348 1.22 0 CA-C-O 117.827 -1.54 . . . . 0.0 116.062 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -62.33 -22.54 74.25 Favored 'Trans proline' 0 CA--C 1.515 -0.433 0 CA-C-N 122.921 3.361 . . . . 0.0 113.199 -172.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.353 0.757 0 CA-C-N 118.653 0.661 . . . . 0.0 111.996 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 43.5 p90 . . . . . 0 N--CA 1.438 -1.038 0 CA-C-O 120.9 0.381 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 68.17 160.06 0.14 Allowed Pre-proline 0 C--N 1.355 0.824 0 C-N-CA 123.947 0.899 . . . . 0.0 111.896 -171.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -65.6 -167.17 0.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 O-C-N 117.226 -2.039 . . . . 0.0 111.125 151.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.2 pt -49.02 -28.27 2.41 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 N-CA-C 117.701 2.482 . . . . 0.0 117.701 -170.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.0 mt -34.99 -45.34 0.26 Allowed 'General case' 0 C--N 1.344 0.365 0 N-CA-C 117.738 2.496 . . . . 0.0 117.738 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.93 -45.44 92.47 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 120.695 -1.253 . . . . 0.0 113.223 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.2 m -67.78 -31.92 72.13 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 120.113 -1.617 . . . . 0.0 114.077 171.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.63 -40.24 92.35 Favored 'General case' 0 CA--C 1.511 -0.529 0 O-C-N 119.235 -2.166 . . . . 0.0 113.375 170.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.4 -42.56 87.41 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 123.415 0.686 . . . . 0.0 111.156 169.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.84 -43.92 97.64 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 172.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -84.28 -41.96 16.33 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 120.25 -1.531 . . . . 0.0 113.968 -173.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -86.58 -18.92 30.23 Favored 'General case' 0 CA--C 1.503 -0.841 0 O-C-N 120.323 -1.486 . . . . 0.0 111.274 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -107.7 86.86 0.47 Allowed Glycine 0 N--CA 1.435 -1.401 0 CA-C-O 117.771 -1.572 . . . . 0.0 110.897 162.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -62.2 -27.64 78.65 Favored 'Trans proline' 0 CA--C 1.514 -0.487 0 CA-C-N 123.095 3.447 . . . . 0.0 109.242 157.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -60.16 -47.85 84.19 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 123.859 0.864 . . . . 0.0 112.484 163.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.4 mt -68.79 -43.39 75.76 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.79 -37.03 83.77 Favored 'General case' 0 C--N 1.347 0.459 0 O-C-N 119.175 -2.203 . . . . 0.0 113.464 176.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 54.2 tp -88.51 -60.87 1.84 Allowed 'General case' 0 C--N 1.35 0.611 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.21 -46.51 77.47 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 C-N-CA 125.434 1.494 . . . . 0.0 111.783 -173.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.8 m -100.91 -1.67 33.97 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-O 122.357 1.075 . . . . 0.0 110.334 -174.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 55.07 45.62 25.81 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 125.716 1.606 . . . . 0.0 114.748 175.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -97.39 2.56 50.63 Favored 'General case' 0 CA--C 1.514 -0.442 0 O-C-N 118.831 -2.418 . . . . 0.0 113.622 -176.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 5.2 p90 . . . . . 0 N--CA 1.443 -0.808 0 CA-C-O 121.229 0.538 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.402 HD21 ' H ' ' A' ' 2' ' ' LEU . 1.5 mm? -45.98 148.7 1.37 Allowed Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 167.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -80.68 -23.01 6.1 Favored 'Trans proline' 0 CA--C 1.515 -0.45 0 CA-C-N 122.153 1.805 . . . . 0.0 109.518 -174.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.6 pt -54.17 -17.06 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 176.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.8 mt -59.43 -38.91 81.89 Favored 'General case' 0 C--N 1.345 0.404 0 O-C-N 120.053 -1.654 . . . . 0.0 113.725 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.26 99.15 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-O 122.55 1.166 . . . . 0.0 113.036 169.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.6 m -64.56 -39.15 93.23 Favored 'General case' 0 C--N 1.345 0.381 0 O-C-N 120.285 -1.509 . . . . 0.0 114.182 174.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.62 -38.42 90.95 Favored 'General case' 0 CA--C 1.51 -0.585 0 O-C-N 120.537 -1.352 . . . . 0.0 113.375 173.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.48 -39.57 80.37 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.862 0.865 . . . . 0.0 112.236 170.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.65 -48.13 67.56 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 168.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -72.55 -42.73 64.35 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -172.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -93.6 -9.26 38.65 Favored 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 120.57 -1.331 . . . . 0.0 110.042 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -120.62 75.19 0.33 Allowed Glycine 0 N--CA 1.434 -1.464 0 CA-C-O 117.694 -1.614 . . . . 0.0 112.584 169.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.81 -29.42 76.71 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 CA-C-N 123.022 3.411 . . . . 0.0 109.025 157.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.2 mtpp -59.6 -45.77 90.92 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.736 1.614 . . . . 0.0 112.839 165.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.7 mp -68.65 -46.1 70.05 Favored 'General case' 0 C--N 1.354 0.761 0 O-C-N 121.031 -1.043 . . . . 0.0 111.934 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -74.71 -10.78 59.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 120.534 -1.354 . . . . 0.0 114.622 -168.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.4 mp -101.92 -58.8 1.81 Allowed 'General case' 0 C--N 1.349 0.555 0 C-N-CA 124.305 1.042 . . . . 0.0 108.453 169.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.4 t -57.02 -37.78 56.73 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 C-N-CA 127.309 2.244 . . . . 0.0 114.207 -165.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 m -141.56 32.53 1.65 Allowed 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 119.471 -2.018 . . . . 0.0 108.768 169.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.2 ptmm? 31.94 58.17 0.34 Allowed 'General case' 0 C--N 1.347 0.475 0 N-CA-C 119.274 3.065 . . . . 0.0 119.274 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -96.21 14.98 22.24 Favored 'General case' 0 C--O 1.224 -0.25 0 O-C-N 119.899 -1.751 . . . . 0.0 112.073 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 39.5 p90 . . . . . 0 N--CA 1.44 -0.943 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.1 mp 70.12 160.89 0.15 Allowed Pre-proline 0 C--N 1.354 0.791 0 C-N-CA 123.774 0.829 . . . . 0.0 112.087 -173.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -66.97 -160.96 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.773 0 O-C-N 117.797 -1.738 . . . . 0.0 111.551 152.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.8 pt -49.58 -27.86 3.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 N-CA-C 117.028 2.233 . . . . 0.0 117.028 -171.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.8 mt -41.88 -43.07 2.92 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.57 -44.04 97.76 Favored 'General case' 0 C--N 1.351 0.661 0 O-C-N 120.686 -1.259 . . . . 0.0 113.004 172.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.1 m -67.38 -33.5 75.33 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 120.394 -1.442 . . . . 0.0 114.153 172.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.9 -42.49 90.16 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 119.739 -1.85 . . . . 0.0 113.315 171.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.1 -40.68 86.09 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 123.827 0.851 . . . . 0.0 111.331 170.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.02 -48.53 78.37 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 172.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -81.3 -45.92 15.49 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 119.463 -2.023 . . . . 0.0 112.729 -175.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -91.2 -8.5 48.37 Favored 'General case' 0 CA--C 1.5 -0.958 0 O-C-N 120.583 -1.323 . . . . 0.0 111.034 -173.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.8 81.58 0.38 Allowed Glycine 0 N--CA 1.439 -1.145 0 CA-C-O 117.625 -1.653 . . . . 0.0 110.626 156.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.07 -19.55 29.82 Favored 'Trans proline' 0 CA--C 1.512 -0.578 0 CA-C-N 123.895 3.847 . . . . 0.0 108.908 167.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -66.76 -45.77 77.48 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 161.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.7 mt -66.05 -41.85 90.3 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.28 18.51 9.45 Favored 'General case' 0 C--N 1.343 0.302 0 O-C-N 119.502 -1.999 . . . . 0.0 113.189 -177.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 58.4 tp -120.59 -71.49 0.73 Allowed 'General case' 0 C--N 1.353 0.729 0 C-N-CA 124.685 1.194 . . . . 0.0 110.159 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.5 t -62.05 -43.24 97.42 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 126.799 2.04 . . . . 0.0 110.91 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.4 m -121.44 137.06 54.88 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -79.54 72.19 6.18 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 119.915 -1.741 . . . . 0.0 114.64 171.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -99.59 -1.92 36.97 Favored 'General case' 0 C--N 1.348 0.532 0 O-C-N 119.27 -2.144 . . . . 0.0 111.202 167.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 39.5 t80 . . . . . 0 N--CA 1.44 -0.955 0 CA-C-O 122.071 0.938 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.1 mp -140.86 160.75 57.33 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 101.306 -3.59 . . . . 0.0 101.306 168.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -93.44 -133.57 0.01 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.485 0 N-CA-C 107.326 -1.836 . . . . 0.0 107.326 167.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.6 pt -49.74 -27.91 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.1 mt -54.27 -40.15 67.54 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -173.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.35 -42.42 99.38 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-O 122.727 1.251 . . . . 0.0 112.801 171.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.2 m -68.68 -32.73 72.75 Favored 'General case' 0 C--N 1.343 0.323 0 O-C-N 120.192 -1.568 . . . . 0.0 114.387 173.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.8 mt -66.12 -40.1 90.42 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 119.429 -2.044 . . . . 0.0 112.981 171.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.44 -43.01 88.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.062 0.545 . . . . 0.0 111.324 168.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.19 -46.35 90.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 173.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -81.07 -44.02 18.62 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 120.8 -1.188 . . . . 0.0 114.127 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -85.86 -17.77 34.68 Favored 'General case' 0 CA--C 1.501 -0.933 0 O-C-N 120.336 -1.477 . . . . 0.0 111.111 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.46 85.35 0.41 Allowed Glycine 0 N--CA 1.435 -1.412 0 CA-C-O 117.804 -1.554 . . . . 0.0 110.633 163.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -62.45 -28.18 77.78 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 CA-C-N 123.071 3.435 . . . . 0.0 109.378 160.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.32 -46.53 89.9 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 123.153 0.581 . . . . 0.0 112.516 163.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.5 mt -66.99 -43.06 83.94 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 120.61 -1.307 . . . . 0.0 114.395 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -31.85 71.43 Favored 'General case' 0 C--N 1.346 0.452 0 O-C-N 119.016 -2.302 . . . . 0.0 113.619 175.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -89.48 -56.76 3.13 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.76 -47.02 78.52 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 C-N-CA 125.23 1.412 . . . . 0.0 111.478 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.3 m -103.85 -0.6 28.95 Favored 'General case' 0 C--N 1.346 0.417 0 O-C-N 120.868 -1.145 . . . . 0.0 110.656 -172.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 56.2 50.11 14.1 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 173.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -106.97 15.75 25.0 Favored 'General case' 0 CA--C 1.514 -0.404 0 O-C-N 119.311 -2.118 . . . . 0.0 112.85 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 34.9 p90 . . . . . 0 N--CA 1.442 -0.84 0 CA-C-O 121.506 0.67 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 64.1 mt -43.71 144.6 1.35 Allowed Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 171.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -81.16 -28.09 2.6 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 O-C-N 117.722 -1.778 . . . . 0.0 109.591 -171.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.4 pt -53.71 -17.62 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 174.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.7 mt -60.48 -35.23 75.42 Favored 'General case' 0 C--N 1.345 0.403 0 O-C-N 120.495 -1.378 . . . . 0.0 113.17 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.85 98.79 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-O 122.193 0.997 . . . . 0.0 112.646 169.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.1 m -64.02 -41.03 97.58 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 120.269 -1.52 . . . . 0.0 113.896 173.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.05 -42.11 99.65 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 120.85 -1.156 . . . . 0.0 113.095 173.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.77 -42.06 92.49 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.676 1.19 . . . . 0.0 112.55 173.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.72 -48.38 66.66 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 172.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -76.95 -45.67 26.82 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -173.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -105.03 -9.28 17.96 Favored 'General case' 0 CA--C 1.5 -0.944 0 O-C-N 121.198 -0.939 . . . . 0.0 110.329 -173.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -107.13 61.45 0.32 Allowed Glycine 0 CA--C 1.5 -0.867 0 CA-C-O 115.603 -2.776 . . . . 0.0 112.134 162.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -65.53 -23.24 57.7 Favored 'Trans proline' 0 N--CA 1.46 -0.493 1 CA-C-N 127.081 5.441 . . . . 0.0 110.714 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -47.28 85.76 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 122.998 0.519 . . . . 0.0 112.171 165.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.48 -44.56 86.72 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 121.227 -0.921 . . . . 0.0 111.894 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -60.88 -41.53 96.17 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 124.081 0.952 . . . . 0.0 112.935 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.4 mp -73.07 -43.44 61.87 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 119.932 -1.73 . . . . 0.0 112.282 176.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.23 -41.02 81.05 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 O-C-N 121.078 -1.014 . . . . 0.0 111.98 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.7 p -134.57 148.42 50.45 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 119.916 -1.74 . . . . 0.0 112.131 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -76.12 84.97 2.97 Favored 'General case' 0 C--N 1.344 0.35 0 O-C-N 117.768 -3.083 . . . . 0.0 112.643 172.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.46 -3.6 22.32 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 119.836 -1.79 . . . . 0.0 109.164 158.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 37.2 t80 . . . . . 0 N--CA 1.437 -1.104 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -45.3 159.15 0.29 Allowed Pre-proline 0 C--N 1.349 0.584 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 156.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -88.02 -155.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.451 0 N-CA-C 108.525 -1.375 . . . . 0.0 108.525 165.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.3 pt -49.08 -28.14 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 127.438 2.295 . . . . 0.0 116.881 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.6 mt -50.94 -38.94 53.55 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.21 -42.94 99.76 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 120.657 -1.277 . . . . 0.0 113.011 171.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.6 m -68.41 -34.04 75.31 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 120.085 -1.635 . . . . 0.0 114.137 172.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.79 -38.12 89.91 Favored 'General case' 0 CA--C 1.508 -0.665 0 O-C-N 119.575 -1.953 . . . . 0.0 113.236 172.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.61 -39.57 77.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.646 0.778 . . . . 0.0 111.551 168.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.27 -47.87 77.91 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 170.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -77.61 -43.12 32.61 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -171.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -91.39 -14.63 30.32 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 120.628 -1.295 . . . . 0.0 110.49 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -112.76 81.2 0.29 Allowed Glycine 0 N--CA 1.437 -1.262 0 CA-C-O 118.474 -1.181 . . . . 0.0 111.317 164.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -62.9 -27.41 74.76 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 CA-C-N 122.151 2.975 . . . . 0.0 109.36 160.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.45 -46.98 87.78 Favored 'General case' 0 C--N 1.35 0.603 0 CA-C-O 121.303 0.573 . . . . 0.0 112.403 163.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.0 mp -67.4 -44.4 78.92 Favored 'General case' 0 C--N 1.35 0.626 0 O-C-N 120.946 -1.096 . . . . 0.0 113.654 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.35 -18.29 55.34 Favored 'General case' 0 C--N 1.348 0.514 0 O-C-N 119.066 -2.272 . . . . 0.0 114.208 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 51.6 tp -90.12 -63.9 1.21 Allowed 'General case' 0 C--N 1.349 0.571 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.5 t -64.91 -46.63 91.18 Favored 'Isoleucine or valine' 0 C--N 1.35 0.587 0 C-N-CA 126.639 1.976 . . . . 0.0 111.96 -171.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.1 m -103.67 2.32 33.01 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-O 122.696 1.236 . . . . 0.0 110.075 -176.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.88 44.53 25.72 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.994 1.717 . . . . 0.0 115.242 167.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -104.15 7.63 36.23 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 119.208 -2.183 . . . . 0.0 113.342 -176.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 CA--C 1.504 -0.801 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -109.74 159.05 33.07 Favored Pre-proline 0 N--CA 1.437 -1.091 0 N-CA-C 103.023 -2.954 . . . . 0.0 103.023 162.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -87.62 -151.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.382 0 N-CA-C 108.198 -1.501 . . . . 0.0 108.198 162.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.7 pt -50.12 -27.45 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 117.137 2.273 . . . . 0.0 117.137 -176.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 64.9 mt -52.13 -41.42 62.49 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -173.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.42 -44.85 95.45 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-O 122.794 1.283 . . . . 0.0 112.685 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.0 m -65.49 -38.6 90.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.982 1.313 . . . . 0.0 113.793 173.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.5 mt -64.32 -38.86 92.53 Favored 'General case' 0 CA--C 1.504 -0.793 0 O-C-N 120.536 -1.352 . . . . 0.0 113.954 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.69 -47.06 83.39 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.25 0.548 . . . . 0.0 111.232 173.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.74 -46.63 87.17 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 169.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.79 -38.4 70.29 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 118.061 -2.899 . . . . 0.0 115.833 -176.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -92.21 -22.24 19.92 Favored 'General case' 0 CA--C 1.496 -1.098 0 O-C-N 119.703 -1.873 . . . . 0.0 112.573 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.27 90.13 0.89 Allowed Glycine 0 CA--C 1.492 -1.38 0 CA-C-O 116.494 -2.281 . . . . 0.0 109.421 161.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -63.59 -27.82 69.57 Favored 'Trans proline' 0 CA--C 1.517 -0.373 1 CA-C-N 125.654 4.727 . . . . 0.0 109.882 170.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -59.6 -45.12 92.86 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.953 1.701 . . . . 0.0 112.453 164.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.7 mt -67.85 -37.26 81.64 Favored 'General case' 0 C--N 1.35 0.602 0 O-C-N 120.766 -1.209 . . . . 0.0 113.865 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.28 -45.54 94.05 Favored 'General case' 0 C--N 1.348 0.532 0 O-C-N 119.161 -2.212 . . . . 0.0 111.482 174.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -80.92 -57.88 3.34 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 119.632 1.106 . . . . 0.0 113.5 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.79 -41.61 90.61 Favored 'Isoleucine or valine' 0 C--N 1.35 0.603 0 C-N-CA 125.772 1.629 . . . . 0.0 111.864 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.2 p -100.53 9.13 42.97 Favored 'General case' 0 C--N 1.349 0.571 0 O-C-N 120.762 -1.211 . . . . 0.0 112.262 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? 47.64 43.85 16.78 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 127.433 2.293 . . . . 0.0 116.857 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -118.71 14.57 13.49 Favored 'General case' 0 C--N 1.347 0.487 0 O-C-N 119.945 -1.722 . . . . 0.0 115.079 -168.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 CA--C 1.501 -0.906 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 64.17 171.19 0.09 OUTLIER Pre-proline 0 C--N 1.352 0.713 0 C-N-CA 125.069 1.348 . . . . 0.0 111.969 -170.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.64 -170.9 0.41 Allowed 'Trans proline' 0 N--CA 1.452 -0.953 0 O-C-N 118.029 -1.616 . . . . 0.0 110.477 151.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.6 pt -49.89 -27.79 3.78 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 -172.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 62.4 mt -38.16 -46.1 1.01 Allowed 'General case' 0 C--N 1.347 0.462 0 C-N-CA 128.242 2.617 . . . . 0.0 117.571 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.53 -45.99 90.47 Favored 'General case' 0 C--N 1.35 0.602 0 O-C-N 120.702 -1.249 . . . . 0.0 113.123 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.3 m -65.76 -39.48 91.09 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 124.994 1.317 . . . . 0.0 113.456 171.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.3 mt -62.59 -36.66 83.42 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 120.718 -1.238 . . . . 0.0 113.634 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.58 -49.09 78.73 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 118.508 0.595 . . . . 0.0 111.795 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.421 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . . . -61.88 -46.15 90.64 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 168.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.13 -38.41 82.16 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 118.642 -2.536 . . . . 0.0 116.589 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -94.48 -19.62 20.4 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 119.589 -1.944 . . . . 0.0 112.37 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.49 93.49 1.43 Allowed Glycine 0 CA--C 1.489 -1.549 0 CA-C-O 116.646 -2.196 . . . . 0.0 110.32 163.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.87 -25.87 67.41 Favored 'Trans proline' 0 C--N 1.328 -0.533 1 CA-C-N 125.779 4.79 . . . . 0.0 110.653 171.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -45.42 92.98 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.068 0.947 . . . . 0.0 112.647 162.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.5 mt -70.29 -32.94 70.95 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.048 1.339 . . . . 0.0 113.834 176.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.421 ' CD1' ' HB2' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -63.69 -42.85 97.96 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 119.301 -2.125 . . . . 0.0 111.847 173.386 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -92.55 -61.58 1.57 Allowed 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.6 t -65.66 -46.23 89.9 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 C-N-CA 125.612 1.565 . . . . 0.0 112.429 -168.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.4 p -99.89 5.95 45.3 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 120.908 -1.12 . . . . 0.0 110.84 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.13 49.39 20.1 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 172.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.29 15.35 20.41 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 119.139 -2.226 . . . . 0.0 114.455 -174.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 45.6 t80 . . . . . 0 N--CA 1.436 -1.142 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 63.96 171.1 0.09 OUTLIER Pre-proline 0 C--N 1.358 0.956 0 C-N-CA 124.521 1.128 . . . . 0.0 110.638 -157.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.55 -172.7 0.58 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 O-C-N 117.154 -2.077 . . . . 0.0 110.495 151.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.0 pt -49.43 -27.45 2.76 Favored 'Isoleucine or valine' 0 C--N 1.344 0.332 0 N-CA-C 117.178 2.288 . . . . 0.0 117.178 -173.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.6 mt -39.05 -43.69 1.03 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 127.744 2.417 . . . . 0.0 117.192 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.25 -43.12 99.56 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 120.512 -1.367 . . . . 0.0 113.309 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 m -69.47 -33.89 73.57 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 120.042 -1.661 . . . . 0.0 113.845 172.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.08 -36.84 85.6 Favored 'General case' 0 CA--C 1.509 -0.63 0 O-C-N 119.919 -1.738 . . . . 0.0 113.296 172.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.42 -42.35 82.19 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.776 0.831 . . . . 0.0 111.235 168.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.17 -49.39 77.38 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 168.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -76.64 -41.66 44.96 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -101.81 -5.51 24.76 Favored 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 120.32 -1.488 . . . . 0.0 111.107 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -112.57 82.33 0.3 Allowed Glycine 0 N--CA 1.437 -1.295 0 CA-C-O 118.644 -1.087 . . . . 0.0 110.73 164.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -62.59 -31.15 79.79 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 122.029 2.915 . . . . 0.0 109.659 162.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -64.45 -45.78 85.97 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 162.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.59 -41.36 92.92 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 120.234 -1.541 . . . . 0.0 113.897 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.16 -21.95 58.43 Favored 'General case' 0 C--N 1.349 0.545 0 O-C-N 118.975 -2.328 . . . . 0.0 114.276 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.2 mt -87.02 -57.89 2.8 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.87 -44.32 85.42 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 125.675 1.59 . . . . 0.0 112.389 -173.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.8 m -118.0 11.47 13.39 Favored 'General case' 0 C--N 1.345 0.399 0 O-C-N 120.914 -1.116 . . . . 0.0 110.828 -171.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.61 53.03 12.89 Favored 'General case' 0 C--N 1.348 0.514 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 168.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -109.15 23.71 14.14 Favored 'General case' 0 CA--C 1.517 -0.306 0 O-C-N 119.871 -1.768 . . . . 0.0 111.672 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 43.7 t80 . . . . . 0 N--CA 1.44 -0.933 0 CA-C-O 122.003 0.906 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 40.6 tp -123.37 144.05 42.89 Favored Pre-proline 0 N--CA 1.434 -1.257 0 N-CA-C 101.531 -3.507 . . . . 0.0 101.531 164.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -109.83 -120.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.959 0 CA-C-N 123.18 2.172 . . . . 0.0 107.608 -171.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.6 pt -49.67 -28.03 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 C-N-CA 127.065 2.146 . . . . 0.0 116.432 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.7 mt -57.65 -37.05 72.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 120.344 -1.473 . . . . 0.0 114.415 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.48 -43.56 98.52 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-O 122.697 1.237 . . . . 0.0 112.606 169.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.2 m -66.06 -35.88 81.73 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 120.366 -1.458 . . . . 0.0 114.746 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.4 mt -65.91 -39.96 91.04 Favored 'General case' 0 CA--C 1.504 -0.801 0 O-C-N 119.63 -1.919 . . . . 0.0 113.189 172.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.17 89.23 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 122.965 0.506 . . . . 0.0 111.113 168.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.33 -46.05 91.86 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 173.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -83.89 -43.7 15.03 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 120.753 -1.217 . . . . 0.0 114.174 -173.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -85.01 -19.7 31.6 Favored 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 120.418 -1.426 . . . . 0.0 111.171 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.18 85.12 0.4 Allowed Glycine 0 N--CA 1.435 -1.367 0 CA-C-O 118.067 -1.407 . . . . 0.0 110.411 161.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -62.43 -31.04 80.95 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 CA-C-N 122.873 3.337 . . . . 0.0 109.056 160.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.6 -45.91 90.52 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.746 1.218 . . . . 0.0 112.822 163.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.5 mt -66.92 -42.97 84.49 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 120.588 -1.32 . . . . 0.0 113.984 176.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -33.78 76.28 Favored 'General case' 0 C--N 1.346 0.455 0 O-C-N 119.182 -2.199 . . . . 0.0 113.795 175.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.46 -58.64 2.46 Favored 'General case' 0 C--N 1.348 0.53 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.6 t -66.33 -45.49 89.43 Favored 'Isoleucine or valine' 0 C--N 1.347 0.492 0 C-N-CA 125.958 1.703 . . . . 0.0 112.091 -173.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.5 m -106.41 1.54 25.74 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 122.407 1.099 . . . . 0.0 110.326 -172.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.9 pttm 51.05 44.16 28.72 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 127.671 2.389 . . . . 0.0 116.684 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.7 mtpt -97.42 19.95 12.45 Favored 'General case' 0 C--N 1.347 0.466 0 O-C-N 119.289 -2.132 . . . . 0.0 113.498 -176.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 70.4 t80 . . . . . 0 N--CA 1.436 -1.131 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.2 tp 68.62 171.04 0.1 Allowed Pre-proline 0 C--N 1.356 0.885 0 C-N-CA 126.371 1.868 . . . . 0.0 110.137 -168.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -73.34 -170.63 0.68 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 O-C-N 116.743 -2.293 . . . . 0.0 111.147 154.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.6 pt -50.25 -28.74 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 127.143 2.177 . . . . 0.0 116.39 -174.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.2 mt -33.1 -44.48 0.12 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 128.06 2.544 . . . . 0.0 117.821 174.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.72 96.11 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 120.582 -1.324 . . . . 0.0 113.155 174.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.2 m -70.7 -30.66 67.28 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.226 -1.546 . . . . 0.0 113.558 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.9 mt -66.96 -40.27 87.44 Favored 'General case' 0 CA--C 1.509 -0.597 0 O-C-N 119.525 -1.984 . . . . 0.0 113.559 170.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.7 -43.53 90.05 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.866 0.866 . . . . 0.0 111.317 169.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.2 -46.84 88.36 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 172.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -79.45 -44.05 22.11 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 120.282 -1.511 . . . . 0.0 114.679 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -85.88 -18.41 32.84 Favored 'General case' 0 CA--C 1.501 -0.928 0 O-C-N 120.156 -1.59 . . . . 0.0 111.177 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -107.2 85.11 0.41 Allowed Glycine 0 N--CA 1.436 -1.354 0 CA-C-O 117.365 -1.797 . . . . 0.0 110.321 162.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -62.27 -27.59 78.23 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 CA-C-N 123.579 3.69 . . . . 0.0 109.469 160.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -45.79 92.04 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 123.829 0.851 . . . . 0.0 112.419 164.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.6 mt -69.16 -42.26 76.17 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.16 -35.64 80.11 Favored 'General case' 0 C--N 1.345 0.402 0 O-C-N 119.386 -2.071 . . . . 0.0 113.566 175.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 52.9 tp -85.47 -59.1 2.42 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.0 t -70.33 -46.92 69.37 Favored 'Isoleucine or valine' 0 C--N 1.348 0.527 0 C-N-CA 125.338 1.455 . . . . 0.0 111.626 -173.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.3 m -103.14 0.66 32.15 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-O 122.248 1.023 . . . . 0.0 110.819 -172.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 53.4 51.79 14.68 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 125.838 1.655 . . . . 0.0 115.183 174.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.7 mtpp -106.46 15.22 26.23 Favored 'General case' 0 C--N 1.345 0.376 0 O-C-N 119.578 -1.951 . . . . 0.0 112.609 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 12.5 p90 . . . . . 0 N--CA 1.442 -0.842 0 CA-C-O 122.104 0.954 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.0 mp -108.06 143.86 28.22 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 158.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -90.31 -121.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.266 0 N-CA-C 107.171 -1.896 . . . . 0.0 107.171 172.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.3 pt -49.69 -28.52 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.6 mt -55.95 -40.22 72.89 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.77 -42.93 97.7 Favored 'General case' 0 C--N 1.349 0.565 0 O-C-N 120.823 -1.173 . . . . 0.0 112.376 171.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.7 m -66.08 -35.98 81.98 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 174.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.0 mt -65.18 -42.01 94.06 Favored 'General case' 0 CA--C 1.506 -0.739 0 O-C-N 119.671 -1.893 . . . . 0.0 112.788 172.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.29 -42.4 91.2 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 123.327 0.651 . . . . 0.0 111.345 169.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.3 -47.83 82.54 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 174.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -84.9 -48.1 9.65 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 119.959 -1.713 . . . . 0.0 112.841 -173.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -84.56 -16.45 42.18 Favored 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 120.518 -1.364 . . . . 0.0 111.123 -175.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.47 84.89 0.47 Allowed Glycine 0 N--CA 1.436 -1.362 0 CA-C-O 117.8 -1.556 . . . . 0.0 111.089 159.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.29 -28.53 63.76 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 CA-C-N 123.461 3.63 . . . . 0.0 109.638 165.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -63.19 -45.75 90.28 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 122.921 0.488 . . . . 0.0 112.149 163.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.27 -42.32 84.06 Favored 'General case' 0 C--N 1.348 0.543 0 O-C-N 120.664 -1.273 . . . . 0.0 113.528 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.69 -35.32 80.43 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 119.054 -2.279 . . . . 0.0 114.072 173.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.6 mt -86.75 -55.21 3.96 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.3 t -71.55 -46.85 61.24 Favored 'Isoleucine or valine' 0 C--N 1.349 0.543 0 C-N-CA 124.876 1.27 . . . . 0.0 111.613 -175.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.9 m -103.35 -1.21 29.04 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 122.538 1.161 . . . . 0.0 110.912 -171.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.2 tmmt? 53.98 53.29 11.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.5 1.52 . . . . 0.0 114.717 176.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -108.16 13.75 25.62 Favored 'General case' 0 C--N 1.345 0.404 0 O-C-N 120.113 -1.617 . . . . 0.0 112.706 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 55.8 t80 . . . . . 0 N--CA 1.436 -1.165 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.4 tp 69.05 170.91 0.11 Allowed Pre-proline 0 C--N 1.356 0.855 0 C-N-CA 126.47 1.908 . . . . 0.0 109.44 -164.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -78.58 -164.54 0.28 Allowed 'Trans proline' 0 N--CA 1.451 -1.021 0 O-C-N 116.86 -2.231 . . . . 0.0 110.193 156.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -49.44 -27.92 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 C-N-CA 127.59 2.356 . . . . 0.0 117.081 -173.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.1 mt -39.45 -42.32 1.09 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 127.667 2.387 . . . . 0.0 116.987 177.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.95 -43.72 98.25 Favored 'General case' 0 C--N 1.35 0.616 0 O-C-N 120.624 -1.298 . . . . 0.0 112.967 173.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.5 m -71.84 -29.27 64.23 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 120.199 -1.563 . . . . 0.0 113.741 172.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.57 -38.95 88.15 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 119.362 -2.086 . . . . 0.0 113.315 170.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.21 -41.78 84.79 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.536 0.734 . . . . 0.0 111.015 168.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.01 -47.27 87.21 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 172.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -80.52 -42.66 22.07 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -173.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -86.39 -18.76 30.97 Favored 'General case' 0 CA--C 1.502 -0.871 0 O-C-N 120.287 -1.508 . . . . 0.0 110.983 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -111.94 85.43 0.39 Allowed Glycine 0 N--CA 1.435 -1.377 0 CA-C-O 118.075 -1.403 . . . . 0.0 111.212 164.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -61.88 -29.54 82.64 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 CA-C-N 122.508 3.154 . . . . 0.0 109.264 157.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -59.62 -47.85 83.98 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.136 0.974 . . . . 0.0 112.461 163.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 90.9 mt -67.44 -43.62 80.71 Favored 'General case' 0 C--N 1.35 0.592 0 O-C-N 120.741 -1.225 . . . . 0.0 114.143 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.72 -27.62 65.12 Favored 'General case' 0 C--N 1.347 0.464 0 O-C-N 119.116 -2.24 . . . . 0.0 113.666 176.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.6 mt -87.8 -54.83 4.05 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -177.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.3 t -69.97 -47.93 66.09 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 C-N-CA 125.015 1.326 . . . . 0.0 111.117 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.9 m -105.34 -0.08 26.53 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-O 122.494 1.14 . . . . 0.0 110.914 -169.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.15 49.74 14.89 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 174.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -106.6 15.89 25.23 Favored 'General case' 0 CA--C 1.517 -0.303 0 O-C-N 119.613 -1.929 . . . . 0.0 112.057 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 72.0 t80 . . . . . 0 N--CA 1.439 -1.0 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 75.6 mt 69.78 169.52 0.11 Allowed Pre-proline 0 C--N 1.359 1.002 0 C-N-CA 124.059 0.943 . . . . 0.0 110.902 -173.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -67.36 178.87 2.8 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 O-C-N 117.253 -2.025 . . . . 0.0 111.391 150.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.254 45.2 pt -44.44 -37.7 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 127.641 2.376 . . . . 0.0 115.243 -174.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 20.6 mt -35.41 -33.72 0.03 OUTLIER 'General case' 0 C--N 1.356 0.851 0 C-N-CA 129.311 3.044 . . . . 0.0 118.35 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.64 85.96 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-O 123.026 1.393 . . . . 0.0 112.619 171.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.9 p -77.4 -19.23 56.45 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 120.301 -1.499 . . . . 0.0 113.402 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.6 mt -65.84 -39.19 90.55 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 120.188 -1.57 . . . . 0.0 112.478 169.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.55 -44.07 89.54 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 121.867 -0.521 . . . . 0.0 111.531 168.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.511 ' HA ' ' CG ' ' A' ' 17' ' ' PHE . . . -61.29 -40.26 93.48 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 174.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -89.75 -46.88 8.28 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -93.47 -9.13 39.54 Favored 'General case' 0 CA--C 1.492 -1.271 0 O-C-N 120.503 -1.373 . . . . 0.0 112.039 -172.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.77 82.6 0.3 Allowed Glycine 0 N--CA 1.43 -1.727 0 O-C-N 121.144 -0.973 . . . . 0.0 111.41 170.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -65.11 -32.13 53.35 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 CA-C-N 123.289 3.544 . . . . 0.0 110.256 157.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -64.94 -44.71 88.54 Favored 'General case' 0 C--N 1.348 0.522 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 166.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 82.7 mt -70.52 -48.11 57.14 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.511 ' CG ' ' HA ' ' A' ' 10' ' ' ALA . 1.1 t80 -102.09 24.31 10.3 Favored 'General case' 0 CA--C 1.505 -0.782 0 O-C-N 119.135 -2.228 . . . . 0.0 113.096 -165.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 54.9 tp -125.31 -49.94 1.67 Allowed 'General case' 0 C--N 1.355 0.843 0 C-N-CA 124.005 0.922 . . . . 0.0 111.865 175.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.2 t -65.69 -28.19 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 C-N-CA 126.996 2.118 . . . . 0.0 111.741 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.3 m -160.25 170.12 21.78 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 101.99 -3.337 . . . . 0.0 101.99 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.9 tttp -106.21 115.31 30.01 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 120.655 1.571 . . . . 0.0 111.279 175.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -114.92 8.58 15.94 Favored 'General case' 0 C--O 1.224 -0.284 0 O-C-N 120.084 -1.635 . . . . 0.0 110.152 155.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 54.1 p90 . . . . . 0 N--CA 1.444 -0.77 0 CA-C-O 122.041 0.924 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.1 mt -150.55 160.57 32.52 Favored Pre-proline 0 N--CA 1.434 -1.227 0 N-CA-C 103.389 -2.819 . . . . 0.0 103.389 176.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -98.36 -135.45 0.01 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.575 0 N-CA-C 107.12 -1.916 . . . . 0.0 107.12 169.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.4 pt -49.23 -28.17 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 N-CA-C 117.034 2.235 . . . . 0.0 117.034 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 62.8 mt -53.72 -38.77 64.64 Favored 'General case' 0 C--N 1.344 0.368 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.98 97.81 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-O 122.46 1.124 . . . . 0.0 112.772 170.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.8 m -67.85 -35.44 78.57 Favored 'General case' 0 C--N 1.343 0.32 0 O-C-N 120.178 -1.577 . . . . 0.0 114.5 174.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.2 mt -65.45 -39.17 91.71 Favored 'General case' 0 CA--C 1.509 -0.63 0 O-C-N 119.733 -1.854 . . . . 0.0 113.391 172.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.1 -39.2 78.02 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.622 0.769 . . . . 0.0 111.356 168.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.49 -48.77 71.44 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 170.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -77.59 -42.67 34.29 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 120.775 -1.203 . . . . 0.0 114.111 -171.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -94.93 -7.75 39.06 Favored 'General case' 0 CA--C 1.502 -0.9 0 O-C-N 120.769 -1.207 . . . . 0.0 110.105 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -117.38 78.8 0.29 Allowed Glycine 0 N--CA 1.432 -1.59 0 CA-C-O 117.215 -1.881 . . . . 0.0 111.184 161.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -62.62 -35.94 67.1 Favored 'Trans proline' 0 CA--C 1.512 -0.588 0 CA-C-N 123.607 3.703 . . . . 0.0 109.351 167.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -36.74 84.74 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 166.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 82.0 mt -68.97 -46.86 67.02 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 120.503 -1.373 . . . . 0.0 113.357 176.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.75 -33.84 74.57 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 121.775 2.08 . . . . 0.0 114.417 176.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -79.04 -56.84 4.08 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 121.132 -0.98 . . . . 0.0 113.436 173.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.3 t -66.79 -43.71 89.67 Favored 'Isoleucine or valine' 0 C--N 1.348 0.537 0 C-N-CA 126.07 1.748 . . . . 0.0 113.242 -171.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 59.0 p -106.73 -3.33 20.63 Favored 'General case' 0 CA--C 1.508 -0.668 0 O-C-N 120.547 -1.346 . . . . 0.0 112.762 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.69 44.5 14.17 Favored 'General case' 0 C--N 1.349 0.571 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 178.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -105.4 21.99 16.22 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 119.313 -2.117 . . . . 0.0 112.04 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 38.7 t80 . . . . . 0 N--CA 1.437 -1.107 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.3 mp 65.57 171.1 0.09 OUTLIER Pre-proline 0 C--N 1.356 0.86 0 C-N-CA 124.548 1.139 . . . . 0.0 111.012 -160.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -68.41 -172.0 0.41 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 O-C-N 117.333 -1.983 . . . . 0.0 110.846 151.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.4 pt -49.35 -28.06 2.95 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 N-CA-C 117.19 2.293 . . . . 0.0 117.19 -174.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.8 mt -39.93 -42.68 1.39 Allowed 'General case' 0 C--N 1.343 0.311 0 C-N-CA 127.754 2.422 . . . . 0.0 117.356 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.92 -43.45 98.82 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 120.592 -1.318 . . . . 0.0 113.191 173.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.2 m -70.73 -31.33 68.13 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 119.902 -1.749 . . . . 0.0 113.873 171.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.66 -36.44 82.55 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 119.261 -2.15 . . . . 0.0 113.41 171.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.03 -38.93 77.16 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.817 0.847 . . . . 0.0 111.465 168.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.57 76.9 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 169.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -77.31 -41.92 38.77 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -170.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -95.05 -5.55 44.15 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 120.627 -1.296 . . . . 0.0 110.177 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -122.58 81.34 0.35 Allowed Glycine 0 N--CA 1.43 -1.705 0 CA-C-O 117.713 -1.604 . . . . 0.0 110.673 164.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.47 -34.33 86.15 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 CA-C-N 122.719 3.259 . . . . 0.0 109.688 164.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -37.24 86.73 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 165.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.6 mp -67.58 -45.27 76.04 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 120.014 -1.679 . . . . 0.0 112.66 172.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -68.81 -33.21 73.47 Favored 'General case' 0 C--N 1.346 0.437 0 O-C-N 119.251 -2.155 . . . . 0.0 114.03 177.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 52.2 tp -94.67 -65.46 0.98 Allowed 'General case' 0 C--N 1.351 0.634 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.5 t -64.54 -46.83 91.49 Favored 'Isoleucine or valine' 0 C--N 1.348 0.532 0 C-N-CA 126.703 2.001 . . . . 0.0 112.094 -171.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.3 m -102.68 2.9 36.48 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 122.89 1.329 . . . . 0.0 109.813 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.64 48.78 14.26 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 117.143 2.275 . . . . 0.0 117.143 174.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -93.82 -0.46 55.81 Favored 'General case' 0 C--N 1.343 0.283 0 O-C-N 119.293 -2.13 . . . . 0.0 112.675 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 8.9 t80 . . . . . 0 N--CA 1.439 -1.005 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 29.7 mt -43.77 144.62 1.37 Allowed Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 168.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -77.87 -25.4 7.67 Favored 'Trans proline' 0 CA--C 1.514 -0.489 0 CA-C-N 122.286 1.852 . . . . 0.0 109.352 -176.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.8 pt -53.95 -17.52 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 174.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.56 -39.0 82.62 Favored 'General case' 0 C--N 1.346 0.425 0 O-C-N 119.953 -1.717 . . . . 0.0 113.599 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.15 -42.87 99.67 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-O 122.507 1.146 . . . . 0.0 112.79 169.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.1 m -63.96 -39.27 93.75 Favored 'General case' 0 C--N 1.345 0.395 0 O-C-N 120.426 -1.421 . . . . 0.0 114.275 174.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.8 mt -64.6 -40.97 96.47 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 120.421 -1.424 . . . . 0.0 113.132 173.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.32 -44.66 88.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.318 0.58 . . . . 0.0 111.519 171.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.88 -45.82 87.68 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 171.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.84 -25.76 19.73 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 118.416 -2.677 . . . . 0.0 114.356 -169.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -99.17 -12.35 20.54 Favored 'General case' 0 CA--C 1.498 -1.024 0 O-C-N 119.548 -1.97 . . . . 0.0 111.209 173.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.68 83.36 0.36 Allowed Glycine 0 N--CA 1.438 -1.176 0 CA-C-O 117.159 -1.912 . . . . 0.0 109.832 157.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -63.06 -29.92 75.45 Favored 'Trans proline' 0 CA--C 1.517 -0.35 1 CA-C-N 124.468 4.134 . . . . 0.0 110.093 168.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -59.96 -47.56 85.3 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 123.815 0.846 . . . . 0.0 111.887 164.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.36 -42.8 96.03 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -61.92 -37.74 85.81 Favored 'General case' 0 C--N 1.347 0.498 0 O-C-N 119.311 -2.118 . . . . 0.0 113.564 178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.72 -46.93 67.63 Favored 'General case' 0 C--N 1.345 0.413 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.6 t -60.77 -39.7 82.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.571 0 C-N-CA 125.48 1.512 . . . . 0.0 111.404 -176.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.7 p -105.22 24.68 11.66 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.545 -1.347 . . . . 0.0 113.451 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? 47.12 54.48 9.31 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 126.613 1.965 . . . . 0.0 115.304 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -138.51 -165.89 1.9 Allowed 'General case' 0 C--N 1.344 0.354 0 O-C-N 119.896 -1.753 . . . . 0.0 110.985 -177.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 24.9 p90 . . . . . 0 N--CA 1.443 -0.787 0 CA-C-O 121.756 0.789 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 38.2 tp -123.83 144.09 43.85 Favored Pre-proline 0 N--CA 1.433 -1.299 0 N-CA-C 102.533 -3.136 . . . . 0.0 102.533 168.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -109.19 -118.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.955 0 CA-C-N 122.81 2.039 . . . . 0.0 107.437 -173.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.5 pt -49.84 -28.14 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 -179.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 64.5 mt -59.56 -38.47 81.18 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 120.122 -1.611 . . . . 0.0 114.671 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.5 -44.67 95.8 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-O 122.805 1.288 . . . . 0.0 112.137 170.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.5 m -63.92 -38.92 92.87 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.952 1.301 . . . . 0.0 114.174 175.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.71 -41.2 92.59 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 125.215 1.406 . . . . 0.0 113.817 175.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.72 -45.91 88.54 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-O 121.888 0.852 . . . . 0.0 111.115 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.44 -48.21 80.67 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 170.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -72.24 -43.52 64.26 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 118.012 -2.93 . . . . 0.0 115.161 -177.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -85.33 -24.12 27.78 Favored 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 120.132 -1.605 . . . . 0.0 112.165 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.2 92.72 0.95 Allowed Glycine 0 CA--C 1.492 -1.389 0 CA-C-O 116.616 -2.213 . . . . 0.0 110.026 167.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -63.7 -28.46 68.82 Favored 'Trans proline' 0 C--N 1.329 -0.484 1 CA-C-N 125.269 4.535 . . . . 0.0 110.028 164.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm -60.03 -46.38 89.71 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.203 1.401 . . . . 0.0 112.828 164.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.5 mt -69.34 -42.69 74.97 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 121.485 -0.759 . . . . 0.0 112.825 176.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.07 -47.84 83.79 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 120.482 -1.387 . . . . 0.0 113.124 -174.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.1 tp -78.8 -47.67 16.27 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 169.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.83 -41.61 90.49 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 C-N-CA 126.148 1.779 . . . . 0.0 111.904 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.1 t -152.4 148.79 27.88 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-O 124.012 1.863 . . . . 0.0 112.782 173.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.44 59.46 3.49 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 118.842 -2.411 . . . . 0.0 114.664 -167.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.81 3.92 54.71 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 120.023 -1.673 . . . . 0.0 110.472 174.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 1.5 t80 . . . . . 0 N--CA 1.442 -0.847 0 CA-C-O 121.67 0.747 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -110.89 159.05 33.95 Favored Pre-proline 0 N--CA 1.44 -0.966 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 168.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -83.61 -158.28 0.09 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.45 0 C-N-CA 121.324 1.349 . . . . 0.0 108.956 163.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.5 pt -49.55 -27.49 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.0 mt -52.64 -40.04 62.39 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -174.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.81 -44.42 96.89 Favored 'General case' 0 C--N 1.35 0.596 0 CA-C-O 122.621 1.201 . . . . 0.0 112.772 172.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.7 m -67.42 -33.9 76.12 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 120.49 -1.381 . . . . 0.0 113.948 173.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.4 mt -65.01 -40.77 95.38 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 119.968 -1.708 . . . . 0.0 113.462 172.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.03 -45.71 90.04 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.461 0.648 . . . . 0.0 111.103 171.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.51 -45.71 93.04 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 172.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.29 -47.72 26.58 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 118.312 -2.742 . . . . 0.0 114.86 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -97.03 -8.98 29.05 Favored 'General case' 0 CA--C 1.498 -1.052 0 O-C-N 120.28 -1.513 . . . . 0.0 111.491 -169.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.31 92.69 0.94 Allowed Glycine 0 N--CA 1.435 -1.415 0 CA-C-O 117.5 -1.722 . . . . 0.0 109.449 158.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.69 -28.78 69.01 Favored 'Trans proline' 0 C--N 1.329 -0.497 0 CA-C-N 123.876 3.838 . . . . 0.0 109.493 160.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -61.37 -48.27 82.02 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 123.471 0.708 . . . . 0.0 112.641 164.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.1 mt -69.65 -41.4 75.62 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -37.34 86.81 Favored 'General case' 0 C--N 1.35 0.596 0 CA-C-N 121.087 1.767 . . . . 0.0 113.424 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.1 tp -69.46 -46.32 66.97 Favored 'General case' 0 C--N 1.349 0.545 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 175.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.0 m -97.96 0.37 10.48 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 O-C-N 120.064 -1.647 . . . . 0.0 112.04 -170.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 68.0 m -155.64 153.54 30.21 Favored 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 119.209 -2.182 . . . . 0.0 107.885 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -74.89 68.12 1.73 Allowed 'General case' 0 C--N 1.349 0.559 0 O-C-N 117.789 -3.069 . . . . 0.0 114.251 170.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -117.0 15.42 15.11 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 125.085 1.354 . . . . 0.0 108.371 170.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 8.2 t80 . . . . . 0 N--CA 1.432 -1.361 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.2 tp -164.6 137.23 3.75 Favored Pre-proline 0 C--N 1.352 0.678 0 O-C-N 120.763 -1.211 . . . . 0.0 110.174 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -68.57 -38.07 11.61 Favored 'Trans proline' 0 C--N 1.333 -0.278 0 CA-C-N 123.371 2.24 . . . . 0.0 112.174 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.313 20.7 pt -54.55 -17.32 2.02 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 172.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 53.6 mt -51.42 -33.62 31.25 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 120.24 -1.538 . . . . 0.0 114.731 174.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.13 -39.67 79.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.759 0.79 . . . . 0.0 111.856 173.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.5 m -64.91 -35.97 82.86 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 120.522 -1.361 . . . . 0.0 114.343 171.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.0 mt -62.9 -45.48 92.31 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 120.269 -1.519 . . . . 0.0 112.875 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.63 -21.67 59.33 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 120.968 -1.083 . . . . 0.0 113.804 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.89 -31.08 23.9 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 119.51 -1.994 . . . . 0.0 113.739 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -97.83 -31.52 12.18 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 120.272 -1.517 . . . . 0.0 111.352 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -110.11 9.17 24.09 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 120.457 -1.402 . . . . 0.0 110.879 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -141.7 46.47 0.89 Allowed Glycine 0 C--N 1.348 1.22 0 CA-C-O 117.827 -1.54 . . . . 0.0 116.062 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -62.33 -22.54 74.25 Favored 'Trans proline' 0 CA--C 1.515 -0.433 0 CA-C-N 122.921 3.361 . . . . 0.0 113.199 -172.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.4 -47.54 85.33 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 118.653 0.661 . . . . 0.0 111.996 176.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.08 -41.44 99.43 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 121.091 -1.006 . . . . 0.0 111.16 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.41 -44.02 97.86 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 175.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.9 mp -82.88 -46.94 12.39 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 119.717 -1.864 . . . . 0.0 111.866 172.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.6 t -60.88 -48.92 86.78 Favored 'Isoleucine or valine' 0 C--N 1.361 1.082 0 C-N-CA 124.241 1.016 . . . . 0.0 111.66 -175.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 p -95.39 6.14 49.78 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 120.914 -1.116 . . . . 0.0 111.94 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 51.65 53.53 12.56 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 125.82 1.648 . . . . 0.0 112.56 177.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -118.33 -152.81 0.51 Allowed 'General case' 0 C--N 1.346 0.438 0 O-C-N 120.665 -1.272 . . . . 0.0 108.741 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.2 pt . . . . . 0 C--O 1.221 -0.431 0 N-CA-C 117.701 2.482 . . . . 0.0 117.701 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.0 mt -34.99 -45.34 0.26 Allowed 'General case' 0 C--N 1.344 0.365 0 N-CA-C 117.738 2.496 . . . . 0.0 117.738 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.93 -45.44 92.47 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 120.695 -1.253 . . . . 0.0 113.223 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.2 m -67.78 -31.92 72.13 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 120.113 -1.617 . . . . 0.0 114.077 171.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.63 -40.24 92.35 Favored 'General case' 0 CA--C 1.511 -0.529 0 O-C-N 119.235 -2.166 . . . . 0.0 113.375 170.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.4 -42.56 87.41 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 123.415 0.686 . . . . 0.0 111.156 169.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.84 -43.92 97.64 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 172.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -84.28 -41.96 16.33 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 120.25 -1.531 . . . . 0.0 113.968 -173.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -86.58 -18.92 30.23 Favored 'General case' 0 CA--C 1.503 -0.841 0 O-C-N 120.323 -1.486 . . . . 0.0 111.274 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -107.7 86.86 0.47 Allowed Glycine 0 N--CA 1.435 -1.401 0 CA-C-O 117.771 -1.572 . . . . 0.0 110.897 162.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -62.2 -27.64 78.65 Favored 'Trans proline' 0 CA--C 1.514 -0.487 0 CA-C-N 123.095 3.447 . . . . 0.0 109.242 157.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.9 mttt . . . . . 0 N--CA 1.445 -0.718 0 C-N-CA 123.859 0.864 . . . . 0.0 112.484 163.972 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.6 pt . . . . . 0 CA--C 1.512 -0.517 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.8 mt -59.43 -38.91 81.89 Favored 'General case' 0 C--N 1.345 0.404 0 O-C-N 120.053 -1.654 . . . . 0.0 113.725 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.26 99.15 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-O 122.55 1.166 . . . . 0.0 113.036 169.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.6 m -64.56 -39.15 93.23 Favored 'General case' 0 C--N 1.345 0.381 0 O-C-N 120.285 -1.509 . . . . 0.0 114.182 174.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.62 -38.42 90.95 Favored 'General case' 0 CA--C 1.51 -0.585 0 O-C-N 120.537 -1.352 . . . . 0.0 113.375 173.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.48 -39.57 80.37 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.862 0.865 . . . . 0.0 112.236 170.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.65 -48.13 67.56 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 168.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -72.55 -42.73 64.35 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -172.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -93.6 -9.26 38.65 Favored 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 120.57 -1.331 . . . . 0.0 110.042 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -120.62 75.19 0.33 Allowed Glycine 0 N--CA 1.434 -1.464 0 CA-C-O 117.694 -1.614 . . . . 0.0 112.584 169.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.81 -29.42 76.71 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 CA-C-N 123.022 3.411 . . . . 0.0 109.025 157.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.2 mtpp . . . . . 0 N--CA 1.445 -0.719 0 C-N-CA 125.736 1.614 . . . . 0.0 112.839 165.291 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.8 pt . . . . . 0 C--O 1.221 -0.403 0 N-CA-C 117.028 2.233 . . . . 0.0 117.028 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.8 mt -41.88 -43.07 2.92 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.57 -44.04 97.76 Favored 'General case' 0 C--N 1.351 0.661 0 O-C-N 120.686 -1.259 . . . . 0.0 113.004 172.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.1 m -67.38 -33.5 75.33 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 120.394 -1.442 . . . . 0.0 114.153 172.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.9 -42.49 90.16 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 119.739 -1.85 . . . . 0.0 113.315 171.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.1 -40.68 86.09 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 123.827 0.851 . . . . 0.0 111.331 170.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.02 -48.53 78.37 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 172.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -81.3 -45.92 15.49 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 119.463 -2.023 . . . . 0.0 112.729 -175.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -91.2 -8.5 48.37 Favored 'General case' 0 CA--C 1.5 -0.958 0 O-C-N 120.583 -1.323 . . . . 0.0 111.034 -173.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.8 81.58 0.38 Allowed Glycine 0 N--CA 1.439 -1.145 0 CA-C-O 117.625 -1.653 . . . . 0.0 110.626 156.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.07 -19.55 29.82 Favored 'Trans proline' 0 CA--C 1.512 -0.578 0 CA-C-N 123.895 3.847 . . . . 0.0 108.908 167.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? . . . . . 0 N--CA 1.44 -0.935 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 161.695 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.6 pt . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.1 mt -54.27 -40.15 67.54 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -173.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.35 -42.42 99.38 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-O 122.727 1.251 . . . . 0.0 112.801 171.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.2 m -68.68 -32.73 72.75 Favored 'General case' 0 C--N 1.343 0.323 0 O-C-N 120.192 -1.568 . . . . 0.0 114.387 173.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.8 mt -66.12 -40.1 90.42 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 119.429 -2.044 . . . . 0.0 112.981 171.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.44 -43.01 88.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.062 0.545 . . . . 0.0 111.324 168.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.19 -46.35 90.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 173.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -81.07 -44.02 18.62 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 120.8 -1.188 . . . . 0.0 114.127 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -85.86 -17.77 34.68 Favored 'General case' 0 CA--C 1.501 -0.933 0 O-C-N 120.336 -1.477 . . . . 0.0 111.111 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.46 85.35 0.41 Allowed Glycine 0 N--CA 1.435 -1.412 0 CA-C-O 117.804 -1.554 . . . . 0.0 110.633 163.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -62.45 -28.18 77.78 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 CA-C-N 123.071 3.435 . . . . 0.0 109.378 160.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.352 0.711 0 C-N-CA 123.153 0.581 . . . . 0.0 112.516 163.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.4 pt . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.7 mt -60.48 -35.23 75.42 Favored 'General case' 0 C--N 1.345 0.403 0 O-C-N 120.495 -1.378 . . . . 0.0 113.17 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.85 98.79 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-O 122.193 0.997 . . . . 0.0 112.646 169.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.1 m -64.02 -41.03 97.58 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 120.269 -1.52 . . . . 0.0 113.896 173.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.05 -42.11 99.65 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 120.85 -1.156 . . . . 0.0 113.095 173.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.77 -42.06 92.49 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.676 1.19 . . . . 0.0 112.55 173.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.72 -48.38 66.66 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 172.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -76.95 -45.67 26.82 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -173.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -105.03 -9.28 17.96 Favored 'General case' 0 CA--C 1.5 -0.944 0 O-C-N 121.198 -0.939 . . . . 0.0 110.329 -173.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -107.13 61.45 0.32 Allowed Glycine 0 CA--C 1.5 -0.867 0 CA-C-O 115.603 -2.776 . . . . 0.0 112.134 162.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -65.53 -23.24 57.7 Favored 'Trans proline' 0 N--CA 1.46 -0.493 1 CA-C-N 127.081 5.441 . . . . 0.0 110.714 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.352 0.699 0 C-N-CA 122.998 0.519 . . . . 0.0 112.171 165.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.3 pt . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.6 mt -50.94 -38.94 53.55 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.21 -42.94 99.76 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 120.657 -1.277 . . . . 0.0 113.011 171.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.6 m -68.41 -34.04 75.31 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 120.085 -1.635 . . . . 0.0 114.137 172.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.79 -38.12 89.91 Favored 'General case' 0 CA--C 1.508 -0.665 0 O-C-N 119.575 -1.953 . . . . 0.0 113.236 172.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.61 -39.57 77.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.646 0.778 . . . . 0.0 111.551 168.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.27 -47.87 77.91 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 170.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -77.61 -43.12 32.61 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -171.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -91.39 -14.63 30.32 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 120.628 -1.295 . . . . 0.0 110.49 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -112.76 81.2 0.29 Allowed Glycine 0 N--CA 1.437 -1.262 0 CA-C-O 118.474 -1.181 . . . . 0.0 111.317 164.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -62.9 -27.41 74.76 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 CA-C-N 122.151 2.975 . . . . 0.0 109.36 160.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.35 0.603 0 CA-C-O 121.303 0.573 . . . . 0.0 112.403 163.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.7 pt . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 117.137 2.273 . . . . 0.0 117.137 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 64.9 mt -52.13 -41.42 62.49 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -173.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.42 -44.85 95.45 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-O 122.794 1.283 . . . . 0.0 112.685 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.0 m -65.49 -38.6 90.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.982 1.313 . . . . 0.0 113.793 173.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.5 mt -64.32 -38.86 92.53 Favored 'General case' 0 CA--C 1.504 -0.793 0 O-C-N 120.536 -1.352 . . . . 0.0 113.954 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.69 -47.06 83.39 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.25 0.548 . . . . 0.0 111.232 173.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.74 -46.63 87.17 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 169.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.79 -38.4 70.29 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 118.061 -2.899 . . . . 0.0 115.833 -176.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -92.21 -22.24 19.92 Favored 'General case' 0 CA--C 1.496 -1.098 0 O-C-N 119.703 -1.873 . . . . 0.0 112.573 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.27 90.13 0.89 Allowed Glycine 0 CA--C 1.492 -1.38 0 CA-C-O 116.494 -2.281 . . . . 0.0 109.421 161.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -63.59 -27.82 69.57 Favored 'Trans proline' 0 CA--C 1.517 -0.373 1 CA-C-N 125.654 4.727 . . . . 0.0 109.882 170.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 89.7 mttt . . . . . 0 N--CA 1.445 -0.722 0 C-N-CA 125.953 1.701 . . . . 0.0 112.453 164.364 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.6 pt . . . . . 0 C--O 1.224 -0.24 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 62.4 mt -38.16 -46.1 1.01 Allowed 'General case' 0 C--N 1.347 0.462 0 C-N-CA 128.242 2.617 . . . . 0.0 117.571 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.53 -45.99 90.47 Favored 'General case' 0 C--N 1.35 0.602 0 O-C-N 120.702 -1.249 . . . . 0.0 113.123 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.3 m -65.76 -39.48 91.09 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 124.994 1.317 . . . . 0.0 113.456 171.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.3 mt -62.59 -36.66 83.42 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 120.718 -1.238 . . . . 0.0 113.634 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.58 -49.09 78.73 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 118.508 0.595 . . . . 0.0 111.795 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.88 -46.15 90.64 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 168.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.13 -38.41 82.16 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 118.642 -2.536 . . . . 0.0 116.589 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -94.48 -19.62 20.4 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 119.589 -1.944 . . . . 0.0 112.37 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.49 93.49 1.43 Allowed Glycine 0 CA--C 1.489 -1.549 0 CA-C-O 116.646 -2.196 . . . . 0.0 110.32 163.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.87 -25.87 67.41 Favored 'Trans proline' 0 C--N 1.328 -0.533 1 CA-C-N 125.779 4.79 . . . . 0.0 110.653 171.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.692 0 C-N-CA 124.068 0.947 . . . . 0.0 112.647 162.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.0 pt . . . . . 0 C--O 1.224 -0.284 0 N-CA-C 117.178 2.288 . . . . 0.0 117.178 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.6 mt -39.05 -43.69 1.03 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 127.744 2.417 . . . . 0.0 117.192 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.25 -43.12 99.56 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 120.512 -1.367 . . . . 0.0 113.309 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 m -69.47 -33.89 73.57 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 120.042 -1.661 . . . . 0.0 113.845 172.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.08 -36.84 85.6 Favored 'General case' 0 CA--C 1.509 -0.63 0 O-C-N 119.919 -1.738 . . . . 0.0 113.296 172.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.42 -42.35 82.19 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.776 0.831 . . . . 0.0 111.235 168.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.17 -49.39 77.38 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 168.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -76.64 -41.66 44.96 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -101.81 -5.51 24.76 Favored 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 120.32 -1.488 . . . . 0.0 111.107 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -112.57 82.33 0.3 Allowed Glycine 0 N--CA 1.437 -1.295 0 CA-C-O 118.644 -1.087 . . . . 0.0 110.73 164.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -62.59 -31.15 79.79 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 122.029 2.915 . . . . 0.0 109.659 162.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.8 mptt . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 162.6 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.6 pt . . . . . 0 N--CA 1.446 -0.631 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.7 mt -57.65 -37.05 72.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 120.344 -1.473 . . . . 0.0 114.415 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.48 -43.56 98.52 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-O 122.697 1.237 . . . . 0.0 112.606 169.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.2 m -66.06 -35.88 81.73 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 120.366 -1.458 . . . . 0.0 114.746 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.4 mt -65.91 -39.96 91.04 Favored 'General case' 0 CA--C 1.504 -0.801 0 O-C-N 119.63 -1.919 . . . . 0.0 113.189 172.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.17 89.23 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 122.965 0.506 . . . . 0.0 111.113 168.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.33 -46.05 91.86 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 173.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -83.89 -43.7 15.03 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 120.753 -1.217 . . . . 0.0 114.174 -173.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -85.01 -19.7 31.6 Favored 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 120.418 -1.426 . . . . 0.0 111.171 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.18 85.12 0.4 Allowed Glycine 0 N--CA 1.435 -1.367 0 CA-C-O 118.067 -1.407 . . . . 0.0 110.411 161.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -62.43 -31.04 80.95 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 CA-C-N 122.873 3.337 . . . . 0.0 109.056 160.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.443 -0.779 0 C-N-CA 124.746 1.218 . . . . 0.0 112.822 163.823 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.6 pt . . . . . 0 CA--C 1.513 -0.447 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.2 mt -33.1 -44.48 0.12 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 128.06 2.544 . . . . 0.0 117.821 174.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.72 96.11 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 120.582 -1.324 . . . . 0.0 113.155 174.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.2 m -70.7 -30.66 67.28 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.226 -1.546 . . . . 0.0 113.558 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.9 mt -66.96 -40.27 87.44 Favored 'General case' 0 CA--C 1.509 -0.597 0 O-C-N 119.525 -1.984 . . . . 0.0 113.559 170.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.7 -43.53 90.05 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.866 0.866 . . . . 0.0 111.317 169.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.2 -46.84 88.36 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 172.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -79.45 -44.05 22.11 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 120.282 -1.511 . . . . 0.0 114.679 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -85.88 -18.41 32.84 Favored 'General case' 0 CA--C 1.501 -0.928 0 O-C-N 120.156 -1.59 . . . . 0.0 111.177 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -107.2 85.11 0.41 Allowed Glycine 0 N--CA 1.436 -1.354 0 CA-C-O 117.365 -1.797 . . . . 0.0 110.321 162.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -62.27 -27.59 78.23 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 CA-C-N 123.579 3.69 . . . . 0.0 109.469 160.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.352 0.7 0 C-N-CA 123.829 0.851 . . . . 0.0 112.419 164.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.3 pt . . . . . 0 N--CA 1.447 -0.59 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.6 mt -55.95 -40.22 72.89 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.77 -42.93 97.7 Favored 'General case' 0 C--N 1.349 0.565 0 O-C-N 120.823 -1.173 . . . . 0.0 112.376 171.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.7 m -66.08 -35.98 81.98 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 174.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.0 mt -65.18 -42.01 94.06 Favored 'General case' 0 CA--C 1.506 -0.739 0 O-C-N 119.671 -1.893 . . . . 0.0 112.788 172.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.29 -42.4 91.2 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 123.327 0.651 . . . . 0.0 111.345 169.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.3 -47.83 82.54 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 174.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -84.9 -48.1 9.65 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 119.959 -1.713 . . . . 0.0 112.841 -173.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -84.56 -16.45 42.18 Favored 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 120.518 -1.364 . . . . 0.0 111.123 -175.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.47 84.89 0.47 Allowed Glycine 0 N--CA 1.436 -1.362 0 CA-C-O 117.8 -1.556 . . . . 0.0 111.089 159.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.29 -28.53 63.76 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 CA-C-N 123.461 3.63 . . . . 0.0 109.638 165.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? . . . . . 0 N--CA 1.445 -0.695 0 C-N-CA 122.921 0.488 . . . . 0.0 112.149 163.928 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.513 -0.479 0 N-CA-C 117.081 2.252 . . . . 0.0 117.081 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.1 mt -39.45 -42.32 1.09 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 127.667 2.387 . . . . 0.0 116.987 177.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.95 -43.72 98.25 Favored 'General case' 0 C--N 1.35 0.616 0 O-C-N 120.624 -1.298 . . . . 0.0 112.967 173.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.5 m -71.84 -29.27 64.23 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 120.199 -1.563 . . . . 0.0 113.741 172.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.57 -38.95 88.15 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 119.362 -2.086 . . . . 0.0 113.315 170.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.21 -41.78 84.79 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.536 0.734 . . . . 0.0 111.015 168.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.01 -47.27 87.21 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 172.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -80.52 -42.66 22.07 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -173.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -86.39 -18.76 30.97 Favored 'General case' 0 CA--C 1.502 -0.871 0 O-C-N 120.287 -1.508 . . . . 0.0 110.983 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -111.94 85.43 0.39 Allowed Glycine 0 N--CA 1.435 -1.377 0 CA-C-O 118.075 -1.403 . . . . 0.0 111.212 164.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -61.88 -29.54 82.64 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 CA-C-N 122.508 3.154 . . . . 0.0 109.264 157.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.3 mttt . . . . . 0 N--CA 1.445 -0.705 0 C-N-CA 124.136 0.974 . . . . 0.0 112.461 163.654 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.254 45.2 pt . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 20.6 mt -35.41 -33.72 0.03 OUTLIER 'General case' 0 C--N 1.356 0.851 0 C-N-CA 129.311 3.044 . . . . 0.0 118.35 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.64 85.96 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-O 123.026 1.393 . . . . 0.0 112.619 171.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.9 p -77.4 -19.23 56.45 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 120.301 -1.499 . . . . 0.0 113.402 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.6 mt -65.84 -39.19 90.55 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 120.188 -1.57 . . . . 0.0 112.478 169.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.55 -44.07 89.54 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 121.867 -0.521 . . . . 0.0 111.531 168.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.29 -40.26 93.48 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 174.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -89.75 -46.88 8.28 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -93.47 -9.13 39.54 Favored 'General case' 0 CA--C 1.492 -1.271 0 O-C-N 120.503 -1.373 . . . . 0.0 112.039 -172.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.77 82.6 0.3 Allowed Glycine 0 N--CA 1.43 -1.727 0 O-C-N 121.144 -0.973 . . . . 0.0 111.41 170.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -65.11 -32.13 53.35 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 CA-C-N 123.289 3.544 . . . . 0.0 110.256 157.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.7 tptm . . . . . 0 C--N 1.348 0.522 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 166.228 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 CA--C 1.511 -0.543 0 N-CA-C 117.034 2.235 . . . . 0.0 117.034 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 62.8 mt -53.72 -38.77 64.64 Favored 'General case' 0 C--N 1.344 0.368 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.98 97.81 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-O 122.46 1.124 . . . . 0.0 112.772 170.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.8 m -67.85 -35.44 78.57 Favored 'General case' 0 C--N 1.343 0.32 0 O-C-N 120.178 -1.577 . . . . 0.0 114.5 174.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.2 mt -65.45 -39.17 91.71 Favored 'General case' 0 CA--C 1.509 -0.63 0 O-C-N 119.733 -1.854 . . . . 0.0 113.391 172.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.1 -39.2 78.02 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.622 0.769 . . . . 0.0 111.356 168.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.49 -48.77 71.44 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 170.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -77.59 -42.67 34.29 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 120.775 -1.203 . . . . 0.0 114.111 -171.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -94.93 -7.75 39.06 Favored 'General case' 0 CA--C 1.502 -0.9 0 O-C-N 120.769 -1.207 . . . . 0.0 110.105 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -117.38 78.8 0.29 Allowed Glycine 0 N--CA 1.432 -1.59 0 CA-C-O 117.215 -1.881 . . . . 0.0 111.184 161.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -62.62 -35.94 67.1 Favored 'Trans proline' 0 CA--C 1.512 -0.588 0 CA-C-N 123.607 3.703 . . . . 0.0 109.351 167.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.703 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 166.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.4 pt . . . . . 0 C--O 1.223 -0.325 0 N-CA-C 117.19 2.293 . . . . 0.0 117.19 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.8 mt -39.93 -42.68 1.39 Allowed 'General case' 0 C--N 1.343 0.311 0 C-N-CA 127.754 2.422 . . . . 0.0 117.356 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.92 -43.45 98.82 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 120.592 -1.318 . . . . 0.0 113.191 173.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 14.2 m -70.73 -31.33 68.13 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 119.902 -1.749 . . . . 0.0 113.873 171.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.66 -36.44 82.55 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 119.261 -2.15 . . . . 0.0 113.41 171.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.03 -38.93 77.16 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.817 0.847 . . . . 0.0 111.465 168.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 7' ' ' SER . . . -63.56 -48.57 76.9 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 169.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -77.31 -41.92 38.77 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -170.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -95.05 -5.55 44.15 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 120.627 -1.296 . . . . 0.0 110.177 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -122.58 81.34 0.35 Allowed Glycine 0 N--CA 1.43 -1.705 0 CA-C-O 117.713 -1.604 . . . . 0.0 110.673 164.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.47 -34.33 86.15 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 CA-C-N 122.719 3.259 . . . . 0.0 109.688 164.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.665 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 165.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.8 pt . . . . . 0 CA--C 1.511 -0.536 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.56 -39.0 82.62 Favored 'General case' 0 C--N 1.346 0.425 0 O-C-N 119.953 -1.717 . . . . 0.0 113.599 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.15 -42.87 99.67 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-O 122.507 1.146 . . . . 0.0 112.79 169.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.1 m -63.96 -39.27 93.75 Favored 'General case' 0 C--N 1.345 0.395 0 O-C-N 120.426 -1.421 . . . . 0.0 114.275 174.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.8 mt -64.6 -40.97 96.47 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 120.421 -1.424 . . . . 0.0 113.132 173.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.32 -44.66 88.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.318 0.58 . . . . 0.0 111.519 171.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.88 -45.82 87.68 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 171.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.84 -25.76 19.73 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 118.416 -2.677 . . . . 0.0 114.356 -169.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -99.17 -12.35 20.54 Favored 'General case' 0 CA--C 1.498 -1.024 0 O-C-N 119.548 -1.97 . . . . 0.0 111.209 173.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.68 83.36 0.36 Allowed Glycine 0 N--CA 1.438 -1.176 0 CA-C-O 117.159 -1.912 . . . . 0.0 109.832 157.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -63.06 -29.92 75.45 Favored 'Trans proline' 0 CA--C 1.517 -0.35 1 CA-C-N 124.468 4.134 . . . . 0.0 110.093 168.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--N 1.353 0.747 0 C-N-CA 123.815 0.846 . . . . 0.0 111.887 164.364 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.5 pt . . . . . 0 N--CA 1.446 -0.675 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 64.5 mt -59.56 -38.47 81.18 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 120.122 -1.611 . . . . 0.0 114.671 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.5 -44.67 95.8 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-O 122.805 1.288 . . . . 0.0 112.137 170.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.5 m -63.92 -38.92 92.87 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.952 1.301 . . . . 0.0 114.174 175.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.71 -41.2 92.59 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 125.215 1.406 . . . . 0.0 113.817 175.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.72 -45.91 88.54 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-O 121.888 0.852 . . . . 0.0 111.115 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.44 -48.21 80.67 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 170.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -72.24 -43.52 64.26 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 118.012 -2.93 . . . . 0.0 115.161 -177.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -85.33 -24.12 27.78 Favored 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 120.132 -1.605 . . . . 0.0 112.165 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.2 92.72 0.95 Allowed Glycine 0 CA--C 1.492 -1.389 0 CA-C-O 116.616 -2.213 . . . . 0.0 110.026 167.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -63.7 -28.46 68.82 Favored 'Trans proline' 0 C--N 1.329 -0.484 1 CA-C-N 125.269 4.535 . . . . 0.0 110.028 164.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm . . . . . 0 C--N 1.35 0.626 0 C-N-CA 125.203 1.401 . . . . 0.0 112.828 164.426 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.5 pt . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.0 mt -52.64 -40.04 62.39 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -174.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.81 -44.42 96.89 Favored 'General case' 0 C--N 1.35 0.596 0 CA-C-O 122.621 1.201 . . . . 0.0 112.772 172.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.7 m -67.42 -33.9 76.12 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 120.49 -1.381 . . . . 0.0 113.948 173.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.4 mt -65.01 -40.77 95.38 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 119.968 -1.708 . . . . 0.0 113.462 172.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.03 -45.71 90.04 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.461 0.648 . . . . 0.0 111.103 171.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.51 -45.71 93.04 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 172.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.29 -47.72 26.58 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 118.312 -2.742 . . . . 0.0 114.86 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -97.03 -8.98 29.05 Favored 'General case' 0 CA--C 1.498 -1.052 0 O-C-N 120.28 -1.513 . . . . 0.0 111.491 -169.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.31 92.69 0.94 Allowed Glycine 0 N--CA 1.435 -1.415 0 CA-C-O 117.5 -1.722 . . . . 0.0 109.449 158.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.69 -28.78 69.01 Favored 'Trans proline' 0 C--N 1.329 -0.497 0 CA-C-N 123.876 3.838 . . . . 0.0 109.493 160.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt . . . . . 0 C--N 1.351 0.639 0 C-N-CA 123.471 0.708 . . . . 0.0 112.641 164.032 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.313 20.7 pt . . . . . 0 C--O 1.225 -0.196 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 53.6 mt -51.42 -33.62 31.25 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 120.24 -1.538 . . . . 0.0 114.731 174.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.13 -39.67 79.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.759 0.79 . . . . 0.0 111.856 173.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.5 m -64.91 -35.97 82.86 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 120.522 -1.361 . . . . 0.0 114.343 171.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.0 mt -62.9 -45.48 92.31 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 120.269 -1.519 . . . . 0.0 112.875 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.63 -21.67 59.33 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 120.968 -1.083 . . . . 0.0 113.804 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.89 -31.08 23.9 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 119.51 -1.994 . . . . 0.0 113.739 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -97.83 -31.52 12.18 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 120.272 -1.517 . . . . 0.0 111.352 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -110.11 9.17 24.09 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 120.457 -1.402 . . . . 0.0 110.879 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -141.7 46.47 0.89 Allowed Glycine 0 C--N 1.348 1.22 0 CA-C-O 117.827 -1.54 . . . . 0.0 116.062 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -62.33 -22.54 74.25 Favored 'Trans proline' 0 CA--C 1.515 -0.433 0 CA-C-N 122.921 3.361 . . . . 0.0 113.199 -172.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.353 0.757 0 CA-C-N 118.653 0.661 . . . . 0.0 111.996 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 43.5 p90 . . . . . 0 N--CA 1.438 -1.038 0 CA-C-O 120.9 0.381 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 68.17 160.06 0.14 Allowed Pre-proline 0 C--N 1.355 0.824 0 C-N-CA 123.947 0.899 . . . . 0.0 111.896 -171.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -65.6 -167.17 0.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 O-C-N 117.226 -2.039 . . . . 0.0 111.125 151.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.2 pt -49.02 -28.27 2.41 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 N-CA-C 117.701 2.482 . . . . 0.0 117.701 -170.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.0 mt -34.99 -45.34 0.26 Allowed 'General case' 0 C--N 1.344 0.365 0 N-CA-C 117.738 2.496 . . . . 0.0 117.738 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.93 -45.44 92.47 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 120.695 -1.253 . . . . 0.0 113.223 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.2 m -67.78 -31.92 72.13 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 120.113 -1.617 . . . . 0.0 114.077 171.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.63 -40.24 92.35 Favored 'General case' 0 CA--C 1.511 -0.529 0 O-C-N 119.235 -2.166 . . . . 0.0 113.375 170.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.4 -42.56 87.41 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 123.415 0.686 . . . . 0.0 111.156 169.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.84 -43.92 97.64 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 172.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -84.28 -41.96 16.33 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 120.25 -1.531 . . . . 0.0 113.968 -173.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -86.58 -18.92 30.23 Favored 'General case' 0 CA--C 1.503 -0.841 0 O-C-N 120.323 -1.486 . . . . 0.0 111.274 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -107.7 86.86 0.47 Allowed Glycine 0 N--CA 1.435 -1.401 0 CA-C-O 117.771 -1.572 . . . . 0.0 110.897 162.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -62.2 -27.64 78.65 Favored 'Trans proline' 0 CA--C 1.514 -0.487 0 CA-C-N 123.095 3.447 . . . . 0.0 109.242 157.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -60.16 -47.85 84.19 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 123.859 0.864 . . . . 0.0 112.484 163.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.4 mt -68.79 -43.39 75.76 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.79 -37.03 83.77 Favored 'General case' 0 C--N 1.347 0.459 0 O-C-N 119.175 -2.203 . . . . 0.0 113.464 176.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 54.2 tp -88.51 -60.87 1.84 Allowed 'General case' 0 C--N 1.35 0.611 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.21 -46.51 77.47 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 C-N-CA 125.434 1.494 . . . . 0.0 111.783 -173.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.8 m -100.91 -1.67 33.97 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-O 122.357 1.075 . . . . 0.0 110.334 -174.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 55.07 45.62 25.81 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 125.716 1.606 . . . . 0.0 114.748 175.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -97.39 2.56 50.63 Favored 'General case' 0 CA--C 1.514 -0.442 0 O-C-N 118.831 -2.418 . . . . 0.0 113.622 -176.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 5.2 p90 . . . . . 0 N--CA 1.443 -0.808 0 CA-C-O 121.229 0.538 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.631 ' H ' HD22 ' A' ' 2' ' ' LEU . 1.5 mm? -45.98 148.7 1.37 Allowed Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 167.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -80.68 -23.01 6.1 Favored 'Trans proline' 0 CA--C 1.515 -0.45 0 CA-C-N 122.153 1.805 . . . . 0.0 109.518 -174.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.6 pt -54.17 -17.06 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 176.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.8 mt -59.43 -38.91 81.89 Favored 'General case' 0 C--N 1.345 0.404 0 O-C-N 120.053 -1.654 . . . . 0.0 113.725 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.26 99.15 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-O 122.55 1.166 . . . . 0.0 113.036 169.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.6 m -64.56 -39.15 93.23 Favored 'General case' 0 C--N 1.345 0.381 0 O-C-N 120.285 -1.509 . . . . 0.0 114.182 174.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.62 -38.42 90.95 Favored 'General case' 0 CA--C 1.51 -0.585 0 O-C-N 120.537 -1.352 . . . . 0.0 113.375 173.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.48 -39.57 80.37 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.862 0.865 . . . . 0.0 112.236 170.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . . . -67.65 -48.13 67.56 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 168.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -72.55 -42.73 64.35 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -172.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -93.6 -9.26 38.65 Favored 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 120.57 -1.331 . . . . 0.0 110.042 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -120.62 75.19 0.33 Allowed Glycine 0 N--CA 1.434 -1.464 0 CA-C-O 117.694 -1.614 . . . . 0.0 112.584 169.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.81 -29.42 76.71 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 CA-C-N 123.022 3.411 . . . . 0.0 109.025 157.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.2 mtpp -59.6 -45.77 90.92 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.736 1.614 . . . . 0.0 112.839 165.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.7 mp -68.65 -46.1 70.05 Favored 'General case' 0 C--N 1.354 0.761 0 O-C-N 121.031 -1.043 . . . . 0.0 111.934 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -74.71 -10.78 59.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 120.534 -1.354 . . . . 0.0 114.622 -168.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.4 mp -101.92 -58.8 1.81 Allowed 'General case' 0 C--N 1.349 0.555 0 C-N-CA 124.305 1.042 . . . . 0.0 108.453 169.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.4 t -57.02 -37.78 56.73 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 C-N-CA 127.309 2.244 . . . . 0.0 114.207 -165.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 m -141.56 32.53 1.65 Allowed 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 119.471 -2.018 . . . . 0.0 108.768 169.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.2 ptmm? 31.94 58.17 0.34 Allowed 'General case' 0 C--N 1.347 0.475 0 N-CA-C 119.274 3.065 . . . . 0.0 119.274 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -96.21 14.98 22.24 Favored 'General case' 0 C--O 1.224 -0.25 0 O-C-N 119.899 -1.751 . . . . 0.0 112.073 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 39.5 p90 . . . . . 0 N--CA 1.44 -0.943 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.1 mp 70.12 160.89 0.15 Allowed Pre-proline 0 C--N 1.354 0.791 0 C-N-CA 123.774 0.829 . . . . 0.0 112.087 -173.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -66.97 -160.96 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.773 0 O-C-N 117.797 -1.738 . . . . 0.0 111.551 152.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.8 pt -49.58 -27.86 3.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 N-CA-C 117.028 2.233 . . . . 0.0 117.028 -171.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.8 mt -41.88 -43.07 2.92 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.57 -44.04 97.76 Favored 'General case' 0 C--N 1.351 0.661 0 O-C-N 120.686 -1.259 . . . . 0.0 113.004 172.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.1 m -67.38 -33.5 75.33 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 120.394 -1.442 . . . . 0.0 114.153 172.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.9 -42.49 90.16 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 119.739 -1.85 . . . . 0.0 113.315 171.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.1 -40.68 86.09 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 123.827 0.851 . . . . 0.0 111.331 170.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.02 -48.53 78.37 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 172.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -81.3 -45.92 15.49 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 119.463 -2.023 . . . . 0.0 112.729 -175.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -91.2 -8.5 48.37 Favored 'General case' 0 CA--C 1.5 -0.958 0 O-C-N 120.583 -1.323 . . . . 0.0 111.034 -173.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.8 81.58 0.38 Allowed Glycine 0 N--CA 1.439 -1.145 0 CA-C-O 117.625 -1.653 . . . . 0.0 110.626 156.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.07 -19.55 29.82 Favored 'Trans proline' 0 CA--C 1.512 -0.578 0 CA-C-N 123.895 3.847 . . . . 0.0 108.908 167.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -66.76 -45.77 77.48 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 161.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.7 mt -66.05 -41.85 90.3 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.28 18.51 9.45 Favored 'General case' 0 C--N 1.343 0.302 0 O-C-N 119.502 -1.999 . . . . 0.0 113.189 -177.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 58.4 tp -120.59 -71.49 0.73 Allowed 'General case' 0 C--N 1.353 0.729 0 C-N-CA 124.685 1.194 . . . . 0.0 110.159 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.5 t -62.05 -43.24 97.42 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 126.799 2.04 . . . . 0.0 110.91 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.4 m -121.44 137.06 54.88 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -79.54 72.19 6.18 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 119.915 -1.741 . . . . 0.0 114.64 171.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -99.59 -1.92 36.97 Favored 'General case' 0 C--N 1.348 0.532 0 O-C-N 119.27 -2.144 . . . . 0.0 111.202 167.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 39.5 t80 . . . . . 0 N--CA 1.44 -0.955 0 CA-C-O 122.071 0.938 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.1 mp -140.86 160.75 57.33 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 101.306 -3.59 . . . . 0.0 101.306 168.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -93.44 -133.57 0.01 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.485 0 N-CA-C 107.326 -1.836 . . . . 0.0 107.326 167.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.6 pt -49.74 -27.91 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.1 mt -54.27 -40.15 67.54 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -173.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.35 -42.42 99.38 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-O 122.727 1.251 . . . . 0.0 112.801 171.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.2 m -68.68 -32.73 72.75 Favored 'General case' 0 C--N 1.343 0.323 0 O-C-N 120.192 -1.568 . . . . 0.0 114.387 173.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.8 mt -66.12 -40.1 90.42 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 119.429 -2.044 . . . . 0.0 112.981 171.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.44 -43.01 88.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.062 0.545 . . . . 0.0 111.324 168.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.496 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -60.19 -46.35 90.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 173.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -81.07 -44.02 18.62 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 120.8 -1.188 . . . . 0.0 114.127 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -85.86 -17.77 34.68 Favored 'General case' 0 CA--C 1.501 -0.933 0 O-C-N 120.336 -1.477 . . . . 0.0 111.111 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.46 85.35 0.41 Allowed Glycine 0 N--CA 1.435 -1.412 0 CA-C-O 117.804 -1.554 . . . . 0.0 110.633 163.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -62.45 -28.18 77.78 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 CA-C-N 123.071 3.435 . . . . 0.0 109.378 160.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.32 -46.53 89.9 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 123.153 0.581 . . . . 0.0 112.516 163.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.5 mt -66.99 -43.06 83.94 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 120.61 -1.307 . . . . 0.0 114.395 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.496 ' CE2' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -68.46 -31.85 71.43 Favored 'General case' 0 C--N 1.346 0.452 0 O-C-N 119.016 -2.302 . . . . 0.0 113.619 175.822 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -89.48 -56.76 3.13 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.76 -47.02 78.52 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 C-N-CA 125.23 1.412 . . . . 0.0 111.478 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.3 m -103.85 -0.6 28.95 Favored 'General case' 0 C--N 1.346 0.417 0 O-C-N 120.868 -1.145 . . . . 0.0 110.656 -172.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 56.2 50.11 14.1 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 173.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -106.97 15.75 25.0 Favored 'General case' 0 CA--C 1.514 -0.404 0 O-C-N 119.311 -2.118 . . . . 0.0 112.85 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 34.9 p90 . . . . . 0 N--CA 1.442 -0.84 0 CA-C-O 121.506 0.67 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 64.1 mt -43.71 144.6 1.35 Allowed Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 171.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -81.16 -28.09 2.6 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 O-C-N 117.722 -1.778 . . . . 0.0 109.591 -171.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.4 pt -53.71 -17.62 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 174.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.7 mt -60.48 -35.23 75.42 Favored 'General case' 0 C--N 1.345 0.403 0 O-C-N 120.495 -1.378 . . . . 0.0 113.17 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.85 98.79 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-O 122.193 0.997 . . . . 0.0 112.646 169.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.1 m -64.02 -41.03 97.58 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 120.269 -1.52 . . . . 0.0 113.896 173.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.05 -42.11 99.65 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 120.85 -1.156 . . . . 0.0 113.095 173.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.77 -42.06 92.49 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.676 1.19 . . . . 0.0 112.55 173.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.72 -48.38 66.66 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 172.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -76.95 -45.67 26.82 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -173.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -105.03 -9.28 17.96 Favored 'General case' 0 CA--C 1.5 -0.944 0 O-C-N 121.198 -0.939 . . . . 0.0 110.329 -173.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -107.13 61.45 0.32 Allowed Glycine 0 CA--C 1.5 -0.867 0 CA-C-O 115.603 -2.776 . . . . 0.0 112.134 162.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -65.53 -23.24 57.7 Favored 'Trans proline' 0 N--CA 1.46 -0.493 1 CA-C-N 127.081 5.441 . . . . 0.0 110.714 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -47.28 85.76 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 122.998 0.519 . . . . 0.0 112.171 165.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.48 -44.56 86.72 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 121.227 -0.921 . . . . 0.0 111.894 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -60.88 -41.53 96.17 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 124.081 0.952 . . . . 0.0 112.935 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.4 mp -73.07 -43.44 61.87 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 119.932 -1.73 . . . . 0.0 112.282 176.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.23 -41.02 81.05 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 O-C-N 121.078 -1.014 . . . . 0.0 111.98 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.7 p -134.57 148.42 50.45 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 119.916 -1.74 . . . . 0.0 112.131 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -76.12 84.97 2.97 Favored 'General case' 0 C--N 1.344 0.35 0 O-C-N 117.768 -3.083 . . . . 0.0 112.643 172.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.46 -3.6 22.32 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 119.836 -1.79 . . . . 0.0 109.164 158.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 37.2 t80 . . . . . 0 N--CA 1.437 -1.104 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -45.3 159.15 0.29 Allowed Pre-proline 0 C--N 1.349 0.584 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 156.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -88.02 -155.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.451 0 N-CA-C 108.525 -1.375 . . . . 0.0 108.525 165.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.3 pt -49.08 -28.14 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 127.438 2.295 . . . . 0.0 116.881 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.6 mt -50.94 -38.94 53.55 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.21 -42.94 99.76 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 120.657 -1.277 . . . . 0.0 113.011 171.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.6 m -68.41 -34.04 75.31 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 120.085 -1.635 . . . . 0.0 114.137 172.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.79 -38.12 89.91 Favored 'General case' 0 CA--C 1.508 -0.665 0 O-C-N 119.575 -1.953 . . . . 0.0 113.236 172.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.61 -39.57 77.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.646 0.778 . . . . 0.0 111.551 168.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.27 -47.87 77.91 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 170.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -77.61 -43.12 32.61 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -171.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -91.39 -14.63 30.32 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 120.628 -1.295 . . . . 0.0 110.49 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -112.76 81.2 0.29 Allowed Glycine 0 N--CA 1.437 -1.262 0 CA-C-O 118.474 -1.181 . . . . 0.0 111.317 164.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -62.9 -27.41 74.76 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 CA-C-N 122.151 2.975 . . . . 0.0 109.36 160.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.45 -46.98 87.78 Favored 'General case' 0 C--N 1.35 0.603 0 CA-C-O 121.303 0.573 . . . . 0.0 112.403 163.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.0 mp -67.4 -44.4 78.92 Favored 'General case' 0 C--N 1.35 0.626 0 O-C-N 120.946 -1.096 . . . . 0.0 113.654 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.35 -18.29 55.34 Favored 'General case' 0 C--N 1.348 0.514 0 O-C-N 119.066 -2.272 . . . . 0.0 114.208 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 51.6 tp -90.12 -63.9 1.21 Allowed 'General case' 0 C--N 1.349 0.571 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.5 t -64.91 -46.63 91.18 Favored 'Isoleucine or valine' 0 C--N 1.35 0.587 0 C-N-CA 126.639 1.976 . . . . 0.0 111.96 -171.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.1 m -103.67 2.32 33.01 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-O 122.696 1.236 . . . . 0.0 110.075 -176.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.88 44.53 25.72 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.994 1.717 . . . . 0.0 115.242 167.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -104.15 7.63 36.23 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 119.208 -2.183 . . . . 0.0 113.342 -176.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 CA--C 1.504 -0.801 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -109.74 159.05 33.07 Favored Pre-proline 0 N--CA 1.437 -1.091 0 N-CA-C 103.023 -2.954 . . . . 0.0 103.023 162.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -87.62 -151.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.382 0 N-CA-C 108.198 -1.501 . . . . 0.0 108.198 162.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.7 pt -50.12 -27.45 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 117.137 2.273 . . . . 0.0 117.137 -176.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 64.9 mt -52.13 -41.42 62.49 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -173.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.42 -44.85 95.45 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-O 122.794 1.283 . . . . 0.0 112.685 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.0 m -65.49 -38.6 90.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.982 1.313 . . . . 0.0 113.793 173.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.5 mt -64.32 -38.86 92.53 Favored 'General case' 0 CA--C 1.504 -0.793 0 O-C-N 120.536 -1.352 . . . . 0.0 113.954 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.69 -47.06 83.39 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.25 0.548 . . . . 0.0 111.232 173.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.468 ' HB1' ' CD1' ' A' ' 17' ' ' PHE . . . -62.74 -46.63 87.17 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 169.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.79 -38.4 70.29 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 118.061 -2.899 . . . . 0.0 115.833 -176.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -92.21 -22.24 19.92 Favored 'General case' 0 CA--C 1.496 -1.098 0 O-C-N 119.703 -1.873 . . . . 0.0 112.573 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.27 90.13 0.89 Allowed Glycine 0 CA--C 1.492 -1.38 0 CA-C-O 116.494 -2.281 . . . . 0.0 109.421 161.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -63.59 -27.82 69.57 Favored 'Trans proline' 0 CA--C 1.517 -0.373 1 CA-C-N 125.654 4.727 . . . . 0.0 109.882 170.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -59.6 -45.12 92.86 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.953 1.701 . . . . 0.0 112.453 164.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.7 mt -67.85 -37.26 81.64 Favored 'General case' 0 C--N 1.35 0.602 0 O-C-N 120.766 -1.209 . . . . 0.0 113.865 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.468 ' CD1' ' HB1' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -61.28 -45.54 94.05 Favored 'General case' 0 C--N 1.348 0.532 0 O-C-N 119.161 -2.212 . . . . 0.0 111.482 174.818 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -80.92 -57.88 3.34 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 119.632 1.106 . . . . 0.0 113.5 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.79 -41.61 90.61 Favored 'Isoleucine or valine' 0 C--N 1.35 0.603 0 C-N-CA 125.772 1.629 . . . . 0.0 111.864 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.2 p -100.53 9.13 42.97 Favored 'General case' 0 C--N 1.349 0.571 0 O-C-N 120.762 -1.211 . . . . 0.0 112.262 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? 47.64 43.85 16.78 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 127.433 2.293 . . . . 0.0 116.857 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -118.71 14.57 13.49 Favored 'General case' 0 C--N 1.347 0.487 0 O-C-N 119.945 -1.722 . . . . 0.0 115.079 -168.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 CA--C 1.501 -0.906 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 64.17 171.19 0.09 OUTLIER Pre-proline 0 C--N 1.352 0.713 0 C-N-CA 125.069 1.348 . . . . 0.0 111.969 -170.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.64 -170.9 0.41 Allowed 'Trans proline' 0 N--CA 1.452 -0.953 0 O-C-N 118.029 -1.616 . . . . 0.0 110.477 151.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.6 pt -49.89 -27.79 3.78 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 -172.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 62.4 mt -38.16 -46.1 1.01 Allowed 'General case' 0 C--N 1.347 0.462 0 C-N-CA 128.242 2.617 . . . . 0.0 117.571 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.53 -45.99 90.47 Favored 'General case' 0 C--N 1.35 0.602 0 O-C-N 120.702 -1.249 . . . . 0.0 113.123 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.3 m -65.76 -39.48 91.09 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 124.994 1.317 . . . . 0.0 113.456 171.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.3 mt -62.59 -36.66 83.42 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 120.718 -1.238 . . . . 0.0 113.634 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.58 -49.09 78.73 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 118.508 0.595 . . . . 0.0 111.795 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.88 -46.15 90.64 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 168.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.13 -38.41 82.16 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 118.642 -2.536 . . . . 0.0 116.589 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -94.48 -19.62 20.4 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 119.589 -1.944 . . . . 0.0 112.37 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.49 93.49 1.43 Allowed Glycine 0 CA--C 1.489 -1.549 0 CA-C-O 116.646 -2.196 . . . . 0.0 110.32 163.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.87 -25.87 67.41 Favored 'Trans proline' 0 C--N 1.328 -0.533 1 CA-C-N 125.779 4.79 . . . . 0.0 110.653 171.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -45.42 92.98 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.068 0.947 . . . . 0.0 112.647 162.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.5 mt -70.29 -32.94 70.95 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.048 1.339 . . . . 0.0 113.834 176.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -42.85 97.96 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 119.301 -2.125 . . . . 0.0 111.847 173.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -92.55 -61.58 1.57 Allowed 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.6 t -65.66 -46.23 89.9 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 C-N-CA 125.612 1.565 . . . . 0.0 112.429 -168.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.4 p -99.89 5.95 45.3 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 120.908 -1.12 . . . . 0.0 110.84 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.13 49.39 20.1 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 172.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.29 15.35 20.41 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 119.139 -2.226 . . . . 0.0 114.455 -174.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 45.6 t80 . . . . . 0 N--CA 1.436 -1.142 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 63.96 171.1 0.09 OUTLIER Pre-proline 0 C--N 1.358 0.956 0 C-N-CA 124.521 1.128 . . . . 0.0 110.638 -157.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.55 -172.7 0.58 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 O-C-N 117.154 -2.077 . . . . 0.0 110.495 151.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.0 pt -49.43 -27.45 2.76 Favored 'Isoleucine or valine' 0 C--N 1.344 0.332 0 N-CA-C 117.178 2.288 . . . . 0.0 117.178 -173.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.6 mt -39.05 -43.69 1.03 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 127.744 2.417 . . . . 0.0 117.192 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.25 -43.12 99.56 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 120.512 -1.367 . . . . 0.0 113.309 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 m -69.47 -33.89 73.57 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 120.042 -1.661 . . . . 0.0 113.845 172.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.08 -36.84 85.6 Favored 'General case' 0 CA--C 1.509 -0.63 0 O-C-N 119.919 -1.738 . . . . 0.0 113.296 172.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.42 -42.35 82.19 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.776 0.831 . . . . 0.0 111.235 168.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.508 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -61.17 -49.39 77.38 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 168.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -76.64 -41.66 44.96 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -101.81 -5.51 24.76 Favored 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 120.32 -1.488 . . . . 0.0 111.107 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -112.57 82.33 0.3 Allowed Glycine 0 N--CA 1.437 -1.295 0 CA-C-O 118.644 -1.087 . . . . 0.0 110.73 164.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -62.59 -31.15 79.79 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 122.029 2.915 . . . . 0.0 109.659 162.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -64.45 -45.78 85.97 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 162.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.59 -41.36 92.92 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 120.234 -1.541 . . . . 0.0 113.897 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -75.16 -21.95 58.43 Favored 'General case' 0 C--N 1.349 0.545 0 O-C-N 118.975 -2.328 . . . . 0.0 114.276 174.831 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.2 mt -87.02 -57.89 2.8 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.87 -44.32 85.42 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 125.675 1.59 . . . . 0.0 112.389 -173.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.8 m -118.0 11.47 13.39 Favored 'General case' 0 C--N 1.345 0.399 0 O-C-N 120.914 -1.116 . . . . 0.0 110.828 -171.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.61 53.03 12.89 Favored 'General case' 0 C--N 1.348 0.514 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 168.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -109.15 23.71 14.14 Favored 'General case' 0 CA--C 1.517 -0.306 0 O-C-N 119.871 -1.768 . . . . 0.0 111.672 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 43.7 t80 . . . . . 0 N--CA 1.44 -0.933 0 CA-C-O 122.003 0.906 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 40.6 tp -123.37 144.05 42.89 Favored Pre-proline 0 N--CA 1.434 -1.257 0 N-CA-C 101.531 -3.507 . . . . 0.0 101.531 164.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -109.83 -120.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.959 0 CA-C-N 123.18 2.172 . . . . 0.0 107.608 -171.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.6 pt -49.67 -28.03 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 C-N-CA 127.065 2.146 . . . . 0.0 116.432 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.7 mt -57.65 -37.05 72.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 120.344 -1.473 . . . . 0.0 114.415 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.48 -43.56 98.52 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-O 122.697 1.237 . . . . 0.0 112.606 169.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.2 m -66.06 -35.88 81.73 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 120.366 -1.458 . . . . 0.0 114.746 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.4 mt -65.91 -39.96 91.04 Favored 'General case' 0 CA--C 1.504 -0.801 0 O-C-N 119.63 -1.919 . . . . 0.0 113.189 172.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.17 89.23 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 122.965 0.506 . . . . 0.0 111.113 168.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.468 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -61.33 -46.05 91.86 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 173.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -83.89 -43.7 15.03 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 120.753 -1.217 . . . . 0.0 114.174 -173.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -85.01 -19.7 31.6 Favored 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 120.418 -1.426 . . . . 0.0 111.171 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.18 85.12 0.4 Allowed Glycine 0 N--CA 1.435 -1.367 0 CA-C-O 118.067 -1.407 . . . . 0.0 110.411 161.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -62.43 -31.04 80.95 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 CA-C-N 122.873 3.337 . . . . 0.0 109.056 160.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.6 -45.91 90.52 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.746 1.218 . . . . 0.0 112.822 163.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.5 mt -66.92 -42.97 84.49 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 120.588 -1.32 . . . . 0.0 113.984 176.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -67.03 -33.78 76.28 Favored 'General case' 0 C--N 1.346 0.455 0 O-C-N 119.182 -2.199 . . . . 0.0 113.795 175.619 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.46 -58.64 2.46 Favored 'General case' 0 C--N 1.348 0.53 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.6 t -66.33 -45.49 89.43 Favored 'Isoleucine or valine' 0 C--N 1.347 0.492 0 C-N-CA 125.958 1.703 . . . . 0.0 112.091 -173.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.5 m -106.41 1.54 25.74 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 122.407 1.099 . . . . 0.0 110.326 -172.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.9 pttm 51.05 44.16 28.72 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 127.671 2.389 . . . . 0.0 116.684 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.7 mtpt -97.42 19.95 12.45 Favored 'General case' 0 C--N 1.347 0.466 0 O-C-N 119.289 -2.132 . . . . 0.0 113.498 -176.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 70.4 t80 . . . . . 0 N--CA 1.436 -1.131 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.2 tp 68.62 171.04 0.1 Allowed Pre-proline 0 C--N 1.356 0.885 0 C-N-CA 126.371 1.868 . . . . 0.0 110.137 -168.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -73.34 -170.63 0.68 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 O-C-N 116.743 -2.293 . . . . 0.0 111.147 154.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.6 pt -50.25 -28.74 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 127.143 2.177 . . . . 0.0 116.39 -174.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.2 mt -33.1 -44.48 0.12 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 128.06 2.544 . . . . 0.0 117.821 174.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.72 96.11 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 120.582 -1.324 . . . . 0.0 113.155 174.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.2 m -70.7 -30.66 67.28 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.226 -1.546 . . . . 0.0 113.558 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.9 mt -66.96 -40.27 87.44 Favored 'General case' 0 CA--C 1.509 -0.597 0 O-C-N 119.525 -1.984 . . . . 0.0 113.559 170.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.7 -43.53 90.05 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.866 0.866 . . . . 0.0 111.317 169.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.2 -46.84 88.36 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 172.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -79.45 -44.05 22.11 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 120.282 -1.511 . . . . 0.0 114.679 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -85.88 -18.41 32.84 Favored 'General case' 0 CA--C 1.501 -0.928 0 O-C-N 120.156 -1.59 . . . . 0.0 111.177 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -107.2 85.11 0.41 Allowed Glycine 0 N--CA 1.436 -1.354 0 CA-C-O 117.365 -1.797 . . . . 0.0 110.321 162.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -62.27 -27.59 78.23 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 CA-C-N 123.579 3.69 . . . . 0.0 109.469 160.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -45.79 92.04 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 123.829 0.851 . . . . 0.0 112.419 164.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.6 mt -69.16 -42.26 76.17 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.16 -35.64 80.11 Favored 'General case' 0 C--N 1.345 0.402 0 O-C-N 119.386 -2.071 . . . . 0.0 113.566 175.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 52.9 tp -85.47 -59.1 2.42 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.0 t -70.33 -46.92 69.37 Favored 'Isoleucine or valine' 0 C--N 1.348 0.527 0 C-N-CA 125.338 1.455 . . . . 0.0 111.626 -173.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.3 m -103.14 0.66 32.15 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-O 122.248 1.023 . . . . 0.0 110.819 -172.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 53.4 51.79 14.68 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 125.838 1.655 . . . . 0.0 115.183 174.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.7 mtpp -106.46 15.22 26.23 Favored 'General case' 0 C--N 1.345 0.376 0 O-C-N 119.578 -1.951 . . . . 0.0 112.609 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 12.5 p90 . . . . . 0 N--CA 1.442 -0.842 0 CA-C-O 122.104 0.954 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.0 mp -108.06 143.86 28.22 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 158.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -90.31 -121.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.266 0 N-CA-C 107.171 -1.896 . . . . 0.0 107.171 172.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.3 pt -49.69 -28.52 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.6 mt -55.95 -40.22 72.89 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.77 -42.93 97.7 Favored 'General case' 0 C--N 1.349 0.565 0 O-C-N 120.823 -1.173 . . . . 0.0 112.376 171.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.7 m -66.08 -35.98 81.98 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 174.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.0 mt -65.18 -42.01 94.06 Favored 'General case' 0 CA--C 1.506 -0.739 0 O-C-N 119.671 -1.893 . . . . 0.0 112.788 172.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.29 -42.4 91.2 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 123.327 0.651 . . . . 0.0 111.345 169.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.3 -47.83 82.54 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 174.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -84.9 -48.1 9.65 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 119.959 -1.713 . . . . 0.0 112.841 -173.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -84.56 -16.45 42.18 Favored 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 120.518 -1.364 . . . . 0.0 111.123 -175.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.47 84.89 0.47 Allowed Glycine 0 N--CA 1.436 -1.362 0 CA-C-O 117.8 -1.556 . . . . 0.0 111.089 159.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.29 -28.53 63.76 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 CA-C-N 123.461 3.63 . . . . 0.0 109.638 165.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -63.19 -45.75 90.28 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 122.921 0.488 . . . . 0.0 112.149 163.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.27 -42.32 84.06 Favored 'General case' 0 C--N 1.348 0.543 0 O-C-N 120.664 -1.273 . . . . 0.0 113.528 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.69 -35.32 80.43 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 119.054 -2.279 . . . . 0.0 114.072 173.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.6 mt -86.75 -55.21 3.96 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.3 t -71.55 -46.85 61.24 Favored 'Isoleucine or valine' 0 C--N 1.349 0.543 0 C-N-CA 124.876 1.27 . . . . 0.0 111.613 -175.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.9 m -103.35 -1.21 29.04 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 122.538 1.161 . . . . 0.0 110.912 -171.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.2 tmmt? 53.98 53.29 11.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.5 1.52 . . . . 0.0 114.717 176.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -108.16 13.75 25.62 Favored 'General case' 0 C--N 1.345 0.404 0 O-C-N 120.113 -1.617 . . . . 0.0 112.706 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 55.8 t80 . . . . . 0 N--CA 1.436 -1.165 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.4 tp 69.05 170.91 0.11 Allowed Pre-proline 0 C--N 1.356 0.855 0 C-N-CA 126.47 1.908 . . . . 0.0 109.44 -164.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -78.58 -164.54 0.28 Allowed 'Trans proline' 0 N--CA 1.451 -1.021 0 O-C-N 116.86 -2.231 . . . . 0.0 110.193 156.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -49.44 -27.92 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 C-N-CA 127.59 2.356 . . . . 0.0 117.081 -173.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.1 mt -39.45 -42.32 1.09 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 127.667 2.387 . . . . 0.0 116.987 177.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.95 -43.72 98.25 Favored 'General case' 0 C--N 1.35 0.616 0 O-C-N 120.624 -1.298 . . . . 0.0 112.967 173.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.5 m -71.84 -29.27 64.23 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 120.199 -1.563 . . . . 0.0 113.741 172.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.57 -38.95 88.15 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 119.362 -2.086 . . . . 0.0 113.315 170.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.21 -41.78 84.79 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.536 0.734 . . . . 0.0 111.015 168.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.576 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -61.01 -47.27 87.21 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 172.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -80.52 -42.66 22.07 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -173.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -86.39 -18.76 30.97 Favored 'General case' 0 CA--C 1.502 -0.871 0 O-C-N 120.287 -1.508 . . . . 0.0 110.983 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -111.94 85.43 0.39 Allowed Glycine 0 N--CA 1.435 -1.377 0 CA-C-O 118.075 -1.403 . . . . 0.0 111.212 164.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -61.88 -29.54 82.64 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 CA-C-N 122.508 3.154 . . . . 0.0 109.264 157.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -59.62 -47.85 83.98 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.136 0.974 . . . . 0.0 112.461 163.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 90.9 mt -67.44 -43.62 80.71 Favored 'General case' 0 C--N 1.35 0.592 0 O-C-N 120.741 -1.225 . . . . 0.0 114.143 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.576 ' CE2' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -69.72 -27.62 65.12 Favored 'General case' 0 C--N 1.347 0.464 0 O-C-N 119.116 -2.24 . . . . 0.0 113.666 176.674 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.6 mt -87.8 -54.83 4.05 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -177.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.3 t -69.97 -47.93 66.09 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 C-N-CA 125.015 1.326 . . . . 0.0 111.117 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.9 m -105.34 -0.08 26.53 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-O 122.494 1.14 . . . . 0.0 110.914 -169.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.15 49.74 14.89 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 174.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -106.6 15.89 25.23 Favored 'General case' 0 CA--C 1.517 -0.303 0 O-C-N 119.613 -1.929 . . . . 0.0 112.057 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 72.0 t80 . . . . . 0 N--CA 1.439 -1.0 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 75.6 mt 69.78 169.52 0.11 Allowed Pre-proline 0 C--N 1.359 1.002 0 C-N-CA 124.059 0.943 . . . . 0.0 110.902 -173.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -67.36 178.87 2.8 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 O-C-N 117.253 -2.025 . . . . 0.0 111.391 150.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.254 45.2 pt -44.44 -37.7 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 127.641 2.376 . . . . 0.0 115.243 -174.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 20.6 mt -35.41 -33.72 0.03 OUTLIER 'General case' 0 C--N 1.356 0.851 0 C-N-CA 129.311 3.044 . . . . 0.0 118.35 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.64 85.96 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-O 123.026 1.393 . . . . 0.0 112.619 171.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.9 p -77.4 -19.23 56.45 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 120.301 -1.499 . . . . 0.0 113.402 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.6 mt -65.84 -39.19 90.55 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 120.188 -1.57 . . . . 0.0 112.478 169.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.55 -44.07 89.54 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 121.867 -0.521 . . . . 0.0 111.531 168.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.505 ' HA ' ' CG ' ' A' ' 17' ' ' PHE . . . -61.29 -40.26 93.48 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 174.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -89.75 -46.88 8.28 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -93.47 -9.13 39.54 Favored 'General case' 0 CA--C 1.492 -1.271 0 O-C-N 120.503 -1.373 . . . . 0.0 112.039 -172.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.77 82.6 0.3 Allowed Glycine 0 N--CA 1.43 -1.727 0 O-C-N 121.144 -0.973 . . . . 0.0 111.41 170.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -65.11 -32.13 53.35 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 CA-C-N 123.289 3.544 . . . . 0.0 110.256 157.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -64.94 -44.71 88.54 Favored 'General case' 0 C--N 1.348 0.522 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 166.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 82.7 mt -70.52 -48.11 57.14 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.505 ' CG ' ' HA ' ' A' ' 10' ' ' ALA . 1.1 t80 -102.09 24.31 10.3 Favored 'General case' 0 CA--C 1.505 -0.782 0 O-C-N 119.135 -2.228 . . . . 0.0 113.096 -165.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 54.9 tp -125.31 -49.94 1.67 Allowed 'General case' 0 C--N 1.355 0.843 0 C-N-CA 124.005 0.922 . . . . 0.0 111.865 175.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.2 t -65.69 -28.19 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 C-N-CA 126.996 2.118 . . . . 0.0 111.741 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.3 m -160.25 170.12 21.78 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 101.99 -3.337 . . . . 0.0 101.99 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.9 tttp -106.21 115.31 30.01 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 120.655 1.571 . . . . 0.0 111.279 175.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -114.92 8.58 15.94 Favored 'General case' 0 C--O 1.224 -0.284 0 O-C-N 120.084 -1.635 . . . . 0.0 110.152 155.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 54.1 p90 . . . . . 0 N--CA 1.444 -0.77 0 CA-C-O 122.041 0.924 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.1 mt -150.55 160.57 32.52 Favored Pre-proline 0 N--CA 1.434 -1.227 0 N-CA-C 103.389 -2.819 . . . . 0.0 103.389 176.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -98.36 -135.45 0.01 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.575 0 N-CA-C 107.12 -1.916 . . . . 0.0 107.12 169.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.4 pt -49.23 -28.17 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 N-CA-C 117.034 2.235 . . . . 0.0 117.034 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 62.8 mt -53.72 -38.77 64.64 Favored 'General case' 0 C--N 1.344 0.368 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.98 97.81 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-O 122.46 1.124 . . . . 0.0 112.772 170.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.8 m -67.85 -35.44 78.57 Favored 'General case' 0 C--N 1.343 0.32 0 O-C-N 120.178 -1.577 . . . . 0.0 114.5 174.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.2 mt -65.45 -39.17 91.71 Favored 'General case' 0 CA--C 1.509 -0.63 0 O-C-N 119.733 -1.854 . . . . 0.0 113.391 172.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.1 -39.2 78.02 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.622 0.769 . . . . 0.0 111.356 168.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.49 -48.77 71.44 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 170.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -77.59 -42.67 34.29 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 120.775 -1.203 . . . . 0.0 114.111 -171.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -94.93 -7.75 39.06 Favored 'General case' 0 CA--C 1.502 -0.9 0 O-C-N 120.769 -1.207 . . . . 0.0 110.105 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -117.38 78.8 0.29 Allowed Glycine 0 N--CA 1.432 -1.59 0 CA-C-O 117.215 -1.881 . . . . 0.0 111.184 161.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -62.62 -35.94 67.1 Favored 'Trans proline' 0 CA--C 1.512 -0.588 0 CA-C-N 123.607 3.703 . . . . 0.0 109.351 167.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -36.74 84.74 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 166.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 82.0 mt -68.97 -46.86 67.02 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 120.503 -1.373 . . . . 0.0 113.357 176.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.75 -33.84 74.57 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 121.775 2.08 . . . . 0.0 114.417 176.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -79.04 -56.84 4.08 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 121.132 -0.98 . . . . 0.0 113.436 173.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.3 t -66.79 -43.71 89.67 Favored 'Isoleucine or valine' 0 C--N 1.348 0.537 0 C-N-CA 126.07 1.748 . . . . 0.0 113.242 -171.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 59.0 p -106.73 -3.33 20.63 Favored 'General case' 0 CA--C 1.508 -0.668 0 O-C-N 120.547 -1.346 . . . . 0.0 112.762 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.69 44.5 14.17 Favored 'General case' 0 C--N 1.349 0.571 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 178.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -105.4 21.99 16.22 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 119.313 -2.117 . . . . 0.0 112.04 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 38.7 t80 . . . . . 0 N--CA 1.437 -1.107 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.3 mp 65.57 171.1 0.09 OUTLIER Pre-proline 0 C--N 1.356 0.86 0 C-N-CA 124.548 1.139 . . . . 0.0 111.012 -160.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -68.41 -172.0 0.41 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 O-C-N 117.333 -1.983 . . . . 0.0 110.846 151.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.4 pt -49.35 -28.06 2.95 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 N-CA-C 117.19 2.293 . . . . 0.0 117.19 -174.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.8 mt -39.93 -42.68 1.39 Allowed 'General case' 0 C--N 1.343 0.311 0 C-N-CA 127.754 2.422 . . . . 0.0 117.356 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.92 -43.45 98.82 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 120.592 -1.318 . . . . 0.0 113.191 173.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 14.2 m -70.73 -31.33 68.13 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 119.902 -1.749 . . . . 0.0 113.873 171.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.66 -36.44 82.55 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 119.261 -2.15 . . . . 0.0 113.41 171.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.03 -38.93 77.16 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.817 0.847 . . . . 0.0 111.465 168.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.58 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -63.56 -48.57 76.9 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 169.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -77.31 -41.92 38.77 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -170.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -95.05 -5.55 44.15 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 120.627 -1.296 . . . . 0.0 110.177 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -122.58 81.34 0.35 Allowed Glycine 0 N--CA 1.43 -1.705 0 CA-C-O 117.713 -1.604 . . . . 0.0 110.673 164.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.47 -34.33 86.15 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 CA-C-N 122.719 3.259 . . . . 0.0 109.688 164.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -37.24 86.73 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 165.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.6 mp -67.58 -45.27 76.04 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 120.014 -1.679 . . . . 0.0 112.66 172.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.58 ' CE2' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -68.81 -33.21 73.47 Favored 'General case' 0 C--N 1.346 0.437 0 O-C-N 119.251 -2.155 . . . . 0.0 114.03 177.131 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 52.2 tp -94.67 -65.46 0.98 Allowed 'General case' 0 C--N 1.351 0.634 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.5 t -64.54 -46.83 91.49 Favored 'Isoleucine or valine' 0 C--N 1.348 0.532 0 C-N-CA 126.703 2.001 . . . . 0.0 112.094 -171.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.3 m -102.68 2.9 36.48 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 122.89 1.329 . . . . 0.0 109.813 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.64 48.78 14.26 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 117.143 2.275 . . . . 0.0 117.143 174.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -93.82 -0.46 55.81 Favored 'General case' 0 C--N 1.343 0.283 0 O-C-N 119.293 -2.13 . . . . 0.0 112.675 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 8.9 t80 . . . . . 0 N--CA 1.439 -1.005 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 29.7 mt -43.77 144.62 1.37 Allowed Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 168.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -77.87 -25.4 7.67 Favored 'Trans proline' 0 CA--C 1.514 -0.489 0 CA-C-N 122.286 1.852 . . . . 0.0 109.352 -176.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.8 pt -53.95 -17.52 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 174.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.56 -39.0 82.62 Favored 'General case' 0 C--N 1.346 0.425 0 O-C-N 119.953 -1.717 . . . . 0.0 113.599 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.15 -42.87 99.67 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-O 122.507 1.146 . . . . 0.0 112.79 169.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.1 m -63.96 -39.27 93.75 Favored 'General case' 0 C--N 1.345 0.395 0 O-C-N 120.426 -1.421 . . . . 0.0 114.275 174.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.8 mt -64.6 -40.97 96.47 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 120.421 -1.424 . . . . 0.0 113.132 173.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.32 -44.66 88.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.318 0.58 . . . . 0.0 111.519 171.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.88 -45.82 87.68 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 171.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.84 -25.76 19.73 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 118.416 -2.677 . . . . 0.0 114.356 -169.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -99.17 -12.35 20.54 Favored 'General case' 0 CA--C 1.498 -1.024 0 O-C-N 119.548 -1.97 . . . . 0.0 111.209 173.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.68 83.36 0.36 Allowed Glycine 0 N--CA 1.438 -1.176 0 CA-C-O 117.159 -1.912 . . . . 0.0 109.832 157.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -63.06 -29.92 75.45 Favored 'Trans proline' 0 CA--C 1.517 -0.35 1 CA-C-N 124.468 4.134 . . . . 0.0 110.093 168.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -59.96 -47.56 85.3 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 123.815 0.846 . . . . 0.0 111.887 164.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.36 -42.8 96.03 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -61.92 -37.74 85.81 Favored 'General case' 0 C--N 1.347 0.498 0 O-C-N 119.311 -2.118 . . . . 0.0 113.564 178.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.72 -46.93 67.63 Favored 'General case' 0 C--N 1.345 0.413 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.6 t -60.77 -39.7 82.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.571 0 C-N-CA 125.48 1.512 . . . . 0.0 111.404 -176.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.7 p -105.22 24.68 11.66 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.545 -1.347 . . . . 0.0 113.451 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? 47.12 54.48 9.31 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 126.613 1.965 . . . . 0.0 115.304 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -138.51 -165.89 1.9 Allowed 'General case' 0 C--N 1.344 0.354 0 O-C-N 119.896 -1.753 . . . . 0.0 110.985 -177.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 24.9 p90 . . . . . 0 N--CA 1.443 -0.787 0 CA-C-O 121.756 0.789 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 38.2 tp -123.83 144.09 43.85 Favored Pre-proline 0 N--CA 1.433 -1.299 0 N-CA-C 102.533 -3.136 . . . . 0.0 102.533 168.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -109.19 -118.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.955 0 CA-C-N 122.81 2.039 . . . . 0.0 107.437 -173.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.5 pt -49.84 -28.14 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 -179.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 64.5 mt -59.56 -38.47 81.18 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 120.122 -1.611 . . . . 0.0 114.671 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.5 -44.67 95.8 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-O 122.805 1.288 . . . . 0.0 112.137 170.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.5 m -63.92 -38.92 92.87 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.952 1.301 . . . . 0.0 114.174 175.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.71 -41.2 92.59 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 125.215 1.406 . . . . 0.0 113.817 175.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.72 -45.91 88.54 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-O 121.888 0.852 . . . . 0.0 111.115 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.44 -48.21 80.67 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 170.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -72.24 -43.52 64.26 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 118.012 -2.93 . . . . 0.0 115.161 -177.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -85.33 -24.12 27.78 Favored 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 120.132 -1.605 . . . . 0.0 112.165 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.2 92.72 0.95 Allowed Glycine 0 CA--C 1.492 -1.389 0 CA-C-O 116.616 -2.213 . . . . 0.0 110.026 167.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -63.7 -28.46 68.82 Favored 'Trans proline' 0 C--N 1.329 -0.484 1 CA-C-N 125.269 4.535 . . . . 0.0 110.028 164.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm -60.03 -46.38 89.71 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.203 1.401 . . . . 0.0 112.828 164.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.5 mt -69.34 -42.69 74.97 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 121.485 -0.759 . . . . 0.0 112.825 176.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.07 -47.84 83.79 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 120.482 -1.387 . . . . 0.0 113.124 -174.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.1 tp -78.8 -47.67 16.27 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 169.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.83 -41.61 90.49 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 C-N-CA 126.148 1.779 . . . . 0.0 111.904 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.1 t -152.4 148.79 27.88 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-O 124.012 1.863 . . . . 0.0 112.782 173.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.44 59.46 3.49 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 118.842 -2.411 . . . . 0.0 114.664 -167.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.81 3.92 54.71 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 120.023 -1.673 . . . . 0.0 110.472 174.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 1.5 t80 . . . . . 0 N--CA 1.442 -0.847 0 CA-C-O 121.67 0.747 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -110.89 159.05 33.95 Favored Pre-proline 0 N--CA 1.44 -0.966 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 168.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -83.61 -158.28 0.09 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.45 0 C-N-CA 121.324 1.349 . . . . 0.0 108.956 163.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.5 pt -49.55 -27.49 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.0 mt -52.64 -40.04 62.39 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -174.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.81 -44.42 96.89 Favored 'General case' 0 C--N 1.35 0.596 0 CA-C-O 122.621 1.201 . . . . 0.0 112.772 172.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.7 m -67.42 -33.9 76.12 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 120.49 -1.381 . . . . 0.0 113.948 173.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.4 mt -65.01 -40.77 95.38 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 119.968 -1.708 . . . . 0.0 113.462 172.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.03 -45.71 90.04 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.461 0.648 . . . . 0.0 111.103 171.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.51 -45.71 93.04 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 172.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.29 -47.72 26.58 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 118.312 -2.742 . . . . 0.0 114.86 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -97.03 -8.98 29.05 Favored 'General case' 0 CA--C 1.498 -1.052 0 O-C-N 120.28 -1.513 . . . . 0.0 111.491 -169.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.31 92.69 0.94 Allowed Glycine 0 N--CA 1.435 -1.415 0 CA-C-O 117.5 -1.722 . . . . 0.0 109.449 158.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.69 -28.78 69.01 Favored 'Trans proline' 0 C--N 1.329 -0.497 0 CA-C-N 123.876 3.838 . . . . 0.0 109.493 160.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -61.37 -48.27 82.02 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 123.471 0.708 . . . . 0.0 112.641 164.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.1 mt -69.65 -41.4 75.62 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -37.34 86.81 Favored 'General case' 0 C--N 1.35 0.596 0 CA-C-N 121.087 1.767 . . . . 0.0 113.424 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.1 tp -69.46 -46.32 66.97 Favored 'General case' 0 C--N 1.349 0.545 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 175.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.0 m -97.96 0.37 10.48 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 O-C-N 120.064 -1.647 . . . . 0.0 112.04 -170.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 68.0 m -155.64 153.54 30.21 Favored 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 119.209 -2.182 . . . . 0.0 107.885 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -74.89 68.12 1.73 Allowed 'General case' 0 C--N 1.349 0.559 0 O-C-N 117.789 -3.069 . . . . 0.0 114.251 170.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -117.0 15.42 15.11 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 125.085 1.354 . . . . 0.0 108.371 170.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 8.2 t80 . . . . . 0 N--CA 1.432 -1.361 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.2 tp -164.6 137.23 3.75 Favored Pre-proline 0 C--N 1.352 0.678 0 O-C-N 120.763 -1.211 . . . . 0.0 110.174 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -68.57 -38.07 11.61 Favored 'Trans proline' 0 C--N 1.333 -0.278 0 CA-C-N 123.371 2.24 . . . . 0.0 112.174 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.313 20.7 pt -54.55 -17.32 2.02 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 172.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 53.6 mt -51.42 -33.62 31.25 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 120.24 -1.538 . . . . 0.0 114.731 174.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.13 -39.67 79.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.759 0.79 . . . . 0.0 111.856 173.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.5 m -64.91 -35.97 82.86 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 120.522 -1.361 . . . . 0.0 114.343 171.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.0 mt -62.9 -45.48 92.31 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 120.269 -1.519 . . . . 0.0 112.875 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.63 -21.67 59.33 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 120.968 -1.083 . . . . 0.0 113.804 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.89 -31.08 23.9 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 119.51 -1.994 . . . . 0.0 113.739 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -97.83 -31.52 12.18 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 120.272 -1.517 . . . . 0.0 111.352 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -110.11 9.17 24.09 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 120.457 -1.402 . . . . 0.0 110.879 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -141.7 46.47 0.89 Allowed Glycine 0 C--N 1.348 1.22 0 CA-C-O 117.827 -1.54 . . . . 0.0 116.062 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -62.33 -22.54 74.25 Favored 'Trans proline' 0 CA--C 1.515 -0.433 0 CA-C-N 122.921 3.361 . . . . 0.0 113.199 -172.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.4 -47.54 85.33 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 118.653 0.661 . . . . 0.0 111.996 176.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.08 -41.44 99.43 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 121.091 -1.006 . . . . 0.0 111.16 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.41 -44.02 97.86 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 175.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.9 mp -82.88 -46.94 12.39 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 119.717 -1.864 . . . . 0.0 111.866 172.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.6 t -60.88 -48.92 86.78 Favored 'Isoleucine or valine' 0 C--N 1.361 1.082 0 C-N-CA 124.241 1.016 . . . . 0.0 111.66 -175.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 p -95.39 6.14 49.78 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 120.914 -1.116 . . . . 0.0 111.94 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 51.65 53.53 12.56 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 125.82 1.648 . . . . 0.0 112.56 177.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -118.33 -152.81 0.51 Allowed 'General case' 0 C--N 1.346 0.438 0 O-C-N 120.665 -1.272 . . . . 0.0 108.741 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.2 pt . . . . . 0 C--O 1.221 -0.431 0 N-CA-C 117.701 2.482 . . . . 0.0 117.701 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.0 mt -34.99 -45.34 0.26 Allowed 'General case' 0 C--N 1.344 0.365 0 N-CA-C 117.738 2.496 . . . . 0.0 117.738 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.93 -45.44 92.47 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 120.695 -1.253 . . . . 0.0 113.223 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.2 m -67.78 -31.92 72.13 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 120.113 -1.617 . . . . 0.0 114.077 171.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.63 -40.24 92.35 Favored 'General case' 0 CA--C 1.511 -0.529 0 O-C-N 119.235 -2.166 . . . . 0.0 113.375 170.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.4 -42.56 87.41 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 123.415 0.686 . . . . 0.0 111.156 169.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.84 -43.92 97.64 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 172.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -84.28 -41.96 16.33 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 120.25 -1.531 . . . . 0.0 113.968 -173.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -86.58 -18.92 30.23 Favored 'General case' 0 CA--C 1.503 -0.841 0 O-C-N 120.323 -1.486 . . . . 0.0 111.274 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -107.7 86.86 0.47 Allowed Glycine 0 N--CA 1.435 -1.401 0 CA-C-O 117.771 -1.572 . . . . 0.0 110.897 162.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -62.2 -27.64 78.65 Favored 'Trans proline' 0 CA--C 1.514 -0.487 0 CA-C-N 123.095 3.447 . . . . 0.0 109.242 157.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.9 mttt . . . . . 0 N--CA 1.445 -0.718 0 C-N-CA 123.859 0.864 . . . . 0.0 112.484 163.972 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.6 pt . . . . . 0 CA--C 1.512 -0.517 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.8 mt -59.43 -38.91 81.89 Favored 'General case' 0 C--N 1.345 0.404 0 O-C-N 120.053 -1.654 . . . . 0.0 113.725 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.26 99.15 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-O 122.55 1.166 . . . . 0.0 113.036 169.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.6 m -64.56 -39.15 93.23 Favored 'General case' 0 C--N 1.345 0.381 0 O-C-N 120.285 -1.509 . . . . 0.0 114.182 174.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.62 -38.42 90.95 Favored 'General case' 0 CA--C 1.51 -0.585 0 O-C-N 120.537 -1.352 . . . . 0.0 113.375 173.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.48 -39.57 80.37 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.862 0.865 . . . . 0.0 112.236 170.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.65 -48.13 67.56 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 168.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -72.55 -42.73 64.35 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -172.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -93.6 -9.26 38.65 Favored 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 120.57 -1.331 . . . . 0.0 110.042 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -120.62 75.19 0.33 Allowed Glycine 0 N--CA 1.434 -1.464 0 CA-C-O 117.694 -1.614 . . . . 0.0 112.584 169.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.81 -29.42 76.71 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 CA-C-N 123.022 3.411 . . . . 0.0 109.025 157.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.2 mtpp . . . . . 0 N--CA 1.445 -0.719 0 C-N-CA 125.736 1.614 . . . . 0.0 112.839 165.291 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.8 pt . . . . . 0 C--O 1.221 -0.403 0 N-CA-C 117.028 2.233 . . . . 0.0 117.028 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.8 mt -41.88 -43.07 2.92 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.57 -44.04 97.76 Favored 'General case' 0 C--N 1.351 0.661 0 O-C-N 120.686 -1.259 . . . . 0.0 113.004 172.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.1 m -67.38 -33.5 75.33 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 120.394 -1.442 . . . . 0.0 114.153 172.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.9 -42.49 90.16 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 119.739 -1.85 . . . . 0.0 113.315 171.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.1 -40.68 86.09 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 123.827 0.851 . . . . 0.0 111.331 170.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.02 -48.53 78.37 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 172.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -81.3 -45.92 15.49 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 119.463 -2.023 . . . . 0.0 112.729 -175.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -91.2 -8.5 48.37 Favored 'General case' 0 CA--C 1.5 -0.958 0 O-C-N 120.583 -1.323 . . . . 0.0 111.034 -173.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.8 81.58 0.38 Allowed Glycine 0 N--CA 1.439 -1.145 0 CA-C-O 117.625 -1.653 . . . . 0.0 110.626 156.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.07 -19.55 29.82 Favored 'Trans proline' 0 CA--C 1.512 -0.578 0 CA-C-N 123.895 3.847 . . . . 0.0 108.908 167.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? . . . . . 0 N--CA 1.44 -0.935 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 161.695 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.6 pt . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.1 mt -54.27 -40.15 67.54 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -173.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.35 -42.42 99.38 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-O 122.727 1.251 . . . . 0.0 112.801 171.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.2 m -68.68 -32.73 72.75 Favored 'General case' 0 C--N 1.343 0.323 0 O-C-N 120.192 -1.568 . . . . 0.0 114.387 173.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.8 mt -66.12 -40.1 90.42 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 119.429 -2.044 . . . . 0.0 112.981 171.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.44 -43.01 88.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.062 0.545 . . . . 0.0 111.324 168.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.19 -46.35 90.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 173.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -81.07 -44.02 18.62 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 120.8 -1.188 . . . . 0.0 114.127 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -85.86 -17.77 34.68 Favored 'General case' 0 CA--C 1.501 -0.933 0 O-C-N 120.336 -1.477 . . . . 0.0 111.111 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.46 85.35 0.41 Allowed Glycine 0 N--CA 1.435 -1.412 0 CA-C-O 117.804 -1.554 . . . . 0.0 110.633 163.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -62.45 -28.18 77.78 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 CA-C-N 123.071 3.435 . . . . 0.0 109.378 160.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.352 0.711 0 C-N-CA 123.153 0.581 . . . . 0.0 112.516 163.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.4 pt . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.7 mt -60.48 -35.23 75.42 Favored 'General case' 0 C--N 1.345 0.403 0 O-C-N 120.495 -1.378 . . . . 0.0 113.17 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.85 98.79 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-O 122.193 0.997 . . . . 0.0 112.646 169.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.1 m -64.02 -41.03 97.58 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 120.269 -1.52 . . . . 0.0 113.896 173.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.05 -42.11 99.65 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 120.85 -1.156 . . . . 0.0 113.095 173.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.77 -42.06 92.49 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.676 1.19 . . . . 0.0 112.55 173.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.72 -48.38 66.66 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 172.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -76.95 -45.67 26.82 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -173.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -105.03 -9.28 17.96 Favored 'General case' 0 CA--C 1.5 -0.944 0 O-C-N 121.198 -0.939 . . . . 0.0 110.329 -173.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -107.13 61.45 0.32 Allowed Glycine 0 CA--C 1.5 -0.867 0 CA-C-O 115.603 -2.776 . . . . 0.0 112.134 162.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -65.53 -23.24 57.7 Favored 'Trans proline' 0 N--CA 1.46 -0.493 1 CA-C-N 127.081 5.441 . . . . 0.0 110.714 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.352 0.699 0 C-N-CA 122.998 0.519 . . . . 0.0 112.171 165.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.3 pt . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.6 mt -50.94 -38.94 53.55 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.21 -42.94 99.76 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 120.657 -1.277 . . . . 0.0 113.011 171.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.6 m -68.41 -34.04 75.31 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 120.085 -1.635 . . . . 0.0 114.137 172.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.79 -38.12 89.91 Favored 'General case' 0 CA--C 1.508 -0.665 0 O-C-N 119.575 -1.953 . . . . 0.0 113.236 172.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.61 -39.57 77.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.646 0.778 . . . . 0.0 111.551 168.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.27 -47.87 77.91 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 170.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -77.61 -43.12 32.61 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -171.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -91.39 -14.63 30.32 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 120.628 -1.295 . . . . 0.0 110.49 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -112.76 81.2 0.29 Allowed Glycine 0 N--CA 1.437 -1.262 0 CA-C-O 118.474 -1.181 . . . . 0.0 111.317 164.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -62.9 -27.41 74.76 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 CA-C-N 122.151 2.975 . . . . 0.0 109.36 160.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.35 0.603 0 CA-C-O 121.303 0.573 . . . . 0.0 112.403 163.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.7 pt . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 117.137 2.273 . . . . 0.0 117.137 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 64.9 mt -52.13 -41.42 62.49 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -173.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.42 -44.85 95.45 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-O 122.794 1.283 . . . . 0.0 112.685 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.0 m -65.49 -38.6 90.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.982 1.313 . . . . 0.0 113.793 173.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.5 mt -64.32 -38.86 92.53 Favored 'General case' 0 CA--C 1.504 -0.793 0 O-C-N 120.536 -1.352 . . . . 0.0 113.954 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.69 -47.06 83.39 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.25 0.548 . . . . 0.0 111.232 173.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.74 -46.63 87.17 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 169.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.79 -38.4 70.29 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 118.061 -2.899 . . . . 0.0 115.833 -176.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -92.21 -22.24 19.92 Favored 'General case' 0 CA--C 1.496 -1.098 0 O-C-N 119.703 -1.873 . . . . 0.0 112.573 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.27 90.13 0.89 Allowed Glycine 0 CA--C 1.492 -1.38 0 CA-C-O 116.494 -2.281 . . . . 0.0 109.421 161.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -63.59 -27.82 69.57 Favored 'Trans proline' 0 CA--C 1.517 -0.373 1 CA-C-N 125.654 4.727 . . . . 0.0 109.882 170.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 89.7 mttt . . . . . 0 N--CA 1.445 -0.722 0 C-N-CA 125.953 1.701 . . . . 0.0 112.453 164.364 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.6 pt . . . . . 0 C--O 1.224 -0.24 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 62.4 mt -38.16 -46.1 1.01 Allowed 'General case' 0 C--N 1.347 0.462 0 C-N-CA 128.242 2.617 . . . . 0.0 117.571 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.53 -45.99 90.47 Favored 'General case' 0 C--N 1.35 0.602 0 O-C-N 120.702 -1.249 . . . . 0.0 113.123 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.3 m -65.76 -39.48 91.09 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 124.994 1.317 . . . . 0.0 113.456 171.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.3 mt -62.59 -36.66 83.42 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 120.718 -1.238 . . . . 0.0 113.634 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.58 -49.09 78.73 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 118.508 0.595 . . . . 0.0 111.795 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.88 -46.15 90.64 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 168.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.13 -38.41 82.16 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 118.642 -2.536 . . . . 0.0 116.589 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -94.48 -19.62 20.4 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 119.589 -1.944 . . . . 0.0 112.37 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.49 93.49 1.43 Allowed Glycine 0 CA--C 1.489 -1.549 0 CA-C-O 116.646 -2.196 . . . . 0.0 110.32 163.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.87 -25.87 67.41 Favored 'Trans proline' 0 C--N 1.328 -0.533 1 CA-C-N 125.779 4.79 . . . . 0.0 110.653 171.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.692 0 C-N-CA 124.068 0.947 . . . . 0.0 112.647 162.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.0 pt . . . . . 0 C--O 1.224 -0.284 0 N-CA-C 117.178 2.288 . . . . 0.0 117.178 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.6 mt -39.05 -43.69 1.03 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 127.744 2.417 . . . . 0.0 117.192 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.25 -43.12 99.56 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 120.512 -1.367 . . . . 0.0 113.309 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 m -69.47 -33.89 73.57 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 120.042 -1.661 . . . . 0.0 113.845 172.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.08 -36.84 85.6 Favored 'General case' 0 CA--C 1.509 -0.63 0 O-C-N 119.919 -1.738 . . . . 0.0 113.296 172.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.42 -42.35 82.19 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.776 0.831 . . . . 0.0 111.235 168.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.17 -49.39 77.38 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 168.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -76.64 -41.66 44.96 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -101.81 -5.51 24.76 Favored 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 120.32 -1.488 . . . . 0.0 111.107 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -112.57 82.33 0.3 Allowed Glycine 0 N--CA 1.437 -1.295 0 CA-C-O 118.644 -1.087 . . . . 0.0 110.73 164.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -62.59 -31.15 79.79 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 122.029 2.915 . . . . 0.0 109.659 162.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.8 mptt . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 162.6 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.6 pt . . . . . 0 N--CA 1.446 -0.631 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.7 mt -57.65 -37.05 72.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 120.344 -1.473 . . . . 0.0 114.415 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.48 -43.56 98.52 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-O 122.697 1.237 . . . . 0.0 112.606 169.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.2 m -66.06 -35.88 81.73 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 120.366 -1.458 . . . . 0.0 114.746 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.4 mt -65.91 -39.96 91.04 Favored 'General case' 0 CA--C 1.504 -0.801 0 O-C-N 119.63 -1.919 . . . . 0.0 113.189 172.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.17 89.23 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 122.965 0.506 . . . . 0.0 111.113 168.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.33 -46.05 91.86 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 173.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -83.89 -43.7 15.03 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 120.753 -1.217 . . . . 0.0 114.174 -173.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -85.01 -19.7 31.6 Favored 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 120.418 -1.426 . . . . 0.0 111.171 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.18 85.12 0.4 Allowed Glycine 0 N--CA 1.435 -1.367 0 CA-C-O 118.067 -1.407 . . . . 0.0 110.411 161.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -62.43 -31.04 80.95 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 CA-C-N 122.873 3.337 . . . . 0.0 109.056 160.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.443 -0.779 0 C-N-CA 124.746 1.218 . . . . 0.0 112.822 163.823 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.6 pt . . . . . 0 CA--C 1.513 -0.447 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.2 mt -33.1 -44.48 0.12 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 128.06 2.544 . . . . 0.0 117.821 174.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.72 96.11 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 120.582 -1.324 . . . . 0.0 113.155 174.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.2 m -70.7 -30.66 67.28 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.226 -1.546 . . . . 0.0 113.558 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.9 mt -66.96 -40.27 87.44 Favored 'General case' 0 CA--C 1.509 -0.597 0 O-C-N 119.525 -1.984 . . . . 0.0 113.559 170.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.7 -43.53 90.05 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.866 0.866 . . . . 0.0 111.317 169.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.2 -46.84 88.36 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 172.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -79.45 -44.05 22.11 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 120.282 -1.511 . . . . 0.0 114.679 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -85.88 -18.41 32.84 Favored 'General case' 0 CA--C 1.501 -0.928 0 O-C-N 120.156 -1.59 . . . . 0.0 111.177 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -107.2 85.11 0.41 Allowed Glycine 0 N--CA 1.436 -1.354 0 CA-C-O 117.365 -1.797 . . . . 0.0 110.321 162.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -62.27 -27.59 78.23 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 CA-C-N 123.579 3.69 . . . . 0.0 109.469 160.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.352 0.7 0 C-N-CA 123.829 0.851 . . . . 0.0 112.419 164.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.3 pt . . . . . 0 N--CA 1.447 -0.59 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.6 mt -55.95 -40.22 72.89 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.77 -42.93 97.7 Favored 'General case' 0 C--N 1.349 0.565 0 O-C-N 120.823 -1.173 . . . . 0.0 112.376 171.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.7 m -66.08 -35.98 81.98 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 174.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.0 mt -65.18 -42.01 94.06 Favored 'General case' 0 CA--C 1.506 -0.739 0 O-C-N 119.671 -1.893 . . . . 0.0 112.788 172.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.29 -42.4 91.2 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 123.327 0.651 . . . . 0.0 111.345 169.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.3 -47.83 82.54 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 174.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -84.9 -48.1 9.65 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 119.959 -1.713 . . . . 0.0 112.841 -173.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -84.56 -16.45 42.18 Favored 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 120.518 -1.364 . . . . 0.0 111.123 -175.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.47 84.89 0.47 Allowed Glycine 0 N--CA 1.436 -1.362 0 CA-C-O 117.8 -1.556 . . . . 0.0 111.089 159.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.29 -28.53 63.76 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 CA-C-N 123.461 3.63 . . . . 0.0 109.638 165.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? . . . . . 0 N--CA 1.445 -0.695 0 C-N-CA 122.921 0.488 . . . . 0.0 112.149 163.928 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.513 -0.479 0 N-CA-C 117.081 2.252 . . . . 0.0 117.081 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.1 mt -39.45 -42.32 1.09 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 127.667 2.387 . . . . 0.0 116.987 177.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.95 -43.72 98.25 Favored 'General case' 0 C--N 1.35 0.616 0 O-C-N 120.624 -1.298 . . . . 0.0 112.967 173.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.5 m -71.84 -29.27 64.23 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 120.199 -1.563 . . . . 0.0 113.741 172.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.57 -38.95 88.15 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 119.362 -2.086 . . . . 0.0 113.315 170.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.21 -41.78 84.79 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.536 0.734 . . . . 0.0 111.015 168.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.01 -47.27 87.21 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 172.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -80.52 -42.66 22.07 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -173.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -86.39 -18.76 30.97 Favored 'General case' 0 CA--C 1.502 -0.871 0 O-C-N 120.287 -1.508 . . . . 0.0 110.983 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -111.94 85.43 0.39 Allowed Glycine 0 N--CA 1.435 -1.377 0 CA-C-O 118.075 -1.403 . . . . 0.0 111.212 164.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -61.88 -29.54 82.64 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 CA-C-N 122.508 3.154 . . . . 0.0 109.264 157.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.3 mttt . . . . . 0 N--CA 1.445 -0.705 0 C-N-CA 124.136 0.974 . . . . 0.0 112.461 163.654 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.254 45.2 pt . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 20.6 mt -35.41 -33.72 0.03 OUTLIER 'General case' 0 C--N 1.356 0.851 0 C-N-CA 129.311 3.044 . . . . 0.0 118.35 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.64 85.96 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-O 123.026 1.393 . . . . 0.0 112.619 171.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.9 p -77.4 -19.23 56.45 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 120.301 -1.499 . . . . 0.0 113.402 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.6 mt -65.84 -39.19 90.55 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 120.188 -1.57 . . . . 0.0 112.478 169.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.55 -44.07 89.54 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 121.867 -0.521 . . . . 0.0 111.531 168.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.29 -40.26 93.48 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 174.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -89.75 -46.88 8.28 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -93.47 -9.13 39.54 Favored 'General case' 0 CA--C 1.492 -1.271 0 O-C-N 120.503 -1.373 . . . . 0.0 112.039 -172.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.77 82.6 0.3 Allowed Glycine 0 N--CA 1.43 -1.727 0 O-C-N 121.144 -0.973 . . . . 0.0 111.41 170.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -65.11 -32.13 53.35 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 CA-C-N 123.289 3.544 . . . . 0.0 110.256 157.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.7 tptm . . . . . 0 C--N 1.348 0.522 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 166.228 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.4 pt . . . . . 0 CA--C 1.511 -0.543 0 N-CA-C 117.034 2.235 . . . . 0.0 117.034 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 62.8 mt -53.72 -38.77 64.64 Favored 'General case' 0 C--N 1.344 0.368 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.98 97.81 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-O 122.46 1.124 . . . . 0.0 112.772 170.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.8 m -67.85 -35.44 78.57 Favored 'General case' 0 C--N 1.343 0.32 0 O-C-N 120.178 -1.577 . . . . 0.0 114.5 174.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.2 mt -65.45 -39.17 91.71 Favored 'General case' 0 CA--C 1.509 -0.63 0 O-C-N 119.733 -1.854 . . . . 0.0 113.391 172.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.1 -39.2 78.02 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.622 0.769 . . . . 0.0 111.356 168.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.49 -48.77 71.44 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 170.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -77.59 -42.67 34.29 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 120.775 -1.203 . . . . 0.0 114.111 -171.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -94.93 -7.75 39.06 Favored 'General case' 0 CA--C 1.502 -0.9 0 O-C-N 120.769 -1.207 . . . . 0.0 110.105 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -117.38 78.8 0.29 Allowed Glycine 0 N--CA 1.432 -1.59 0 CA-C-O 117.215 -1.881 . . . . 0.0 111.184 161.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -62.62 -35.94 67.1 Favored 'Trans proline' 0 CA--C 1.512 -0.588 0 CA-C-N 123.607 3.703 . . . . 0.0 109.351 167.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.703 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 166.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.4 pt . . . . . 0 C--O 1.223 -0.325 0 N-CA-C 117.19 2.293 . . . . 0.0 117.19 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.8 mt -39.93 -42.68 1.39 Allowed 'General case' 0 C--N 1.343 0.311 0 C-N-CA 127.754 2.422 . . . . 0.0 117.356 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.92 -43.45 98.82 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 120.592 -1.318 . . . . 0.0 113.191 173.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 14.2 m -70.73 -31.33 68.13 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 119.902 -1.749 . . . . 0.0 113.873 171.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.66 -36.44 82.55 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 119.261 -2.15 . . . . 0.0 113.41 171.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.03 -38.93 77.16 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.817 0.847 . . . . 0.0 111.465 168.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 7' ' ' SER . . . -63.56 -48.57 76.9 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 169.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -77.31 -41.92 38.77 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -170.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -95.05 -5.55 44.15 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 120.627 -1.296 . . . . 0.0 110.177 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -122.58 81.34 0.35 Allowed Glycine 0 N--CA 1.43 -1.705 0 CA-C-O 117.713 -1.604 . . . . 0.0 110.673 164.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.47 -34.33 86.15 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 CA-C-N 122.719 3.259 . . . . 0.0 109.688 164.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.665 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 165.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.8 pt . . . . . 0 CA--C 1.511 -0.536 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.56 -39.0 82.62 Favored 'General case' 0 C--N 1.346 0.425 0 O-C-N 119.953 -1.717 . . . . 0.0 113.599 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.15 -42.87 99.67 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-O 122.507 1.146 . . . . 0.0 112.79 169.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.1 m -63.96 -39.27 93.75 Favored 'General case' 0 C--N 1.345 0.395 0 O-C-N 120.426 -1.421 . . . . 0.0 114.275 174.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.8 mt -64.6 -40.97 96.47 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 120.421 -1.424 . . . . 0.0 113.132 173.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.32 -44.66 88.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.318 0.58 . . . . 0.0 111.519 171.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.88 -45.82 87.68 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 171.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.84 -25.76 19.73 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 118.416 -2.677 . . . . 0.0 114.356 -169.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -99.17 -12.35 20.54 Favored 'General case' 0 CA--C 1.498 -1.024 0 O-C-N 119.548 -1.97 . . . . 0.0 111.209 173.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.68 83.36 0.36 Allowed Glycine 0 N--CA 1.438 -1.176 0 CA-C-O 117.159 -1.912 . . . . 0.0 109.832 157.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -63.06 -29.92 75.45 Favored 'Trans proline' 0 CA--C 1.517 -0.35 1 CA-C-N 124.468 4.134 . . . . 0.0 110.093 168.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--N 1.353 0.747 0 C-N-CA 123.815 0.846 . . . . 0.0 111.887 164.364 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.5 pt . . . . . 0 N--CA 1.446 -0.675 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 64.5 mt -59.56 -38.47 81.18 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 120.122 -1.611 . . . . 0.0 114.671 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.5 -44.67 95.8 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-O 122.805 1.288 . . . . 0.0 112.137 170.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.5 m -63.92 -38.92 92.87 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.952 1.301 . . . . 0.0 114.174 175.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.71 -41.2 92.59 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 125.215 1.406 . . . . 0.0 113.817 175.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.72 -45.91 88.54 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-O 121.888 0.852 . . . . 0.0 111.115 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.44 -48.21 80.67 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 170.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -72.24 -43.52 64.26 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 118.012 -2.93 . . . . 0.0 115.161 -177.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -85.33 -24.12 27.78 Favored 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 120.132 -1.605 . . . . 0.0 112.165 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.2 92.72 0.95 Allowed Glycine 0 CA--C 1.492 -1.389 0 CA-C-O 116.616 -2.213 . . . . 0.0 110.026 167.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -63.7 -28.46 68.82 Favored 'Trans proline' 0 C--N 1.329 -0.484 1 CA-C-N 125.269 4.535 . . . . 0.0 110.028 164.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm . . . . . 0 C--N 1.35 0.626 0 C-N-CA 125.203 1.401 . . . . 0.0 112.828 164.426 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.5 pt . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.0 mt -52.64 -40.04 62.39 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -174.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.81 -44.42 96.89 Favored 'General case' 0 C--N 1.35 0.596 0 CA-C-O 122.621 1.201 . . . . 0.0 112.772 172.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.7 m -67.42 -33.9 76.12 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 120.49 -1.381 . . . . 0.0 113.948 173.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.4 mt -65.01 -40.77 95.38 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 119.968 -1.708 . . . . 0.0 113.462 172.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.03 -45.71 90.04 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.461 0.648 . . . . 0.0 111.103 171.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.51 -45.71 93.04 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 172.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.29 -47.72 26.58 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 118.312 -2.742 . . . . 0.0 114.86 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -97.03 -8.98 29.05 Favored 'General case' 0 CA--C 1.498 -1.052 0 O-C-N 120.28 -1.513 . . . . 0.0 111.491 -169.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.31 92.69 0.94 Allowed Glycine 0 N--CA 1.435 -1.415 0 CA-C-O 117.5 -1.722 . . . . 0.0 109.449 158.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.69 -28.78 69.01 Favored 'Trans proline' 0 C--N 1.329 -0.497 0 CA-C-N 123.876 3.838 . . . . 0.0 109.493 160.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt . . . . . 0 C--N 1.351 0.639 0 C-N-CA 123.471 0.708 . . . . 0.0 112.641 164.032 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.313 20.7 pt . . . . . 0 C--O 1.225 -0.196 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 53.6 mt -51.42 -33.62 31.25 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 120.24 -1.538 . . . . 0.0 114.731 174.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.13 -39.67 79.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.759 0.79 . . . . 0.0 111.856 173.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.5 m -64.91 -35.97 82.86 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 120.522 -1.361 . . . . 0.0 114.343 171.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.0 mt -62.9 -45.48 92.31 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 120.269 -1.519 . . . . 0.0 112.875 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.63 -21.67 59.33 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 120.968 -1.083 . . . . 0.0 113.804 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.89 -31.08 23.9 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 119.51 -1.994 . . . . 0.0 113.739 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -97.83 -31.52 12.18 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 120.272 -1.517 . . . . 0.0 111.352 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -110.11 9.17 24.09 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 120.457 -1.402 . . . . 0.0 110.879 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -141.7 46.47 0.89 Allowed Glycine 0 C--N 1.348 1.22 0 CA-C-O 117.827 -1.54 . . . . 0.0 116.062 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -62.33 -22.54 74.25 Favored 'Trans proline' 0 CA--C 1.515 -0.433 0 CA-C-N 122.921 3.361 . . . . 0.0 113.199 -172.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.353 0.757 0 CA-C-N 118.653 0.661 . . . . 0.0 111.996 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 43.5 p90 . . . . . 0 N--CA 1.438 -1.038 0 CA-C-O 120.9 0.381 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 68.17 160.06 0.14 Allowed Pre-proline 0 C--N 1.355 0.824 0 C-N-CA 123.947 0.899 . . . . 0.0 111.896 -171.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -65.6 -167.17 0.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 O-C-N 117.226 -2.039 . . . . 0.0 111.125 151.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.2 pt -49.02 -28.27 2.41 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 N-CA-C 117.701 2.482 . . . . 0.0 117.701 -170.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 47.0 mt -34.99 -45.34 0.26 Allowed 'General case' 0 C--N 1.344 0.365 0 N-CA-C 117.738 2.496 . . . . 0.0 117.738 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.93 -45.44 92.47 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 120.695 -1.253 . . . . 0.0 113.223 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.2 m -67.78 -31.92 72.13 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 120.113 -1.617 . . . . 0.0 114.077 171.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.63 -40.24 92.35 Favored 'General case' 0 CA--C 1.511 -0.529 0 O-C-N 119.235 -2.166 . . . . 0.0 113.375 170.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.4 -42.56 87.41 Favored 'General case' 0 C--N 1.352 0.68 0 C-N-CA 123.415 0.686 . . . . 0.0 111.156 169.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.84 -43.92 97.64 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 172.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -84.28 -41.96 16.33 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 120.25 -1.531 . . . . 0.0 113.968 -173.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -86.58 -18.92 30.23 Favored 'General case' 0 CA--C 1.503 -0.841 0 O-C-N 120.323 -1.486 . . . . 0.0 111.274 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -107.7 86.86 0.47 Allowed Glycine 0 N--CA 1.435 -1.401 0 CA-C-O 117.771 -1.572 . . . . 0.0 110.897 162.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -62.2 -27.64 78.65 Favored 'Trans proline' 0 CA--C 1.514 -0.487 0 CA-C-N 123.095 3.447 . . . . 0.0 109.242 157.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -60.16 -47.85 84.19 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 123.859 0.864 . . . . 0.0 112.484 163.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.4 mt -68.79 -43.39 75.76 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.79 -37.03 83.77 Favored 'General case' 0 C--N 1.347 0.459 0 O-C-N 119.175 -2.203 . . . . 0.0 113.464 176.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 54.2 tp -88.51 -60.87 1.84 Allowed 'General case' 0 C--N 1.35 0.611 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.21 -46.51 77.47 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 C-N-CA 125.434 1.494 . . . . 0.0 111.783 -173.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.8 m -100.91 -1.67 33.97 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-O 122.357 1.075 . . . . 0.0 110.334 -174.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 55.07 45.62 25.81 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 125.716 1.606 . . . . 0.0 114.748 175.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -97.39 2.56 50.63 Favored 'General case' 0 CA--C 1.514 -0.442 0 O-C-N 118.831 -2.418 . . . . 0.0 113.622 -176.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 5.2 p90 . . . . . 0 N--CA 1.443 -0.808 0 CA-C-O 121.229 0.538 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.631 HD22 ' H ' ' A' ' 2' ' ' LEU . 1.5 mm? -45.98 148.7 1.37 Allowed Pre-proline 0 CA--C 1.542 0.672 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 167.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -80.68 -23.01 6.1 Favored 'Trans proline' 0 CA--C 1.515 -0.45 0 CA-C-N 122.153 1.805 . . . . 0.0 109.518 -174.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.6 pt -54.17 -17.06 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 176.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.8 mt -59.43 -38.91 81.89 Favored 'General case' 0 C--N 1.345 0.404 0 O-C-N 120.053 -1.654 . . . . 0.0 113.725 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.22 -42.26 99.15 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-O 122.55 1.166 . . . . 0.0 113.036 169.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.6 m -64.56 -39.15 93.23 Favored 'General case' 0 C--N 1.345 0.381 0 O-C-N 120.285 -1.509 . . . . 0.0 114.182 174.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.62 -38.42 90.95 Favored 'General case' 0 CA--C 1.51 -0.585 0 O-C-N 120.537 -1.352 . . . . 0.0 113.375 173.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.48 -39.57 80.37 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.862 0.865 . . . . 0.0 112.236 170.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . . . -67.65 -48.13 67.56 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 168.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -72.55 -42.73 64.35 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -172.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -93.6 -9.26 38.65 Favored 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 120.57 -1.331 . . . . 0.0 110.042 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -120.62 75.19 0.33 Allowed Glycine 0 N--CA 1.434 -1.464 0 CA-C-O 117.694 -1.614 . . . . 0.0 112.584 169.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.81 -29.42 76.71 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 CA-C-N 123.022 3.411 . . . . 0.0 109.025 157.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.2 mtpp -59.6 -45.77 90.92 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.736 1.614 . . . . 0.0 112.839 165.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.7 mp -68.65 -46.1 70.05 Favored 'General case' 0 C--N 1.354 0.761 0 O-C-N 121.031 -1.043 . . . . 0.0 111.934 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -74.71 -10.78 59.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 120.534 -1.354 . . . . 0.0 114.622 -168.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.4 mp -101.92 -58.8 1.81 Allowed 'General case' 0 C--N 1.349 0.555 0 C-N-CA 124.305 1.042 . . . . 0.0 108.453 169.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.4 t -57.02 -37.78 56.73 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 C-N-CA 127.309 2.244 . . . . 0.0 114.207 -165.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 m -141.56 32.53 1.65 Allowed 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 119.471 -2.018 . . . . 0.0 108.768 169.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.2 ptmm? 31.94 58.17 0.34 Allowed 'General case' 0 C--N 1.347 0.475 0 N-CA-C 119.274 3.065 . . . . 0.0 119.274 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -96.21 14.98 22.24 Favored 'General case' 0 C--O 1.224 -0.25 0 O-C-N 119.899 -1.751 . . . . 0.0 112.073 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 39.5 p90 . . . . . 0 N--CA 1.44 -0.943 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.1 mp 70.12 160.89 0.15 Allowed Pre-proline 0 C--N 1.354 0.791 0 C-N-CA 123.774 0.829 . . . . 0.0 112.087 -173.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -66.97 -160.96 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.773 0 O-C-N 117.797 -1.738 . . . . 0.0 111.551 152.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.8 pt -49.58 -27.86 3.26 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 N-CA-C 117.028 2.233 . . . . 0.0 117.028 -171.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.8 mt -41.88 -43.07 2.92 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.57 -44.04 97.76 Favored 'General case' 0 C--N 1.351 0.661 0 O-C-N 120.686 -1.259 . . . . 0.0 113.004 172.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.1 m -67.38 -33.5 75.33 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 120.394 -1.442 . . . . 0.0 114.153 172.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.9 -42.49 90.16 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 119.739 -1.85 . . . . 0.0 113.315 171.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.1 -40.68 86.09 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 123.827 0.851 . . . . 0.0 111.331 170.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.02 -48.53 78.37 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 172.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -81.3 -45.92 15.49 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 119.463 -2.023 . . . . 0.0 112.729 -175.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -91.2 -8.5 48.37 Favored 'General case' 0 CA--C 1.5 -0.958 0 O-C-N 120.583 -1.323 . . . . 0.0 111.034 -173.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -102.8 81.58 0.38 Allowed Glycine 0 N--CA 1.439 -1.145 0 CA-C-O 117.625 -1.653 . . . . 0.0 110.626 156.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.07 -19.55 29.82 Favored 'Trans proline' 0 CA--C 1.512 -0.578 0 CA-C-N 123.895 3.847 . . . . 0.0 108.908 167.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -66.76 -45.77 77.48 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 161.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.7 mt -66.05 -41.85 90.3 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.28 18.51 9.45 Favored 'General case' 0 C--N 1.343 0.302 0 O-C-N 119.502 -1.999 . . . . 0.0 113.189 -177.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 58.4 tp -120.59 -71.49 0.73 Allowed 'General case' 0 C--N 1.353 0.729 0 C-N-CA 124.685 1.194 . . . . 0.0 110.159 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.5 t -62.05 -43.24 97.42 Favored 'Isoleucine or valine' 0 C--N 1.352 0.676 0 C-N-CA 126.799 2.04 . . . . 0.0 110.91 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.4 m -121.44 137.06 54.88 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -79.54 72.19 6.18 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 119.915 -1.741 . . . . 0.0 114.64 171.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -99.59 -1.92 36.97 Favored 'General case' 0 C--N 1.348 0.532 0 O-C-N 119.27 -2.144 . . . . 0.0 111.202 167.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 39.5 t80 . . . . . 0 N--CA 1.44 -0.955 0 CA-C-O 122.071 0.938 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.1 mp -140.86 160.75 57.33 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 101.306 -3.59 . . . . 0.0 101.306 168.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -93.44 -133.57 0.01 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.485 0 N-CA-C 107.326 -1.836 . . . . 0.0 107.326 167.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.6 pt -49.74 -27.91 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.1 mt -54.27 -40.15 67.54 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -173.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.35 -42.42 99.38 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-O 122.727 1.251 . . . . 0.0 112.801 171.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.2 m -68.68 -32.73 72.75 Favored 'General case' 0 C--N 1.343 0.323 0 O-C-N 120.192 -1.568 . . . . 0.0 114.387 173.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.8 mt -66.12 -40.1 90.42 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 119.429 -2.044 . . . . 0.0 112.981 171.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.44 -43.01 88.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.062 0.545 . . . . 0.0 111.324 168.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.496 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -60.19 -46.35 90.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 173.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -81.07 -44.02 18.62 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 120.8 -1.188 . . . . 0.0 114.127 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -85.86 -17.77 34.68 Favored 'General case' 0 CA--C 1.501 -0.933 0 O-C-N 120.336 -1.477 . . . . 0.0 111.111 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.46 85.35 0.41 Allowed Glycine 0 N--CA 1.435 -1.412 0 CA-C-O 117.804 -1.554 . . . . 0.0 110.633 163.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -62.45 -28.18 77.78 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 CA-C-N 123.071 3.435 . . . . 0.0 109.378 160.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.32 -46.53 89.9 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 123.153 0.581 . . . . 0.0 112.516 163.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.5 mt -66.99 -43.06 83.94 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 120.61 -1.307 . . . . 0.0 114.395 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.496 ' CE2' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -68.46 -31.85 71.43 Favored 'General case' 0 C--N 1.346 0.452 0 O-C-N 119.016 -2.302 . . . . 0.0 113.619 175.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -89.48 -56.76 3.13 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.76 -47.02 78.52 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 C-N-CA 125.23 1.412 . . . . 0.0 111.478 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.3 m -103.85 -0.6 28.95 Favored 'General case' 0 C--N 1.346 0.417 0 O-C-N 120.868 -1.145 . . . . 0.0 110.656 -172.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 56.2 50.11 14.1 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 173.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -106.97 15.75 25.0 Favored 'General case' 0 CA--C 1.514 -0.404 0 O-C-N 119.311 -2.118 . . . . 0.0 112.85 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 34.9 p90 . . . . . 0 N--CA 1.442 -0.84 0 CA-C-O 121.506 0.67 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 64.1 mt -43.71 144.6 1.35 Allowed Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 171.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -81.16 -28.09 2.6 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 O-C-N 117.722 -1.778 . . . . 0.0 109.591 -171.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.4 pt -53.71 -17.62 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 174.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.7 mt -60.48 -35.23 75.42 Favored 'General case' 0 C--N 1.345 0.403 0 O-C-N 120.495 -1.378 . . . . 0.0 113.17 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.85 98.79 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-O 122.193 0.997 . . . . 0.0 112.646 169.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.1 m -64.02 -41.03 97.58 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 120.269 -1.52 . . . . 0.0 113.896 173.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.05 -42.11 99.65 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 120.85 -1.156 . . . . 0.0 113.095 173.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.77 -42.06 92.49 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.676 1.19 . . . . 0.0 112.55 173.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.72 -48.38 66.66 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 172.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -76.95 -45.67 26.82 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -173.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -105.03 -9.28 17.96 Favored 'General case' 0 CA--C 1.5 -0.944 0 O-C-N 121.198 -0.939 . . . . 0.0 110.329 -173.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -107.13 61.45 0.32 Allowed Glycine 0 CA--C 1.5 -0.867 0 CA-C-O 115.603 -2.776 . . . . 0.0 112.134 162.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -65.53 -23.24 57.7 Favored 'Trans proline' 0 N--CA 1.46 -0.493 1 CA-C-N 127.081 5.441 . . . . 0.0 110.714 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -47.28 85.76 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 122.998 0.519 . . . . 0.0 112.171 165.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.48 -44.56 86.72 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 121.227 -0.921 . . . . 0.0 111.894 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -60.88 -41.53 96.17 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 124.081 0.952 . . . . 0.0 112.935 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.4 mp -73.07 -43.44 61.87 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 119.932 -1.73 . . . . 0.0 112.282 176.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.23 -41.02 81.05 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 O-C-N 121.078 -1.014 . . . . 0.0 111.98 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.7 p -134.57 148.42 50.45 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 119.916 -1.74 . . . . 0.0 112.131 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -76.12 84.97 2.97 Favored 'General case' 0 C--N 1.344 0.35 0 O-C-N 117.768 -3.083 . . . . 0.0 112.643 172.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.46 -3.6 22.32 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 119.836 -1.79 . . . . 0.0 109.164 158.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 37.2 t80 . . . . . 0 N--CA 1.437 -1.104 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -45.3 159.15 0.29 Allowed Pre-proline 0 C--N 1.349 0.584 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 156.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -88.02 -155.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.451 0 N-CA-C 108.525 -1.375 . . . . 0.0 108.525 165.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.3 pt -49.08 -28.14 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 127.438 2.295 . . . . 0.0 116.881 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.6 mt -50.94 -38.94 53.55 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.21 -42.94 99.76 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 120.657 -1.277 . . . . 0.0 113.011 171.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.6 m -68.41 -34.04 75.31 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 120.085 -1.635 . . . . 0.0 114.137 172.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.79 -38.12 89.91 Favored 'General case' 0 CA--C 1.508 -0.665 0 O-C-N 119.575 -1.953 . . . . 0.0 113.236 172.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.61 -39.57 77.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.646 0.778 . . . . 0.0 111.551 168.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.27 -47.87 77.91 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 170.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -77.61 -43.12 32.61 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -171.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -91.39 -14.63 30.32 Favored 'General case' 0 CA--C 1.502 -0.893 0 O-C-N 120.628 -1.295 . . . . 0.0 110.49 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -112.76 81.2 0.29 Allowed Glycine 0 N--CA 1.437 -1.262 0 CA-C-O 118.474 -1.181 . . . . 0.0 111.317 164.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -62.9 -27.41 74.76 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 CA-C-N 122.151 2.975 . . . . 0.0 109.36 160.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.45 -46.98 87.78 Favored 'General case' 0 C--N 1.35 0.603 0 CA-C-O 121.303 0.573 . . . . 0.0 112.403 163.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.0 mp -67.4 -44.4 78.92 Favored 'General case' 0 C--N 1.35 0.626 0 O-C-N 120.946 -1.096 . . . . 0.0 113.654 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.35 -18.29 55.34 Favored 'General case' 0 C--N 1.348 0.514 0 O-C-N 119.066 -2.272 . . . . 0.0 114.208 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 51.6 tp -90.12 -63.9 1.21 Allowed 'General case' 0 C--N 1.349 0.571 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.5 t -64.91 -46.63 91.18 Favored 'Isoleucine or valine' 0 C--N 1.35 0.587 0 C-N-CA 126.639 1.976 . . . . 0.0 111.96 -171.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.1 m -103.67 2.32 33.01 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-O 122.696 1.236 . . . . 0.0 110.075 -176.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.88 44.53 25.72 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.994 1.717 . . . . 0.0 115.242 167.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -104.15 7.63 36.23 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 119.208 -2.183 . . . . 0.0 113.342 -176.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 CA--C 1.504 -0.801 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -109.74 159.05 33.07 Favored Pre-proline 0 N--CA 1.437 -1.091 0 N-CA-C 103.023 -2.954 . . . . 0.0 103.023 162.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -87.62 -151.65 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.382 0 N-CA-C 108.198 -1.501 . . . . 0.0 108.198 162.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.7 pt -50.12 -27.45 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 117.137 2.273 . . . . 0.0 117.137 -176.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 64.9 mt -52.13 -41.42 62.49 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -173.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.42 -44.85 95.45 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-O 122.794 1.283 . . . . 0.0 112.685 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.0 m -65.49 -38.6 90.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.982 1.313 . . . . 0.0 113.793 173.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.5 mt -64.32 -38.86 92.53 Favored 'General case' 0 CA--C 1.504 -0.793 0 O-C-N 120.536 -1.352 . . . . 0.0 113.954 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.69 -47.06 83.39 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.25 0.548 . . . . 0.0 111.232 173.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.468 ' HB1' ' CD1' ' A' ' 17' ' ' PHE . . . -62.74 -46.63 87.17 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 169.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.79 -38.4 70.29 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 118.061 -2.899 . . . . 0.0 115.833 -176.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -92.21 -22.24 19.92 Favored 'General case' 0 CA--C 1.496 -1.098 0 O-C-N 119.703 -1.873 . . . . 0.0 112.573 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -100.27 90.13 0.89 Allowed Glycine 0 CA--C 1.492 -1.38 0 CA-C-O 116.494 -2.281 . . . . 0.0 109.421 161.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -63.59 -27.82 69.57 Favored 'Trans proline' 0 CA--C 1.517 -0.373 1 CA-C-N 125.654 4.727 . . . . 0.0 109.882 170.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -59.6 -45.12 92.86 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.953 1.701 . . . . 0.0 112.453 164.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.7 mt -67.85 -37.26 81.64 Favored 'General case' 0 C--N 1.35 0.602 0 O-C-N 120.766 -1.209 . . . . 0.0 113.865 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.468 ' CD1' ' HB1' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -61.28 -45.54 94.05 Favored 'General case' 0 C--N 1.348 0.532 0 O-C-N 119.161 -2.212 . . . . 0.0 111.482 174.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -80.92 -57.88 3.34 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 119.632 1.106 . . . . 0.0 113.5 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.79 -41.61 90.61 Favored 'Isoleucine or valine' 0 C--N 1.35 0.603 0 C-N-CA 125.772 1.629 . . . . 0.0 111.864 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.2 p -100.53 9.13 42.97 Favored 'General case' 0 C--N 1.349 0.571 0 O-C-N 120.762 -1.211 . . . . 0.0 112.262 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? 47.64 43.85 16.78 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 127.433 2.293 . . . . 0.0 116.857 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -118.71 14.57 13.49 Favored 'General case' 0 C--N 1.347 0.487 0 O-C-N 119.945 -1.722 . . . . 0.0 115.079 -168.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 CA--C 1.501 -0.906 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 64.17 171.19 0.09 OUTLIER Pre-proline 0 C--N 1.352 0.713 0 C-N-CA 125.069 1.348 . . . . 0.0 111.969 -170.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.64 -170.9 0.41 Allowed 'Trans proline' 0 N--CA 1.452 -0.953 0 O-C-N 118.029 -1.616 . . . . 0.0 110.477 151.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.6 pt -49.89 -27.79 3.78 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 -172.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 62.4 mt -38.16 -46.1 1.01 Allowed 'General case' 0 C--N 1.347 0.462 0 C-N-CA 128.242 2.617 . . . . 0.0 117.571 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.53 -45.99 90.47 Favored 'General case' 0 C--N 1.35 0.602 0 O-C-N 120.702 -1.249 . . . . 0.0 113.123 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.3 m -65.76 -39.48 91.09 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 124.994 1.317 . . . . 0.0 113.456 171.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.3 mt -62.59 -36.66 83.42 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 120.718 -1.238 . . . . 0.0 113.634 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.58 -49.09 78.73 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 118.508 0.595 . . . . 0.0 111.795 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.88 -46.15 90.64 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 168.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.13 -38.41 82.16 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 118.642 -2.536 . . . . 0.0 116.589 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -94.48 -19.62 20.4 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 119.589 -1.944 . . . . 0.0 112.37 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.49 93.49 1.43 Allowed Glycine 0 CA--C 1.489 -1.549 0 CA-C-O 116.646 -2.196 . . . . 0.0 110.32 163.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.87 -25.87 67.41 Favored 'Trans proline' 0 C--N 1.328 -0.533 1 CA-C-N 125.779 4.79 . . . . 0.0 110.653 171.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -45.42 92.98 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.068 0.947 . . . . 0.0 112.647 162.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.5 mt -70.29 -32.94 70.95 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.048 1.339 . . . . 0.0 113.834 176.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -42.85 97.96 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 119.301 -2.125 . . . . 0.0 111.847 173.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -92.55 -61.58 1.57 Allowed 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.6 t -65.66 -46.23 89.9 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 C-N-CA 125.612 1.565 . . . . 0.0 112.429 -168.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.4 p -99.89 5.95 45.3 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 120.908 -1.12 . . . . 0.0 110.84 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.13 49.39 20.1 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 172.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.29 15.35 20.41 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 119.139 -2.226 . . . . 0.0 114.455 -174.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 45.6 t80 . . . . . 0 N--CA 1.436 -1.142 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 63.96 171.1 0.09 OUTLIER Pre-proline 0 C--N 1.358 0.956 0 C-N-CA 124.521 1.128 . . . . 0.0 110.638 -157.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.55 -172.7 0.58 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 O-C-N 117.154 -2.077 . . . . 0.0 110.495 151.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.0 pt -49.43 -27.45 2.76 Favored 'Isoleucine or valine' 0 C--N 1.344 0.332 0 N-CA-C 117.178 2.288 . . . . 0.0 117.178 -173.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.6 mt -39.05 -43.69 1.03 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 127.744 2.417 . . . . 0.0 117.192 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.25 -43.12 99.56 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 120.512 -1.367 . . . . 0.0 113.309 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 m -69.47 -33.89 73.57 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 120.042 -1.661 . . . . 0.0 113.845 172.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.08 -36.84 85.6 Favored 'General case' 0 CA--C 1.509 -0.63 0 O-C-N 119.919 -1.738 . . . . 0.0 113.296 172.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.42 -42.35 82.19 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.776 0.831 . . . . 0.0 111.235 168.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.508 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -61.17 -49.39 77.38 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 168.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -76.64 -41.66 44.96 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -101.81 -5.51 24.76 Favored 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 120.32 -1.488 . . . . 0.0 111.107 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -112.57 82.33 0.3 Allowed Glycine 0 N--CA 1.437 -1.295 0 CA-C-O 118.644 -1.087 . . . . 0.0 110.73 164.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -62.59 -31.15 79.79 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 122.029 2.915 . . . . 0.0 109.659 162.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -64.45 -45.78 85.97 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 162.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.59 -41.36 92.92 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 120.234 -1.541 . . . . 0.0 113.897 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -75.16 -21.95 58.43 Favored 'General case' 0 C--N 1.349 0.545 0 O-C-N 118.975 -2.328 . . . . 0.0 114.276 174.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.2 mt -87.02 -57.89 2.8 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.87 -44.32 85.42 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 125.675 1.59 . . . . 0.0 112.389 -173.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.8 m -118.0 11.47 13.39 Favored 'General case' 0 C--N 1.345 0.399 0 O-C-N 120.914 -1.116 . . . . 0.0 110.828 -171.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.61 53.03 12.89 Favored 'General case' 0 C--N 1.348 0.514 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 168.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -109.15 23.71 14.14 Favored 'General case' 0 CA--C 1.517 -0.306 0 O-C-N 119.871 -1.768 . . . . 0.0 111.672 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 43.7 t80 . . . . . 0 N--CA 1.44 -0.933 0 CA-C-O 122.003 0.906 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 40.6 tp -123.37 144.05 42.89 Favored Pre-proline 0 N--CA 1.434 -1.257 0 N-CA-C 101.531 -3.507 . . . . 0.0 101.531 164.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -109.83 -120.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.959 0 CA-C-N 123.18 2.172 . . . . 0.0 107.608 -171.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.6 pt -49.67 -28.03 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 C-N-CA 127.065 2.146 . . . . 0.0 116.432 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 52.7 mt -57.65 -37.05 72.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 120.344 -1.473 . . . . 0.0 114.415 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.48 -43.56 98.52 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-O 122.697 1.237 . . . . 0.0 112.606 169.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.2 m -66.06 -35.88 81.73 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 120.366 -1.458 . . . . 0.0 114.746 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.4 mt -65.91 -39.96 91.04 Favored 'General case' 0 CA--C 1.504 -0.801 0 O-C-N 119.63 -1.919 . . . . 0.0 113.189 172.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.17 89.23 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 122.965 0.506 . . . . 0.0 111.113 168.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.468 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -61.33 -46.05 91.86 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 173.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -83.89 -43.7 15.03 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 120.753 -1.217 . . . . 0.0 114.174 -173.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -85.01 -19.7 31.6 Favored 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 120.418 -1.426 . . . . 0.0 111.171 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.18 85.12 0.4 Allowed Glycine 0 N--CA 1.435 -1.367 0 CA-C-O 118.067 -1.407 . . . . 0.0 110.411 161.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -62.43 -31.04 80.95 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 CA-C-N 122.873 3.337 . . . . 0.0 109.056 160.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.6 -45.91 90.52 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.746 1.218 . . . . 0.0 112.822 163.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.5 mt -66.92 -42.97 84.49 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 120.588 -1.32 . . . . 0.0 113.984 176.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -67.03 -33.78 76.28 Favored 'General case' 0 C--N 1.346 0.455 0 O-C-N 119.182 -2.199 . . . . 0.0 113.795 175.619 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.46 -58.64 2.46 Favored 'General case' 0 C--N 1.348 0.53 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.6 t -66.33 -45.49 89.43 Favored 'Isoleucine or valine' 0 C--N 1.347 0.492 0 C-N-CA 125.958 1.703 . . . . 0.0 112.091 -173.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.5 m -106.41 1.54 25.74 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 122.407 1.099 . . . . 0.0 110.326 -172.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.9 pttm 51.05 44.16 28.72 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 127.671 2.389 . . . . 0.0 116.684 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.7 mtpt -97.42 19.95 12.45 Favored 'General case' 0 C--N 1.347 0.466 0 O-C-N 119.289 -2.132 . . . . 0.0 113.498 -176.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 70.4 t80 . . . . . 0 N--CA 1.436 -1.131 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.2 tp 68.62 171.04 0.1 Allowed Pre-proline 0 C--N 1.356 0.885 0 C-N-CA 126.371 1.868 . . . . 0.0 110.137 -168.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -73.34 -170.63 0.68 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 O-C-N 116.743 -2.293 . . . . 0.0 111.147 154.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.6 pt -50.25 -28.74 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 127.143 2.177 . . . . 0.0 116.39 -174.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.2 mt -33.1 -44.48 0.12 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 128.06 2.544 . . . . 0.0 117.821 174.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.72 96.11 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 120.582 -1.324 . . . . 0.0 113.155 174.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.2 m -70.7 -30.66 67.28 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.226 -1.546 . . . . 0.0 113.558 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.9 mt -66.96 -40.27 87.44 Favored 'General case' 0 CA--C 1.509 -0.597 0 O-C-N 119.525 -1.984 . . . . 0.0 113.559 170.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.7 -43.53 90.05 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.866 0.866 . . . . 0.0 111.317 169.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.2 -46.84 88.36 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 172.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -79.45 -44.05 22.11 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 120.282 -1.511 . . . . 0.0 114.679 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -85.88 -18.41 32.84 Favored 'General case' 0 CA--C 1.501 -0.928 0 O-C-N 120.156 -1.59 . . . . 0.0 111.177 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -107.2 85.11 0.41 Allowed Glycine 0 N--CA 1.436 -1.354 0 CA-C-O 117.365 -1.797 . . . . 0.0 110.321 162.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -62.27 -27.59 78.23 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 CA-C-N 123.579 3.69 . . . . 0.0 109.469 160.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -45.79 92.04 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 123.829 0.851 . . . . 0.0 112.419 164.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.6 mt -69.16 -42.26 76.17 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.16 -35.64 80.11 Favored 'General case' 0 C--N 1.345 0.402 0 O-C-N 119.386 -2.071 . . . . 0.0 113.566 175.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 52.9 tp -85.47 -59.1 2.42 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.0 t -70.33 -46.92 69.37 Favored 'Isoleucine or valine' 0 C--N 1.348 0.527 0 C-N-CA 125.338 1.455 . . . . 0.0 111.626 -173.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.3 m -103.14 0.66 32.15 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-O 122.248 1.023 . . . . 0.0 110.819 -172.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 53.4 51.79 14.68 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 125.838 1.655 . . . . 0.0 115.183 174.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.7 mtpp -106.46 15.22 26.23 Favored 'General case' 0 C--N 1.345 0.376 0 O-C-N 119.578 -1.951 . . . . 0.0 112.609 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 12.5 p90 . . . . . 0 N--CA 1.442 -0.842 0 CA-C-O 122.104 0.954 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.0 mp -108.06 143.86 28.22 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 158.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -90.31 -121.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.266 0 N-CA-C 107.171 -1.896 . . . . 0.0 107.171 172.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.3 pt -49.69 -28.52 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.6 mt -55.95 -40.22 72.89 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.77 -42.93 97.7 Favored 'General case' 0 C--N 1.349 0.565 0 O-C-N 120.823 -1.173 . . . . 0.0 112.376 171.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.7 m -66.08 -35.98 81.98 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 174.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.0 mt -65.18 -42.01 94.06 Favored 'General case' 0 CA--C 1.506 -0.739 0 O-C-N 119.671 -1.893 . . . . 0.0 112.788 172.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.29 -42.4 91.2 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 123.327 0.651 . . . . 0.0 111.345 169.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.3 -47.83 82.54 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 174.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -84.9 -48.1 9.65 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 119.959 -1.713 . . . . 0.0 112.841 -173.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -84.56 -16.45 42.18 Favored 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 120.518 -1.364 . . . . 0.0 111.123 -175.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.47 84.89 0.47 Allowed Glycine 0 N--CA 1.436 -1.362 0 CA-C-O 117.8 -1.556 . . . . 0.0 111.089 159.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.29 -28.53 63.76 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 CA-C-N 123.461 3.63 . . . . 0.0 109.638 165.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -63.19 -45.75 90.28 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 122.921 0.488 . . . . 0.0 112.149 163.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.27 -42.32 84.06 Favored 'General case' 0 C--N 1.348 0.543 0 O-C-N 120.664 -1.273 . . . . 0.0 113.528 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.69 -35.32 80.43 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 119.054 -2.279 . . . . 0.0 114.072 173.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.6 mt -86.75 -55.21 3.96 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.3 t -71.55 -46.85 61.24 Favored 'Isoleucine or valine' 0 C--N 1.349 0.543 0 C-N-CA 124.876 1.27 . . . . 0.0 111.613 -175.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.9 m -103.35 -1.21 29.04 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 122.538 1.161 . . . . 0.0 110.912 -171.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.2 tmmt? 53.98 53.29 11.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.5 1.52 . . . . 0.0 114.717 176.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -108.16 13.75 25.62 Favored 'General case' 0 C--N 1.345 0.404 0 O-C-N 120.113 -1.617 . . . . 0.0 112.706 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 55.8 t80 . . . . . 0 N--CA 1.436 -1.165 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.4 tp 69.05 170.91 0.11 Allowed Pre-proline 0 C--N 1.356 0.855 0 C-N-CA 126.47 1.908 . . . . 0.0 109.44 -164.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -78.58 -164.54 0.28 Allowed 'Trans proline' 0 N--CA 1.451 -1.021 0 O-C-N 116.86 -2.231 . . . . 0.0 110.193 156.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -49.44 -27.92 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 C-N-CA 127.59 2.356 . . . . 0.0 117.081 -173.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 35.1 mt -39.45 -42.32 1.09 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 127.667 2.387 . . . . 0.0 116.987 177.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.95 -43.72 98.25 Favored 'General case' 0 C--N 1.35 0.616 0 O-C-N 120.624 -1.298 . . . . 0.0 112.967 173.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.5 m -71.84 -29.27 64.23 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 120.199 -1.563 . . . . 0.0 113.741 172.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.8 mt -66.57 -38.95 88.15 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 119.362 -2.086 . . . . 0.0 113.315 170.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.21 -41.78 84.79 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.536 0.734 . . . . 0.0 111.015 168.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.576 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -61.01 -47.27 87.21 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 172.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -80.52 -42.66 22.07 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -173.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -86.39 -18.76 30.97 Favored 'General case' 0 CA--C 1.502 -0.871 0 O-C-N 120.287 -1.508 . . . . 0.0 110.983 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -111.94 85.43 0.39 Allowed Glycine 0 N--CA 1.435 -1.377 0 CA-C-O 118.075 -1.403 . . . . 0.0 111.212 164.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -61.88 -29.54 82.64 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 CA-C-N 122.508 3.154 . . . . 0.0 109.264 157.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -59.62 -47.85 83.98 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.136 0.974 . . . . 0.0 112.461 163.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 90.9 mt -67.44 -43.62 80.71 Favored 'General case' 0 C--N 1.35 0.592 0 O-C-N 120.741 -1.225 . . . . 0.0 114.143 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.576 ' CE2' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -69.72 -27.62 65.12 Favored 'General case' 0 C--N 1.347 0.464 0 O-C-N 119.116 -2.24 . . . . 0.0 113.666 176.674 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.6 mt -87.8 -54.83 4.05 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -177.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.3 t -69.97 -47.93 66.09 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 C-N-CA 125.015 1.326 . . . . 0.0 111.117 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.9 m -105.34 -0.08 26.53 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-O 122.494 1.14 . . . . 0.0 110.914 -169.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.15 49.74 14.89 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 174.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -106.6 15.89 25.23 Favored 'General case' 0 CA--C 1.517 -0.303 0 O-C-N 119.613 -1.929 . . . . 0.0 112.057 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 72.0 t80 . . . . . 0 N--CA 1.439 -1.0 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 75.6 mt 69.78 169.52 0.11 Allowed Pre-proline 0 C--N 1.359 1.002 0 C-N-CA 124.059 0.943 . . . . 0.0 110.902 -173.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -67.36 178.87 2.8 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 O-C-N 117.253 -2.025 . . . . 0.0 111.391 150.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.254 45.2 pt -44.44 -37.7 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 127.641 2.376 . . . . 0.0 115.243 -174.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 20.6 mt -35.41 -33.72 0.03 OUTLIER 'General case' 0 C--N 1.356 0.851 0 C-N-CA 129.311 3.044 . . . . 0.0 118.35 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.64 85.96 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-O 123.026 1.393 . . . . 0.0 112.619 171.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.9 p -77.4 -19.23 56.45 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 120.301 -1.499 . . . . 0.0 113.402 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.6 mt -65.84 -39.19 90.55 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 120.188 -1.57 . . . . 0.0 112.478 169.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.55 -44.07 89.54 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 121.867 -0.521 . . . . 0.0 111.531 168.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.505 ' HA ' ' CG ' ' A' ' 17' ' ' PHE . . . -61.29 -40.26 93.48 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 117.647 2.462 . . . . 0.0 117.647 174.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -89.75 -46.88 8.28 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -93.47 -9.13 39.54 Favored 'General case' 0 CA--C 1.492 -1.271 0 O-C-N 120.503 -1.373 . . . . 0.0 112.039 -172.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.77 82.6 0.3 Allowed Glycine 0 N--CA 1.43 -1.727 0 O-C-N 121.144 -0.973 . . . . 0.0 111.41 170.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -65.11 -32.13 53.35 Favored 'Trans proline' 0 N--CA 1.443 -1.487 0 CA-C-N 123.289 3.544 . . . . 0.0 110.256 157.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -64.94 -44.71 88.54 Favored 'General case' 0 C--N 1.348 0.522 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 166.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 82.7 mt -70.52 -48.11 57.14 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.505 ' CG ' ' HA ' ' A' ' 10' ' ' ALA . 1.1 t80 -102.09 24.31 10.3 Favored 'General case' 0 CA--C 1.505 -0.782 0 O-C-N 119.135 -2.228 . . . . 0.0 113.096 -165.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 54.9 tp -125.31 -49.94 1.67 Allowed 'General case' 0 C--N 1.355 0.843 0 C-N-CA 124.005 0.922 . . . . 0.0 111.865 175.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.2 t -65.69 -28.19 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 C-N-CA 126.996 2.118 . . . . 0.0 111.741 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.3 m -160.25 170.12 21.78 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 101.99 -3.337 . . . . 0.0 101.99 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.9 tttp -106.21 115.31 30.01 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 120.655 1.571 . . . . 0.0 111.279 175.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -114.92 8.58 15.94 Favored 'General case' 0 C--O 1.224 -0.284 0 O-C-N 120.084 -1.635 . . . . 0.0 110.152 155.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 54.1 p90 . . . . . 0 N--CA 1.444 -0.77 0 CA-C-O 122.041 0.924 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.1 mt -150.55 160.57 32.52 Favored Pre-proline 0 N--CA 1.434 -1.227 0 N-CA-C 103.389 -2.819 . . . . 0.0 103.389 176.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -98.36 -135.45 0.01 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.575 0 N-CA-C 107.12 -1.916 . . . . 0.0 107.12 169.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.4 pt -49.23 -28.17 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 N-CA-C 117.034 2.235 . . . . 0.0 117.034 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 62.8 mt -53.72 -38.77 64.64 Favored 'General case' 0 C--N 1.344 0.368 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.98 97.81 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-O 122.46 1.124 . . . . 0.0 112.772 170.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.8 m -67.85 -35.44 78.57 Favored 'General case' 0 C--N 1.343 0.32 0 O-C-N 120.178 -1.577 . . . . 0.0 114.5 174.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.2 mt -65.45 -39.17 91.71 Favored 'General case' 0 CA--C 1.509 -0.63 0 O-C-N 119.733 -1.854 . . . . 0.0 113.391 172.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.1 -39.2 78.02 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.622 0.769 . . . . 0.0 111.356 168.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.49 -48.77 71.44 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 170.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -77.59 -42.67 34.29 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 120.775 -1.203 . . . . 0.0 114.111 -171.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -94.93 -7.75 39.06 Favored 'General case' 0 CA--C 1.502 -0.9 0 O-C-N 120.769 -1.207 . . . . 0.0 110.105 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -117.38 78.8 0.29 Allowed Glycine 0 N--CA 1.432 -1.59 0 CA-C-O 117.215 -1.881 . . . . 0.0 111.184 161.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -62.62 -35.94 67.1 Favored 'Trans proline' 0 CA--C 1.512 -0.588 0 CA-C-N 123.607 3.703 . . . . 0.0 109.351 167.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -36.74 84.74 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 166.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 82.0 mt -68.97 -46.86 67.02 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 120.503 -1.373 . . . . 0.0 113.357 176.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.75 -33.84 74.57 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 121.775 2.08 . . . . 0.0 114.417 176.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -79.04 -56.84 4.08 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 121.132 -0.98 . . . . 0.0 113.436 173.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.3 t -66.79 -43.71 89.67 Favored 'Isoleucine or valine' 0 C--N 1.348 0.537 0 C-N-CA 126.07 1.748 . . . . 0.0 113.242 -171.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 59.0 p -106.73 -3.33 20.63 Favored 'General case' 0 CA--C 1.508 -0.668 0 O-C-N 120.547 -1.346 . . . . 0.0 112.762 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.69 44.5 14.17 Favored 'General case' 0 C--N 1.349 0.571 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 178.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -105.4 21.99 16.22 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 119.313 -2.117 . . . . 0.0 112.04 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 38.7 t80 . . . . . 0 N--CA 1.437 -1.107 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.3 mp 65.57 171.1 0.09 OUTLIER Pre-proline 0 C--N 1.356 0.86 0 C-N-CA 124.548 1.139 . . . . 0.0 111.012 -160.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -68.41 -172.0 0.41 Allowed 'Trans proline' 0 N--CA 1.451 -0.972 0 O-C-N 117.333 -1.983 . . . . 0.0 110.846 151.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.4 pt -49.35 -28.06 2.95 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 N-CA-C 117.19 2.293 . . . . 0.0 117.19 -174.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.8 mt -39.93 -42.68 1.39 Allowed 'General case' 0 C--N 1.343 0.311 0 C-N-CA 127.754 2.422 . . . . 0.0 117.356 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.92 -43.45 98.82 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 120.592 -1.318 . . . . 0.0 113.191 173.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 14.2 m -70.73 -31.33 68.13 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 119.902 -1.749 . . . . 0.0 113.873 171.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.66 -36.44 82.55 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 119.261 -2.15 . . . . 0.0 113.41 171.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.03 -38.93 77.16 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 123.817 0.847 . . . . 0.0 111.465 168.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.58 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . . . -63.56 -48.57 76.9 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 169.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -77.31 -41.92 38.77 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -170.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -95.05 -5.55 44.15 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 120.627 -1.296 . . . . 0.0 110.177 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -122.58 81.34 0.35 Allowed Glycine 0 N--CA 1.43 -1.705 0 CA-C-O 117.713 -1.604 . . . . 0.0 110.673 164.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.47 -34.33 86.15 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 CA-C-N 122.719 3.259 . . . . 0.0 109.688 164.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -37.24 86.73 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 165.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.6 mp -67.58 -45.27 76.04 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 120.014 -1.679 . . . . 0.0 112.66 172.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.58 ' CE2' ' HB2' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -68.81 -33.21 73.47 Favored 'General case' 0 C--N 1.346 0.437 0 O-C-N 119.251 -2.155 . . . . 0.0 114.03 177.131 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 52.2 tp -94.67 -65.46 0.98 Allowed 'General case' 0 C--N 1.351 0.634 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.5 t -64.54 -46.83 91.49 Favored 'Isoleucine or valine' 0 C--N 1.348 0.532 0 C-N-CA 126.703 2.001 . . . . 0.0 112.094 -171.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.3 m -102.68 2.9 36.48 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 122.89 1.329 . . . . 0.0 109.813 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.64 48.78 14.26 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 117.143 2.275 . . . . 0.0 117.143 174.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -93.82 -0.46 55.81 Favored 'General case' 0 C--N 1.343 0.283 0 O-C-N 119.293 -2.13 . . . . 0.0 112.675 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 8.9 t80 . . . . . 0 N--CA 1.439 -1.005 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 29.7 mt -43.77 144.62 1.37 Allowed Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 168.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -77.87 -25.4 7.67 Favored 'Trans proline' 0 CA--C 1.514 -0.489 0 CA-C-N 122.286 1.852 . . . . 0.0 109.352 -176.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.8 pt -53.95 -17.52 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 174.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.56 -39.0 82.62 Favored 'General case' 0 C--N 1.346 0.425 0 O-C-N 119.953 -1.717 . . . . 0.0 113.599 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.15 -42.87 99.67 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-O 122.507 1.146 . . . . 0.0 112.79 169.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.1 m -63.96 -39.27 93.75 Favored 'General case' 0 C--N 1.345 0.395 0 O-C-N 120.426 -1.421 . . . . 0.0 114.275 174.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.8 mt -64.6 -40.97 96.47 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 120.421 -1.424 . . . . 0.0 113.132 173.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.32 -44.66 88.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.318 0.58 . . . . 0.0 111.519 171.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.88 -45.82 87.68 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 171.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.84 -25.76 19.73 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 118.416 -2.677 . . . . 0.0 114.356 -169.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -99.17 -12.35 20.54 Favored 'General case' 0 CA--C 1.498 -1.024 0 O-C-N 119.548 -1.97 . . . . 0.0 111.209 173.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.68 83.36 0.36 Allowed Glycine 0 N--CA 1.438 -1.176 0 CA-C-O 117.159 -1.912 . . . . 0.0 109.832 157.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -63.06 -29.92 75.45 Favored 'Trans proline' 0 CA--C 1.517 -0.35 1 CA-C-N 124.468 4.134 . . . . 0.0 110.093 168.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -59.96 -47.56 85.3 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 123.815 0.846 . . . . 0.0 111.887 164.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.9 mt -64.36 -42.8 96.03 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -61.92 -37.74 85.81 Favored 'General case' 0 C--N 1.347 0.498 0 O-C-N 119.311 -2.118 . . . . 0.0 113.564 178.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.72 -46.93 67.63 Favored 'General case' 0 C--N 1.345 0.413 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.6 t -60.77 -39.7 82.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.571 0 C-N-CA 125.48 1.512 . . . . 0.0 111.404 -176.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.7 p -105.22 24.68 11.66 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.545 -1.347 . . . . 0.0 113.451 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? 47.12 54.48 9.31 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 126.613 1.965 . . . . 0.0 115.304 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -138.51 -165.89 1.9 Allowed 'General case' 0 C--N 1.344 0.354 0 O-C-N 119.896 -1.753 . . . . 0.0 110.985 -177.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 24.9 p90 . . . . . 0 N--CA 1.443 -0.787 0 CA-C-O 121.756 0.789 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 38.2 tp -123.83 144.09 43.85 Favored Pre-proline 0 N--CA 1.433 -1.299 0 N-CA-C 102.533 -3.136 . . . . 0.0 102.533 168.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -109.19 -118.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.955 0 CA-C-N 122.81 2.039 . . . . 0.0 107.437 -173.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.5 pt -49.84 -28.14 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 116.555 2.057 . . . . 0.0 116.555 -179.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 64.5 mt -59.56 -38.47 81.18 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 120.122 -1.611 . . . . 0.0 114.671 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.5 -44.67 95.8 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-O 122.805 1.288 . . . . 0.0 112.137 170.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.5 m -63.92 -38.92 92.87 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.952 1.301 . . . . 0.0 114.174 175.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.71 -41.2 92.59 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 125.215 1.406 . . . . 0.0 113.817 175.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.72 -45.91 88.54 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-O 121.888 0.852 . . . . 0.0 111.115 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.44 -48.21 80.67 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 170.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -72.24 -43.52 64.26 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 118.012 -2.93 . . . . 0.0 115.161 -177.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -85.33 -24.12 27.78 Favored 'General case' 0 CA--C 1.498 -1.02 0 O-C-N 120.132 -1.605 . . . . 0.0 112.165 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.2 92.72 0.95 Allowed Glycine 0 CA--C 1.492 -1.389 0 CA-C-O 116.616 -2.213 . . . . 0.0 110.026 167.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -63.7 -28.46 68.82 Favored 'Trans proline' 0 C--N 1.329 -0.484 1 CA-C-N 125.269 4.535 . . . . 0.0 110.028 164.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm -60.03 -46.38 89.71 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.203 1.401 . . . . 0.0 112.828 164.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.5 mt -69.34 -42.69 74.97 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 121.485 -0.759 . . . . 0.0 112.825 176.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.07 -47.84 83.79 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 120.482 -1.387 . . . . 0.0 113.124 -174.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.1 tp -78.8 -47.67 16.27 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 169.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.83 -41.61 90.49 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 C-N-CA 126.148 1.779 . . . . 0.0 111.904 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.1 t -152.4 148.79 27.88 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-O 124.012 1.863 . . . . 0.0 112.782 173.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.44 59.46 3.49 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 118.842 -2.411 . . . . 0.0 114.664 -167.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.81 3.92 54.71 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 120.023 -1.673 . . . . 0.0 110.472 174.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 1.5 t80 . . . . . 0 N--CA 1.442 -0.847 0 CA-C-O 121.67 0.747 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -110.89 159.05 33.95 Favored Pre-proline 0 N--CA 1.44 -0.966 0 N-CA-C 104.512 -2.403 . . . . 0.0 104.512 168.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -83.61 -158.28 0.09 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.45 0 C-N-CA 121.324 1.349 . . . . 0.0 108.956 163.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.5 pt -49.55 -27.49 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.0 mt -52.64 -40.04 62.39 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -174.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.81 -44.42 96.89 Favored 'General case' 0 C--N 1.35 0.596 0 CA-C-O 122.621 1.201 . . . . 0.0 112.772 172.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.7 m -67.42 -33.9 76.12 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 120.49 -1.381 . . . . 0.0 113.948 173.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.4 mt -65.01 -40.77 95.38 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 119.968 -1.708 . . . . 0.0 113.462 172.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.03 -45.71 90.04 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.461 0.648 . . . . 0.0 111.103 171.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.51 -45.71 93.04 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 172.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.29 -47.72 26.58 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 118.312 -2.742 . . . . 0.0 114.86 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -97.03 -8.98 29.05 Favored 'General case' 0 CA--C 1.498 -1.052 0 O-C-N 120.28 -1.513 . . . . 0.0 111.491 -169.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.31 92.69 0.94 Allowed Glycine 0 N--CA 1.435 -1.415 0 CA-C-O 117.5 -1.722 . . . . 0.0 109.449 158.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.69 -28.78 69.01 Favored 'Trans proline' 0 C--N 1.329 -0.497 0 CA-C-N 123.876 3.838 . . . . 0.0 109.493 160.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -61.37 -48.27 82.02 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 123.471 0.708 . . . . 0.0 112.641 164.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.1 mt -69.65 -41.4 75.62 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -37.34 86.81 Favored 'General case' 0 C--N 1.35 0.596 0 CA-C-N 121.087 1.767 . . . . 0.0 113.424 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.1 tp -69.46 -46.32 66.97 Favored 'General case' 0 C--N 1.349 0.545 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 175.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.0 m -97.96 0.37 10.48 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 O-C-N 120.064 -1.647 . . . . 0.0 112.04 -170.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 68.0 m -155.64 153.54 30.21 Favored 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 119.209 -2.182 . . . . 0.0 107.885 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -74.89 68.12 1.73 Allowed 'General case' 0 C--N 1.349 0.559 0 O-C-N 117.789 -3.069 . . . . 0.0 114.251 170.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -117.0 15.42 15.11 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 125.085 1.354 . . . . 0.0 108.371 170.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 8.2 t80 . . . . . 0 N--CA 1.432 -1.361 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.2 tp -164.6 137.23 3.75 Favored Pre-proline 0 C--N 1.352 0.678 0 O-C-N 120.763 -1.211 . . . . 0.0 110.174 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -68.57 -38.07 11.61 Favored 'Trans proline' 0 C--N 1.333 -0.278 0 CA-C-N 123.371 2.24 . . . . 0.0 112.174 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.313 20.7 pt -54.55 -17.32 2.02 Favored 'Isoleucine or valine' 0 C--N 1.349 0.579 0 N-CA-C 116.548 2.055 . . . . 0.0 116.548 172.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 53.6 mt -51.42 -33.62 31.25 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 120.24 -1.538 . . . . 0.0 114.731 174.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.13 -39.67 79.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.759 0.79 . . . . 0.0 111.856 173.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.5 m -64.91 -35.97 82.86 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 120.522 -1.361 . . . . 0.0 114.343 171.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.0 mt -62.9 -45.48 92.31 Favored 'General case' 0 C--N 1.348 0.521 0 O-C-N 120.269 -1.519 . . . . 0.0 112.875 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.63 -21.67 59.33 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 120.968 -1.083 . . . . 0.0 113.804 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.89 -31.08 23.9 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 119.51 -1.994 . . . . 0.0 113.739 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -97.83 -31.52 12.18 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 120.272 -1.517 . . . . 0.0 111.352 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -110.11 9.17 24.09 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 120.457 -1.402 . . . . 0.0 110.879 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -141.7 46.47 0.89 Allowed Glycine 0 C--N 1.348 1.22 0 CA-C-O 117.827 -1.54 . . . . 0.0 116.062 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -62.33 -22.54 74.25 Favored 'Trans proline' 0 CA--C 1.515 -0.433 0 CA-C-N 122.921 3.361 . . . . 0.0 113.199 -172.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.4 -47.54 85.33 Favored 'General case' 0 C--N 1.353 0.757 0 CA-C-N 118.653 0.661 . . . . 0.0 111.996 176.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.08 -41.44 99.43 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 121.091 -1.006 . . . . 0.0 111.16 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.41 -44.02 97.86 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 175.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.9 mp -82.88 -46.94 12.39 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 119.717 -1.864 . . . . 0.0 111.866 172.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.6 t -60.88 -48.92 86.78 Favored 'Isoleucine or valine' 0 C--N 1.361 1.082 0 C-N-CA 124.241 1.016 . . . . 0.0 111.66 -175.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 p -95.39 6.14 49.78 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 120.914 -1.116 . . . . 0.0 111.94 177.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 51.65 53.53 12.56 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 125.82 1.648 . . . . 0.0 112.56 177.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -118.33 -152.81 0.51 Allowed 'General case' 0 C--N 1.346 0.438 0 O-C-N 120.665 -1.272 . . . . 0.0 108.741 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ABA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_